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Abstract
Hepatitis E is an acute hepatitis in humans, first recognised in 1980 and caused by 
hepatitis E virus (HEV). The principal mode of spread of HEV is faecal-oral from 
contaminated water supplies, almost exclusively in developing regions. 
Accumulating evidence indicates that HEV transmission may be zoonotic in 
developed regions from swine and perhaps other animal species serving as 
reservoirs for the virus. The exact transmission routes are unclear, largely because 
HEV is extremely difficult to propagate in vitro, but retail pig products have been 
shown to contain HEV RNA.
This PhD project was part of the EU FP7 project VITAL (Integrated Monitoring 
and Control of Food borne Viruses in European Food Supply Chains). The main 
aim of this PhD project was to investigate the presence and residual infectivity of 
HEV in the pork food chain. This helped to assess the potential importance of the 
pig and its products in zoonotic transmission of HEV. A cell culture system for 
HEV was further optimised for HEV detection in food samples.
A productive HEV infection was established in 3D cell culture (Alexander 
hepatoma PLC/PRF/5) that was permissive for HEV replication. Furthermore, a 
trial to compare the efficiency of 3D, 2D and 3D transferred to 2D cells culture 
systems was performed indicating that replication in the 3D cell culture system was 
the most efficient. In addition, these studies showed that cells grown in 3D and then 
transferred to 2D for infection were able to support HEV replication. Further 
refinements such as heat, UV light and sodium hypochlorite inactivation studies 
were performed. These approaches should enable an assessment of the significance
of the pork food chain in transmission of HEV and facilitate the development of 
control measures.
Within the VITAL project standard methods were developed to have common viral 
detection and extraction methods between all laboratories, and ring trials were 
organized between 15 EU laboratories to assess the efficacy of the Standard 
Operating Procedures (SOPs) developed. Since all the laboratories involved were 
able to detect the viruses with the common SOPs the ring trial was considered 
successful and the second step of the project began, involving the screening by real 
time RT-PCR for HEV throughout the pork food chain. One of 40 pig livers and 6 
of 63 pork sausages were found to be HEV positive. Virus viability was tested using 
the 3D cell culture system but no evidence of viral replication was detected. A 
mathematical model suggested that the circulation of HEV in six European 
countries is endemic. In addition, HEV prevalence in pig’s faeces was investigated 
showing that pigs close to the slaughter age can still be HEV positive.
In conclusion, the work carried out in this PhD projected contributed to our 
understanding of HEV replication in-vitro and provided useful information on the 
prevalence of HEV in the pork food chain in the UK. In addition, progress was 
made with possible inactivation methods and control strategies.
CHAPTER 1 
General Introduction
1 Food-borne viruses
Foodborne viruses are a common and, probably, the most under-recognised cause of 
outbreaks for example of gastroenteritis. Human infection can occur following 
consumption of contaminated food, person-to-person body contact, or release of 
aerosols. Food may be contaminated by infected food handlers or by contact with 
water contaminated by treated or untreated sewage. Outbreaks of viral foodborne 
illness have been associated with the consumption of shellfish that have been 
harvested from sewage-polluted waters, for example. The greatest risk of foodborne 
illness occurs with catering operations preparing ready to eat foods, although 
foodborne spread is difficult to prove. The most common food borne vim ses are 
Norovims and hepatitis A vims. Vimses require a host in order to multiply, and the 
original source of all foodborne vimses is the human intestine. Usually, they cannot 
grow in food. Contamination of food may occur either during preparation and 
serving by infected food handlers or by contact with sewage or sewage-polluted 
water.
Pathogenic vimses originate from two sources to contaminate the food chain: 
humans and animals. To facilitate identification of whether contamination is of 
human or zoonotic origin, monitoring the presence of human and animal vimses at 
various points in the food supply chains is still necessary. Adenovimses infect both 
humans and a wide variety of animal species, are shed in large numbers in the faeces 
of infected individuals [4], and are capable of robust survival [5]. They have been 
proposed as an index of viral contamination, and the specific detection of 
adenovimses from human or animal origin should be a useful tool for tracing the 
source of faecal viral contamination. Hundesa et al. (2006) stated that due to higher
prevalence in fecal and environmental samples of bovine adenoviruses, bovine 
polyomaviruses are the best candidates for tracing a bovine source of viral 
contamination [6]. As well as the index viruses, the presence of HEV in pork 
production is necessary to be examined since that HEV is regarded as a model 
zoonotic virus.
1.1 Hepatitis E virus aetiology
HEV is a hepatotropic virus and the causative agent of hepatitis E, an acute viral 
hepatitis in humans. The infection may vary in severity from inapparent infection to 
fulminant liver failure and death. Although considered an acute disease, chronic 
infections have been observed in liver and kidney transplant and chronic liver 
disease (CLD) patients. The mortality rate is between 1% and 4% [7], (higher than 
hepatitis A virus -  HAV, a Picomavirus) and in people with CLD and in pregnant 
women it can reach 25-30%.
Hepatitis E is an important public health concern and a major contributor to 
enterically transmitted hepatitis worldwide {Figure 1.1) [8]. Based on
seroprevalence data, an estimated one third of the world’s population has been 
infected with HEV [7].
In endemic regions, hepatitis E occurs in epidemic forms meanwhile in developed 
regions HEV occurs sporadically {Figure 1.1).
Hepatitis E is the second most important cause of acute clinical hepatitis in adults 
throughout Asia, Africa and the Middle East where the infection is endemic. In 
these countries, the infection mainly spreads through the contamination of water 
supplies occasionally leading to large-scale outbreaks or epidemics. Hepatitis E is
rare in industrialized countries, where infection is historically mostly related to 
travelling to endemic areas. However, more recently, significant numbers of 
autochthonous cases have been documented in many developed countries [9].
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1.1.1 Hepatitis E in non-endemic regions
In developed regions, the transmission of HEV is most likely mainly via a zoonotic 
route. Evidence of this is given by the many autochthonous (indigenously acquired) 
eases worldwide where swine isolates show a very high RNA sequence homology 
to human HEV isolates [10]. Additional evidence is the experimental transmission 
of human isolates to pigs and of swine HEV to primates [10]. Hepatitis E 
autochthonous transmission has been recorded in most developed countries and 
regions including USA, Europe (including UK, France, the Netherlands, Austria, 
Spain, Greece and Italy), and developed countries of Asia-Pacific (Japan, Taiwan, 
Hong Kong, Australia) [11].
In the UK, the disease appears to be more common among residents of coastal and 
estuarine areas [11]. Zoonotic transmission has been proposed [11] and is now 
widely accepted; in some developed regions transmission appears to be seasonal 
with peaks in spring and summer [11].
Patients with unexplained hepatitis are tested by serological tests and these are the 
cases where the disease is most often recognized. Generally, the symptoms are 
similar to those in endemic regions. In developed areas, the majority of the cases 
have been in middle aged or elderly men, where often another disease already 
coexisted [12] {Table 1.2).
1.1.2 Hepatitis E in disease-endemic regions
Although the majority of hepatitis E eases in resource limited countries are 
sporadic, local epidemic outbreaks occur frequently. They are usually separated by 
a few years and they can affect several thousand individuals [13, 14]. Usually the
8
majority of the outbreaks are due to consumption of drinking water contaminated by 
human faeces and the longevity varies from a few weeks to over a year [14]. The 
outbreaks frequently follow heavy rainfall and floods [15], conflict leading to 
concentrations of displaced persons in refugee camps [15], or are associated with 
disposal of human excreta into rivers [15]. Food-borne transmissions have been 
described in resource-limited areas, but due to a relatively long incubation period 
(up to 9 weeks), establishing a correlation between consumption of pork food and 
occurrence of disease is difficult.
In India HEV is hyper-endemie, the majority of the cases reported are sporadic and 
40% of sewage specimens obtained throughout all seasons are HEV positive [2, 16- 
19]. Interfamilial spread is not common but multiple cases in one family have been 
reported [2, 16-19]. It is suggested that this is due to shared infected water rather 
than person-to-person transmission as the time interval between cases is too short.
Studies in endemic regions show high seroprevalence rates ranging from 15% to 
60% [16, 20-24]. Notably, the age-specifie seroprevalence profiles for HEV are 
found to differ from those reported for antibody to HAV even though, in endemic 
countries, the transmission routes for these two viruses are similar [16]. HAV 
seroprevalence rates reach more than 95% in children by the age of 10 years 
whereas HEV infection is rarely detected in children [16].
The peak incidence in sporadic cases of hepatitis E in endemic regions occurs in 
15-35-year-olds [2, 16-19]. Additionally, HEV infections are predominantly 
reported in men with a male-to-female ratio ranging from 1/1 to 3/1 [25]. This sex 
bias is, however, not seen in children presenting with hepatitis E [26]. The reason 
why men more commonly develop hepatitis E infection is not understood but males
outnumbering females may be due to a greater risk of exposure to HEV infection
[26]. Morbidity rates during hepatitis E epidemics have ranged from 1% to 15%
[27]. Higher mortality rates and fulminant liver disease have been described among 
pregnant women during hepatitis E outbreaks [27]. Furthermore, HEV infection 
during pregnancy is not only associated with severe disease or higher mortality, but 
also with an increased risk of prenatal mortality and low birth weight. In developing 
regions neonatal vertical transmission rates have been estimated at 78.9% [28] but it 
is yet unclear whether the high morbidity and mortality rates during pregnancy are 
also seen in developed regions {Table 1.2). The exact cause for this predilection to 
severe disease in pregnant women still needs to be better studied, including the 
suspicion that it is due to hormonal or immunological factors [29].
1.2 Morphology and Genomic organization
HEV was designated in 2004 as the sole member of the genus Hepevirus in the 
family Hepeviridae [30]. The HEV genome was first cloned from cDNA libraries 
prepared from the bile of macaques experimentally inoculated with stool 
suspensions from human patients [31]. A similar PCR was later used to clone the 
genomes of multiple geographically distinct isolates of HEV [32-34].
HEV is a small, non-enveloped, single-stranded, positive-sense RNA virus. The 
genome size is approximately 7.2 Kb [35, 36] {Figure 1.3). The genome of HEV is 
capped at the 5' end and polyadenylated at the 3' end (Figure 1.3.A). It contains 
short stretches of untranslated regions (UTR) at both ends {Figure 1.3.B, red box). 
The HEV genome has three open reading frames (ORFs), shown in Figure 1.3B. 
ORFl encodes the non structural polyprotein (nsp) that contains various functional 
units: methyltransferase (MeT), papain-like cysteine protease (PCP), RNA helicase
1 0
(Hel) and RNA dependent RNA polymerase (RdRp) [3]. 0RF2 encodes the viral 
capsid protein, the N-terminal signal sequence and glycosylation loci. ORF3 
encodes a small regulatory phosphoprotein. Details of the 0RF3 protein are shown 
in Figure 1.3. The roles of the 0RF3 protein in HEV pathogenesis are promotion of 
cell survival, modulation of the acute phase response and immunosuppression [3].
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Featm^ Eitdeinic regions NcMii-eiuleimc regions
Geographical locations Underdeveloped countries mostly in 
Asia and A&ica
Developed countries in Europe 
North America, parts of Asia, 
Australia,
Epidemiological
patterns
Large epidemics, small outbreaks 
and ^oradic cases
Only sporadic cases with 
occasional small clusters
Water-borne
transmission
Well known ,most common route Unknown, but has been 
detected and may be 
contributory
Zoonotic transmission Not reported Yes
Animal reservoir No Yes
Vims genotype Almost entirely genotypes 1 and 2, a 
few cases of genotype 4 in China
Genotype 3; occasional cases of 
genotype 4 in Taiwan
Age group Young men most commonly 
affected
Usually dderly
Chronic infection Not known Reported in tran^lant 
recipients receiving 
immunosuppressive dmgs
Severity Variable severity, including 
fulminant hepatic 6ilure
Severity and p oor outcome is 
related to coexistent disease 
conditions
Relationship with 
pregnancy
Particularly high rates of 
symptomatic disease and of more 
severe disease in pregnant women 
than in men and non-pregpant 
women
No data on pregnant women, 
but eady evidence indicates 
1 ower mortality/morbidity in 
developed regions
Table 1.2 Differences in epidemiological and clinical features associated with 
hepatitis E in disease-endemic and non-endemic regions. The first column 
describes the HEV features, the second and third column describe the features in 
endemic and non endemic regions. Table adapted from Aggarwal et al, 2010 [1].
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1.3 Viral proteins
Open reading frame one (ORFl) is the largest (5079 nt) of the three ORFs and it 
begins after the 5’ noncoding region (5'-NCR) of 27 to 35 nucleotides (nt). It 
encodes a 1693 aminoacid polyprotein including viral non-structural proteins such 
as methyltransferase, a papain-like cysteine protease, a helicase and an RNA- 
dependent RNA Polymerase (RdRp) [37-41].
The region between the end of ORFl and start of ORF3/ORF2 appears to be 
complex and contains regulatory elements [35] {see sections 1.3.5 and 1.3.6).
1.3.1 Methyltransferase
The Methyltransferase domain has been suggested by computer-assisted 
assignments to encompass an amino terminal domain between 60 to 240 
aminoacids. Downstream of the methyltransferase domain there is a Y domain of 
200 aminoacids but at present no particular function is known. While the HEV 
methyltransferase showed guanine-7-methyltransferase and guanyltransferase 
activities [41, 42], the source of the RNA triphosphatase was not clear but it seems 
that the RNA triphosphatases specifically cleave 5’-phosphate of the nascent 
mRNAs, without attacking the P-phosphoryl group. The RNA triphosphatases from 
RNA viruses are helicases or helicase-like proteins where the active site of the RNA 
triphosphatase is shared or overlaps with the helicase/ NTPase catalytic site. This 
suggested that the HEV helicase has RNA 5’-triphosphatase (RTPase) activity.
A recent report [43], suggested that when a purified recombinant HEV helicase 
protein was incubated with either alpha-3 2p_ labelled RNA or gamma-3 2p_ 
labelled RNA, the HEV helicase had a gamma-phosphatase activity, which might 
catalyze the first step in RNA cap formation. Two reports have shown the presence
14
of a 5’m 7G cap on the HEV genomic RNA. The HEV genomic RNA transcribed in 
vitro from viral cDNA is infectious for primates only when it is capped [44]. A 5’ 
RNA ligase-mediated rapid amplification of cDNA ends (RACE) method designed 
to select capped RNAs amplified the 5’ ends of the SAR-55 (genotype 1) and MEX- 
14 (genotype 2) mRNA, confirming that the HEV genomic RNA is capped [44, 45].
1.3.2 Papain-like cysteine protease
A Papain-like protease domain follows the Y domain {Section 1.3.1) encompassing 
440-610 aminoacids, and has been identified in other viruses such as alphavirus, 
rubella virus and hepatitis C virus (HCV). It is postulated that this viral protease is 
involved in either co- or post-translational viral polyprotein processing to yield 
discrete non-structural protein products [42]. A conserved “X domain” of unknown 
function flanks the papain-like protease domain, preceded by a proline-rich region 
“P” that might constitute a flexible hinge between the X domain and the upstream 
domains [37].
1.3.3 Helicase
The Helicase domain is similar to the typical Helicase superfamily and shows the 
highest overall homology with the helicase of beet necrotic yellow vein virus 
(>10%). It promotes unwinding of DNA, RNA or DNA duplexes required for 
genome replication, recombination, repair and transcription [42].
1.3.4 RNA-dependent RNA polymerase (RdRp)
The RdRp domain, encompassing 1200-1700 aminoacids of the carboxy terminal 
region of ORFl, shows a conserved amino acid motif recognised in all positive 
strand RNA viruses as the canonical Glycine-Aspartate-Aspartate (GDD) motif. It
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has been observed that mutations in this motif (GDD to GAD) generate replication- 
deficient HEV viruses unable to replicate. The RdRp has a crucial role in binding to 
the 3’UTR (untranslated region) of HEV RNA and directing the synthesis of the 
complementary strand RNA [42]. Several linear B-cell epitopes have been 
identified in the ORFl protein, and appear to be particularly concentrated in the 
region of the RdRp [46].
1.3.5 ORF2 and the major capsid protein
Open reading frame 2 is about 1980 nt in length from nt 5147 to nt 7124, 
downstream of ORFl. Translation of this region produces the HEV structural 
polypeptide (pORF2) of 660/599 aminoacids [47] and this appears to be highly 
conserved. The 5’ end of 0RF2 region presents an average of approximately 350- 
450 nt most conserved among HEV isolates; recently it has been used for 
classifying different subgenotypes of HEV [48].
In animal cells, the major capsid protein is expressed in a -74 KDa form (pORF2) 
and a -88 KDa glycosylated form (gpORF2) that was immunoreactive with sera 
from chimpanzees infected with HEV [49]. pORF2 is synthesized as an 82 KDa 
precursor (ppORF2) that co-translationally translocates via the N-terminal signal 
sequence to the endoplasmic reticulum (ER) membrane. The putative signal 
peptides consist of three regions: an amino terminal region of 22 amino acids with 
positively charged residues (Arg), a central hydrophobic core with 14 residues and a 
third region containing a turn-inducing stretch of proline residues, followed by the 
signal peptidase cleavage site. Processing of ppORF2 is by cleavage in the 
endoplasmic reticulum into the mature polypeptide (pORF2), and then it is 
glycosylated (gpORF2) at N-linked glycosylation sites “Asn-X-Ser/Thr” (N-X-S-T)
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at residues 137, 310 (these appear to be the major sites of N-Glycan addition) and 
561, attached as a core unit of oligosaccharides (Glc3Man9Glc-NAc2), while the 
polypeptide chains are translocated across the ER membrane [50]. This process 
occurs usually for the synthesis of envelope proteins. The glycosylation sites are 
conserved in the 0RF2 sequences of all HEV isolates sequenced [32, 35, 51, 52]. 
Mutations in the pORF2 glycosylation sites prevented the formation of infectious 
virus particles and resulted in low infectivity in macaques [53]. The 88 KDa 
gpORF2 obtained is transported to the cell surface by a bulk flow mechanism in the 
absence of any signal of retention in the endoplasmic reticulum. Final assembly 
occurs at the cytoplasmic membrane with encapsidation of HEV positive-stranded 
genomic RNA.
Expression of gpORF2 in mammalian cells (COS-1 and HepG2) showed that it is 
expressed intracellularly, as well as on the cell surface, and has the potential to form 
non-covalent homodimers [42, 49, 50, 54]. Recently, it has been suggested that 
gpORF2 is an unstable form of the protein [55]. Although pORF2 is proposed to 
take part in capsid assembly, the role of gpORF2 is not clear, being possibly 
involved in apoptotic signalling [49].
ORF-2 has been expressed in vitro and characterized by heterologous expression 
systems including Escherichia coli [56], mammalian cells using plasmids [49], 
alphavirus vectors [55, 57], baculovirus expression systems [58], recombinant 
vaccinia virus [59] and yeast [60]. The full length 0RF2 product expressed in insect 
cells is insoluble, whereas the truncated products, mapping to aminoacids 112-660, 
assemble into virus-like particles (VLP), indicating that cleavage and assembly of 
the capsid protein occurs in the system [61-64]. The size of empty VLPs (23.7nm) is
17
smaller than the authentic native HEV virions (27nm) and similar virus particles 
have not been found in the bile or stools from patients infected with hepatitis E or 
from experimentally infected monkeys. Expressed VLPs were used as antigen for 
enzyme-linked immunosorbent assay (ELISA) against antibodies to HEV, 
appearing to be specific and sensitive enough to detect anti-HEV IgG as well as 
IgM in human and experimentally infected monkey sera [65, 66]. Immunodominant 
epitopes in ORF2 and 0RF3 have been included in commercially available 
diagnostic ELIS As for HEV [67]. The 0RF2 epitopes are located at the extreme 3’ 
end of that reading frame [67]. The antibody response to pORF2 shows that it is 
highly immunogenic and protective [7]. Currently, a single serotype has been 
described, with extensive cross-reactivity among circulating human and swine and 
chicken strains [47, 68].
To support the hypothesis that ORF2 is essential for the generation of infectious 
virions, Parvez et al (2011) [69] constructed a recombinant baculovirus 
(vBacORF2) that expressed the full-length 0RF2 capsid protein of a genotype (gt) 1 
strain of HEV. Results showed that the baculovirus-expressed ORF2 protein was 
able to transencapsidate the viral replicon and form a particle that could infect naïve 
HepG2/C3A cells. Parvez et al (2011) [69] confirmed the results obtained by Xing 
et al [70] that HEV virus-like particles formed in insect cells captured some of the 
template 0RF2 RNA used to produce the particles. In conclusion it is strongly 
considered that the 0RF2 protein transcomplements a replicon that is deficient in 
capsid protein production and efficiently encapsidates the replicon viral RNA to 
form stable HEV particles which are infectious for naïve hepatoma cells [69]. This
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ex vivo RNA packaging-system could be further used to study many aspects of HEV 
molecular biology [69].
1.3.6 ORF3 and its product
Open reading frame 3 (ORF3) partially overlaps with ORFl by 4 nt and shares most 
of the remaining nucleotides of 0RF2 at the 5’ end [42]. 0RF3 encodes for a 
123/122 amino acid immunogenic phosphoprotein of 13.5 KDa (pORF3) with yet, a 
not fully defined function [35].
Recent studies using a HEV replicon with a deleted ORF3 in cell culture showed 
normal RNA replication, suggesting that 0RF3 is not required for HEV replication, 
virion assembly or infection of culture cells [71].
Yamada et al provided evidence that pORF3 is required for virion egress from 
infected cells [72]. In addition, pORF3 is present on the surface of HEV particles 
suggesting that the HEV particles released from infected cells are lipid-associated. 
In its primary sequence, pORF3 contains two large hydrophobic domains in its N- 
terminus that are rich in polycysteine [72]. Domain 1 may serve as a cytoskeleton 
anchor at which pORF2 can assemble the viral nucleocapsid, although it was 
reported that recombinant 0RF2 protein assembled into small but typical 
icosahedrons in the total absence of ORF3 [73, 74] and also bound mitogen- 
activated protein kinase phosphatase (MAPKP) [75]. Another smaller hydrophobic 
domain (Domain 2) follows in the primary sequence, which has been shown to 
homo-dimerize in a yeast cellular environment, and in human hepatoma cells it was 
demonstrated to interact with another host protein endogenous hemopexin (Hpx), an 
acute-phase plasma glycoprotein that plays important roles in inflammation. The
19
pORF3-Hpx interactions may have significant importance in viral pathogenesis 
(Figure 1.4) [76].
Chandra et al [77] described studies that suggested that the 0RF3 blocks phospho- 
STAT3 nuclear transport (Figure 1.4). A  block in receptor mediated endocytosis 
inhibits the nuclear transport of STAT3 [77]. It is known that STAT3 is involved in 
the acute response and activation of acute phase proteins and it regulates the 
transcription of a number of acute phase genes such as interleukin-6 (IL-6) [77]. 
The acute phase proteins (APPs) are expressed mainly by the liver and have a wide 
range of activities that contribute to host defence. The main role of APPs is 
neutralizing inflammatory agents and minimizing the extent of local tissue damage, 
as well as participate in tissue repair and regeneration [77]. In conclusion, Chandra 
at al. suggested that ORF3 could attenuate inflammatory responses and create an 
environment for increased viral replication and survival mainly in the liver [77].
20
Receptor Tyrosine Kinase
Endocytosis
PSTAT3
(A)
Promotion of 
cell survival m dm
I.KlWWlI
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Ill-micro
globulin
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Modulation of 
acute phase response
ïicreasediil-microglobuBn secretion 
(Cl knm unosuppreg ion
Figure 1.4 Role of the ORF3 protein in HEV pathogenesis. (A) Promotion o f 
cell survival. The ORF3 protein activates MAP kinase by binding and inactivating 
its cognate phosphatase (MKP). Additionally, it upregulates and promotes homo­
oligomerization of the outer mitochondrial membrane porin, VDAC, and increases 
hexokinase levels, thus reducing mitochondrial depolarization and inhibiting 
intrinsic cell death. (B) Modulation o f the acute phase response. The ORF3 protein 
localizes to early and recycling endosomes, and inhibits the movement of activated 
growth factor receptors to late endosomes. This prolongs endomembrane growth 
factor signaling and contributes to cell survival. Through this mechanism, pORF3 
also reduces the nuclear transport of pSTAT3, a critical transcription factor for the 
expression of acute phase response genes. (C) Immunosuppression. The ORF3 
protein promotes the secretion of a  1-microglobulin, an immunosuppressive protein 
that could act in the immediate vicinity of the infected cell. Figure taken form 
Chandra et al 2008 [3].
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1.4 The HEV replication cycle
1.4.1 Viral receptor and entry: The cell surface molecules that bind HEV or its 
capsid proteins are not known yet. He et al (2008) described that a truncated peptide 
of 0RF2 is involved in binding and entry of the following cell lines: HepG2, Huh-7, 
PLC/PRF5 and A549 cells [78].
1.4.2 Model of HEV replication: The process by which HEV RNA enters the 
target cells is still unknown (Figure 1.5:1-2). In the cytoplasm the genomic RNA is 
translated into non-structural proteins (Figure 1.5: 3). The genome amplification 
step involves replication of positive strand genomic RNA into negative strand RNA 
intermediates (Figure 1.5: 4A). These are used as template for the synthesis of the 
genomic positive strands (Figure 1.5: 4B). This is akin to alphaviruses and a region 
homologous to alphavirus junction sequences is proposed to serve as the 
subgenomic promoter. The subgenomic RNA can then be translated into the 
structural protein(s) (Figure 1.5: 5). Based on in vitro expression and replicon 
studies, some details have now begun to emerge. The genomic RNA is packaged 
with the capsid protein to assemble new virions (Figure 1.5: 6). The mechanism by 
which the virion is released from the cell has yet to be characterized [3].
It is unclear whether gut cells are infected following ingestion of the virus. It is 
believed that the primary site of HEV replication is the liver, with hepatocytes being 
the most likely cell type [79]. Results support infection and replication in non- 
hepatic cell types such as A549 lung carcinoma cells and in Caco-2 colon 
carcinoma cells. Although it is not efficient, viral replication has been demonstrated. 
In pigs experimentally infected with swine HEV, positive-sense viral RNA was 
detected in almost all tissues at some point during the infection, but negative-sense
22
RNA intermediates were detected primarily in the small intestine, lymph node, 
colon and liver [79]. In a recent report, HEV RNA was detected in peripheral blood 
mononuclear cells, but due to the lack of an efficient HEV in vitro cell culture 
verifying the evidence of viral replication in this compartment in patients with HEV 
infection was not possible [80].
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1.5 Potential targets for the development of antiviral drugs
Various steps in the HEV life cycle can be potential targets for the development of 
antiviral drugs. The methyltransferase and guanyltransferase activities in the ORFl 
protein {Section 1.3) are strictly virus-specific and thus good targets for antiviral 
development [41]. The RNA helicase of HEV has been biochemically characterized 
and it is essential for replication of the viral RNA genome [43], but it is not clear 
how distinct it is from human helicases to be a potential drug target. The HEV 
RdRp expressed in E. coli was shown to bind the 3’ end of the viral RNA genome
[81], but its biochemical activity has so far not been characterized. Since the RdRp 
is unique to RNA viruses, it would again be a good drug target, and perhaps some 
viral inhibitors can be explored against this target, for example the RdRp is used as 
inhibitor of viral replication for HCV infections. Interference with HEV RNA 
replication has been attempted using ribozymes and small interfering RNAs. Mono- 
and di- hammerhead ribozymes designed against the 3‘ end of the HEV genomic 
RNA were shown to inhibit expression from a reporter construct in HepG2 cells
[82]. In A549 cells infected with HEV, small interfering RNAs (siRNAs) against 
the ORF2 region were also shown to offer protection [83]. While such approaches 
are feasible in vitro, the delivery and targeting of such inhibitors in vivo would be 
the real challenge. At least one study in immunocompromised transplant patients 
with chronic HEV infection has also shown the efficacy of Ribavirin monotherapy 
[84]. Again, the utility of this approach among the vast majority of HEV infections 
that are acute remains questionable.
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1.6 HEV inactivation studies
HEV has proven difficult to propagate in vitro [85], and despite some recent 
improvements, there is no doubt that the failure to develop a repeatable and efficient 
in-vitro propagation system for HEV has hindered attempts to understand the 
environmental survival and other physical and pathobiological characteristics of 
HEV. The determination of these qualities would potentially offer much valuable 
information in understanding the epidemiology and control of HEV infections.
Feagins et al in 2008 [85] performed a HEV heat inactivation study in a pig animal 
model. The objective of the study was to determine if traditional cooking methods 
are effective in inactivating infectious HEV present in contaminated commercial pig 
livers. The result obtained was that four of the five pigs inoculated with a pool of 
two HEV-positive liver homogenates incubated at 56°C [86] for 1 h developed an 
active HEV infection shedding virus in the faeces. The pigs inoculated with a 
pooled homogenate of two HEV-positive livers stir-fried at 191°C [86] for 5 
minutes and the group of pigs inoculated with a pooled homogenate of two HEV- 
positive livers boiled in water for 5 minutes showed no evidence of infection as 
there was no seroconversion, viraemia, or faecal virus shedding in any of the 
inoculated pigs [87].
What is not clear is how effective the usual processing procedures for uncooked pig 
products are in inactivating pathogens such as HEV. Moreover, the risk of HEV 
infection via the consumption of HEV-contaminated pig tissues raises public health 
concerns since it is not clear what cooking conditions will be effective in 
inactivating the virus present in the contaminated pig tissues.
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HEV can be found in the liver, blood, intestinal tract and skeletal muscle, all of 
which are consumed in one form or another and often together, such as in sausages. 
How safe are these products? The question is difficult to answer because HEV 
grows poorly in cell culture, and testing HEV viability in vivo requires nonstandard 
laboratory animals.
Other inactivation studies with HEV have not been performed thus far. Inactivation 
studies with UV light were performed with other viruses such as HAV, calicivirus 
or other enteric viruses, or with bacteria [88, 89]. Exposure to solar ultraviolet (UV) 
radiation is a primary means of virus inactivation in the environment, and 
germicidal (UVC) light is used to inactivate viruses in hospitals and other critical 
public and military environments [90, 91]. Safety and security constraints have 
hindered exposing highly virulent viruses to UV and gathering the data needed to 
assess the risk of environments contaminated with high-consequence viruses [92]. 
UV sensitivity for some viruses has been extrapolated from data obtained with UVC 
(254 nm) radiation by using a model based on the type, size and strandedness of the 
nucleic acid genomes of the different virus families [93, 94]. Therefore, there was 
little information to allow accurate modelling, confident extrapolation, and 
prediction of the UV sensitivity of viruses deposited on contaminated surfaces, 
conditions more likely to be relevant to public health or biodefence. One of the 
goals of this study was to determine the inactivation kinetics produced by exposure 
to UV light (UV, 254 nm radiation) of HEV since that is relevant to public health 
(Section 5.2).
Other inactivation studies with disinfectants such as chlorine were not performed 
until now with HEV. Sodium hypochlorite, a derivate of chlorine solution.
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commonly known as bleach, is frequently used as a disinfectant or a bleaching 
agent. US Government regulations (21 CFR Part 178) allow food processing 
equipment and food contact surfaces to be sanitized with solutions containing 
bleach, provided that the solutions do not exceed 200 parts per million (ppm) 
available chlorine. A l-in-5 dilution of household bleach with water is effective 
against many bacteria and viruses {Section 5.2).
1.7 Taxonomy: Evolutionary History and Population Dynamics of Hepatitis E 
Virus
HEV segregates as four genotypes and the characterization is based on the genomic 
sequence analysis of human and animal isolates [95, 96]. A genetically distinct 
group has also been identified in avian samples, sharing 50% homology with 
mammalian isolates [94].
Genotypes 1 and 2 appear to be anthroponotic whereas gts 3 and 4 are zoonotic 
[97]. All four genotypes belong to a single serotype [30]. The recent discovery of 
novel lineages of HEV in rabbits [98, 99], rats [100], and wild boar [101] has 
expanded further the mammalian HEV diversity. It has been suggested that the 
HEV sequences found in rabbits represent a novel genotype [102, 103]. However, 
additional phylogenetic analysis indicated that rabbit HEV is closest to gt 3 [100, 
104] and may have zoonotic potential. In addition, the discovery of a genetically 
distinct avian HEV [105] indicates a very long evolutionary history for the HEV 
group of viruses. Contrary to swine HEV (asymptomatic in pigs), avian HEV shows 
hepatomegaly in poultry.
The first animal strain of HEV was detected in swine (swine HEV) in 1997 in the 
USA [52]. Since then, swine HEV strains have been isolated from all over the world
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and from several animal species (e.g. wild boar, mongoose and sika deer). In 
developed regions the human and swine strains show a sympatric distribution [106].
Purdy et al [107] suggested that HEV can be segregated into two clades. One clade 
is the enterically transmitted, epidemic form represented by gts 1 and 2, and the 
other clade is the zoonotically transmitted, sporadic form exemplified by gts 3 and 4 
[9, 97, 108].
Genotypes 1 and 2 have been identified only in humans, gts 3 and 4 have been 
identified both in humans and in animals [42, 47, 52, 109]. Gt 1 HEV has been 
identified from human cases in Asia and Africa [48] whilst gt 2 was firstly 
identified in Mexico and subsequently in Africa. Gt 3 has been identified in humans 
and animals in several developed countries, such as Europe, Japan, Australia and 
New Zealand. Gt 4 has been identified in both animals and humans in China, 
Taiwan, Japan and Vietnam and most recently in The Netherlands [110]. HEV 
strains of gts 1 and 2 have less genomic variability than those of gt 3 and 4 [47]. 
This could be due to the differences in the transmission patterns between the 
genotypes. In addition, the presence of an animal reservoir for gts 3 and 4 could 
have caused an independent evolution of the virus in specific animal species [47].
That HEV has an animal origin [111] suggests that some ancestral HEV variants 
could have subsequently developed the capacity to efficiently transmit to and 
between humans. To prevent emergence of novel human diseases a better 
understanding of epidemiological and evolutionary processes facilitating this 
transition from enzootic to human-to-human transmission is necessary. The clear 
division between HEV genotypes into two modes of transmission offers an 
important opportunity for studying molecular evolutionary processes related to the
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transition from one mode to another. Prudy et al [107] studied the evolutionary 
history of HEV using several models estimating population dynamics, in terms of 
time to the most recent common ancestor (TMRCA), and variation in selective 
pressures acting on different HEV genotypes. Purdy et al [107] did not analyse 
HEV gt 2 due to lack of available samples. ORF2 analysis suggests that the mean 
time of emergence of the ancestor for modern HEV genotypes ranged from 536 to 
1344 years ago. For gt 3, from 265 to 342 years ago; for gt 4, from 131 to 266 years 
ago; and for gt 1, from 87 to 199 years ago. Thus, the anthroponotic gt 1 is the most 
recent compared to the enzootic gts 3 and 4 [107].
Following Drummond et al [l\2 \, Purdy et al [107] decided to set up a model using 
0RF2 sequences for gts 1, 3 and 4 to understand the genotype dynamics and to 
study the demographic history of HEV genotypes. Gt 1 went through an increase in 
population size between 25-35 years ago. Gt 3 population was stable since 1760, 
but it had a dramatic shift in its size over the 20th century. The effective population 
size of gt 4 remained constant until 20 years ago when it rapidly decreased over 10 
years to the original level. [107].
Purdy et al [107] suggested that HEV has histories dating back tens of thousands to 
millions of years but early members have been replaced by the modern variants 
[107]. A more ancient TMRCA is suggested due to contacts between humans and 
domesticated swine about 11.000 years ago [38] immediately after urbanization 
started [39]. HEV gt 1 increased in the last 35 years. Gts 3 and 4 showed decreases 
around 1990 [107] and this may be due to greater awareness of the HEV health 
problem around the world and improved diagnostics rather than an actual expansion 
of the HEV [107]. During the Second World War the increase of HEV cases was
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probably related to the increasing population size rather than meat consumption 
[111]. The country-specific HEV evolutionary history observed probably reflects 
temporal variations in rates of transmission and/or exposure for HEV strains of the 
same genotype circulating in different geographic regions [107].
1.8 Genotype classification
Extensive genomic diversity has been observed among HEV isolates, but a single 
serotype is recognised [47, 113]. Genotype 1 was first identified and subjected to 
sequencing in 1991 [35] from a sample that came from Myanmar (Burma strain) 
showing more than 88% nucleotide identity with other gt 1 strains isolated in Asia 
(China, India, Nepal and Pakistan) and Africa (Chad and Morocco) [47].
In 1992, a new strain which was completely different from the Burma strain was 
sequenced from outbreaks in Mexico (1986) and classified as gt 2. Compared to gt 
1, which is present in many geographic regions, gt 2 occurs in fewer countries [48].
Genotype 3 was identified in 1997 in the USA from an autochthonous infection in a 
patient without history of travel abroad; it was sequenced and became the first strain 
belonging to gt 3 [114]. Later on, gt 3 HEV was shown to be distributed in many 
countries worldwide including Asia, Europe, Oceania, North and South America 
[106, 115-117].
Currently, the four genotypes are classified into different subtypes, based on 
approximately 300-450 nucleotides of sequence in the 5’ end of the ORF2 region 
which are most conserved among all HEV isolates. The phylogenetic analysis 
demonstrated that HEV can be divided into total 24 subtypes. Gt 1 was divided in 5 
subtypes (la, lb, Ic, Id, le), gt 2 in two subtypes (2a, 2b), gts 3 segregate in 10
31
subtypes (3a, 3b, 3c, 3d, 3e, 3f, 3g, 3h, 3i, 3j) and gt 4 in 7 subtypes (4a, 4b, 4c, 4d, 
4e, 4f and 4g) [48] (Figure 1.6) [118].
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1.9 Epidemiology of HEV
1.9.1 Epidemiology in humans
The epidemiology of HEV differs significantly in industrialized and non­
industrialized countries. In resource-limited countries, the infection is endemic and 
spreads mainly through contamination of water supplies.
Data from sero-surveys forced re-evaluation of the epidemiology of hepatitis E and 
gave an indirect indication to vocationally acquired HEV infections in industrialized 
countries [2].
In industrialized countries, Hepatitis E occurs sporadically and affects mainly 
visitors returning from endemic areas. Some of the cases in industrialized countries 
however, are non-travel-related and are considered as being autochthonous. 
Autochthonous cases have been reported in N and S America, many European 
countries and industrialized countries of the Asia-Pacific area, including Japan, 
Taiwan, Hong Kong and Australia.
Zoonotic spread of the virus was first suspected when genomic sequences of HEV 
isolates from two autochthonous cases in the USA were found to be closely related 
to swine HEV [114].
In 2001 [119] HEV swine strains were identified in The Netherlands, showing close 
genetic similarity to European human strains. In 2002 field isolates of swine HEV 
were identified from different geographic areas [120] demonstrating nucleotide 
identity between swine (88-100%) and human strains (89-98%). In 2004 in the 
United Kingdom two UK swine HEV strains were identified with 100% amino acid
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sequence identity over a partial sequence amplified by PCR, to one autochthonous 
human case of HEV in the UK (Figure 1.7) [121].
In Spain, 2006, de Deus et al [122] identified swine affected by HEV with 
nucleotide identity (85.7%-100%) between swine and human strains.
Recently, a hepatitis E outbreak on board in a UK cruise ship returning from an 80 
night world cruise was investigated. The UK Health Protection Agency (HPA) was 
informed of four cases of jaundice on board a cruise ship which departed from 
Southampton on 7 January and returned on 28 March 2008. An epidemiological 
investigation was launched by HP A to identify any additional cases of hepatitis E 
and potential risk factor for infection. The investigation was a cohort study to 
include all 2850 UK passengers who were on the cruise at any point. A total of 851 
of the 2850 eligible passengers took part in the investigation. Finally, 33 (4%) 
individuals were identified with recent acute HEV infection, although only 11 of 
these were symptomatic cases. A common source outbreak was shellfish eaten on 
board the cruise ship. The causative agent was identified as HEV gt 3 which was 
closely related to the other gt 3 strains isolated in Europe [113, 123, 124].
The route of transmission has not been determined in most of these cases, although 
zoonotic spread has been proposed [125]. To investigate the possible presence of 
animal reservoirs, several animal species have been tested for anti-HEV antibodies. 
HEV antibodies have been detected in different animal species, monkeys, pigs, 
rodents, chickens, dogs, cats, cattle and sheep, both in resource-limited and 
industrialized countries, suggesting that these animals could be infected by HEV 
[113, 123, 124].
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Figure 1.7 Phylogenetic tree. Human United Kingdom isolate (AY362357) is 
shown in bold and compared with closely related swine and human hepatitis E virus 
isolates. Bootstrap values greater than 70% are considered significant and are 
indicated. Figure taken from Banks et al, 2004, [121].
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Water-borne (effectively faecal-oral) and food-borne transmissions, as well as 
transfusion of infected blood products and vertical (maternal-foetal) transmission 
[1], are now established routes of HEV transmission.
Aggarwal et al have reported an example of materno-fetal transmission of HEV 
infection [126]. HEV-RNA or immunoglobulin (Ig) M anti-HEV antibodies have 
been detected in seven of eight babies born to mothers with acute hepatitis E in the 
third trimester of pregnancy [127].
Blood transfusion HEV infection has been described by Kriittgen et al in 2011 
[128]. The study reported the youngest ever case of a five-month-old Caucasian girl 
presenting with diarrhoea, emesis, and elevated ALT. Surprisingly, acute infection 
with Hepatitis E virus (HEV) gt 3 was laboratory-confirmed by reverse transcriptase 
polymerase chain reaction (RT-PCR) and sequencing [128]. In HEV endemic and 
non-endemic areas, the presence of HEV viremia among healthy blood donors and 
transmission of this infection to transfusion recipients has been documented [129].
Faecal-oral transmission of HEV occurs primarily through contaminated water in 
endemic-regions where it is responsible for both sporadic and epidemic outbreaks 
[130]. In epidemic form, the disease may involve tens of thousands of cases and is 
the cause of considerable morbidity and mortality, posing a major public health 
problem in endemic regions. In India alone, over 2.2 million cases of hepatitis E are 
thought to occur annually. Hepatitis E in resource-limited countries has different 
epidemiological and clinical features and investigation is patchy. Disruption of 
water supplies in conflict zones has been shown to have caused major outbreaks of 
hepatitis E amongst disrupted persons [131, 132]. During the conflict in Darfur, 
Sudan, over 6 months in 2004, 2621 hepatitis E cases were recorded (incidence
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3.3%), with a case-fatality rate of 1.7% (45 deaths, 19 of which involved were 
pregnant women). Interestingly in this outbreak, as well as age, a risk factor for 
infection was drinking chlorinated surface water (odds ratio, 2.49; 95% confidence 
interval, 1.22-5.08) [132] {Tablel.8 [132]).
Although, supported by phylogenetic data, it is assumed the disease was around for 
many years, hepatitis E was first recognised during an epidemic of hepatitis, which 
occurred in Kashmir Valley in 1978. The epidemic involved an estimated 52,000 
cases of icteric hepatitis with 1700 deaths (Figure 1.9) [1].
Based on these data, the possibility of another human hepatitis virus distinct from 
post-transfusion non-A, non-B hepatitis was postulated. Balayan et al (1983) [130] 
successfully transmitted the disease to himself by oral administration of pooled 
stool extracts of 9 patients from a non-A, non-B hepatitis outbreak which had 
occurred in a Soviet military camp located in Afghanistan. Over the years, hepatitis 
E was identified as a major health problem in resource-limited countries with unsafe 
water supplies and poor sanitary disposal.
38
Exposure
No. of individuals
Asymptomatic 
All HEV infection 
in = 104) in = 491
Risk of 
asymptomatic 
HEV infection, % RR (95% Cl)
Age group, years
>45 17 5 29.4 Reference
15-45 51 22 43.1 1.47 (0.48-4.47)
0-14 36 22 61.1 2.08 (0.67-6.43)
Sex
Female 73 35 47.9 Reference
Male 31 14 45.2 0.94 (0.45-1.99)
Size of the family
« 6  persons 65 29 44.6 Reference
>6 persons 39 20 513 1.15 (0.57-2.30)
Presence of animals in the house
No 54 23 42.6 Reference
Yes 50 26 52.0 1.22 (0.62-2.41)
Ever collected water from river
Never 76 35 46.1 Reference
Yes 28 14 50.0 1.09 (0.51-2.31)
No. of water reservoirs in house
1 19 6 31.6 Reference
2 37 16 432 1.37 (0.46^.07)
>2 48 27 56.3 1.78 (0.63-5.00)
Source of drinking water
Borehole, unchlorinated 42 17 40.5 Reference
Surface water, chlorinated 55 28 50.9 1.26 (0.61-2.59)
Other 7 4 57.1 1.41 (0.37-5.45)
Use latrines
.At least sometimes 81 37 45.7 Reference
Never 23 12 52.2 1.14 (0.51-2.54)
Wash hands before eating
At least sometimes 80 35 43.8 Reference
Never 24 14 58.3 1.33 (0.62-2.88)
Wash hands after defecating
At least sometimes 83 38 45.8 Reference
Never 21 11 52.4 1.14 (0.50-2.61)
NOTE. RR, risk ratio.
Table 1.8 Risk factors for asymptomatic hepatitis E virus infection in a random 
sample of Mornay population, Darfur, Sudan, September 2004. Figure taken 
from Guthamann et al, 2006, [132].
39
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
40
Food-borne transmission of HEV was first demonstrated in clusters of Japanese 
patients that had eaten raw or undercooked meat of pig, wild boar or sika deer. The 
genomic sequences of HEV identified from these patients were identical to those 
recovered from the frozen leftover meat [133].
In addition, Colson et al [134] reported HEV evidence based on epidemiological 
findings that 5 cases of autochthonous acute hepatitis E were linked to ingestion of 
raw figatelli [134]. Figatelli are traditional sausages from Corsica, they are made 
with pig liver and are commonly eaten uncooked, and they can be considered as a 
possible source of HEV infection in France [134].
Legrand-Abravanel et al [135], studied 38 patients in south-western France with 
HEV gt 3 infection. The patients were compared with matched control participants 
in south-western France who had no evidence of HEV infection. According to the 
results of a questionnaire, consumption of game meat, consumption of processed 
pork and consumption of mussels were all statistically significantly more common 
among case patients than among control participants. Eating undercooked pork and 
pork products is quite common in Europe. Although the study by Legrand- 
Abravanel et al [135] did not address the consumption of undercooked meat, other 
studies have explored it’s association with hepatitis E. A case-control study by 
Wichmann et al [136] in Germany, found that consumption of raw or undercooked 
wild boar meat, and offal (liver, kidney, and intestine) was statistically significantly 
associated with autochthonous HEV infection.
Other direct evidence of zoonotic transmission was recently reported by Kim et al 
[137]. A sporadic case of acute hepatitis E was confirmed as gt 4 HEV in a 51 year 
old Korean female. The case was reported as the first case of presumably zoonotic
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transmission of HEV identified as gt 4 in a patient with acute hepatitis E after 
ingestion of raw bile juice from a wild boar living on a mountain in South Korea. 
Although drinking of raw bile juice is not a common practice in Korea, like other 
parts of the world, some believe that bile juice could increase their energy or 
stamina as a folk remedy.
Furthermore, it has been shown that commercial pig livers purchased from local 
grocery stores as food in Japan, the United States (11%) and Europe [87, 138] are 
contaminated by HEV and that some of the HEV-contaminated commercial pig 
livers still contain infectious virus [87].
A study performed in an UK hospital tested 500 blood donors, 336 individuals over 
the age of 60 years and 126 patients with chronic liver disease were tested for HEV 
IgG. At the end of the study 40 cases of autochthonous hepatitis E (gt 3) were 
identified [9]. These patients did not have a recent travel history and the major 
probability was autochthonous hepatitis [9]. Autochthonous hepatitis E in developed 
regions is frequently misdiagnosed as drug-induced liver injury, a common problem 
that occurs with increased frequency in elderly people. The outcome can be poor in 
those individuals with underlying chronic liver disease, with mortality approaching 
70% [9].
Seroprevalence data from industrialised countries suggests that subelinical or 
unrecognised infection is common. However, the real incidence of clinical 
autochthonous hepatitis E in the UK is not known [139] but increased and improved 
surveillance for hepatitis E has shown it may be more common than hepatitis A. [9, 
140]. Data from France and Japan show similar trends [141, 142]. The literature
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contains relatively few reports from the USA regarding autochthonous hepatitis E 
[143]. It is known that the HEV human seroprevalence is around 21% in blood 
donors, it is strongly possible that the majority of the patients with unexplained 
hepatitis are “missed” since hepatitis E infection is often not considered a diagnostic 
possibility in the USA [143].
1.9.2 Epidemiology in pigs and other animals
It is now accepted that autochthonous hepatitis E in developed regions has a largely 
zoonotic source.
Evidence of this statement is described in many reports where HEV sequences 
derived from pigs are closely related to HEV sequences from humans. Many 
animals, for example domestic pigs, wild boar, deer, mongoose, trout and bivalves 
are found to be HEV positive [144, 145]. In addition, HEV antibodies are detected 
in domestic and feral animals. Gts 3 and 4 are the most commonly detected in this 
wide range of animals. Data obtained from animal experiments suggest that 
genotype 3 (zoonotic) is the most attenuated relative to genotype 1 and 2 (human to 
human) where they cause more severe pathology [146-148]. Although genotype 3 is 
considered by some to be the most attenuated for human beings, differences in 
genotype virulence is still not well understood [149]. It is also suggested that gt 4 in 
India differed relative to gt 4 subtypes found in China, Japan, and Taiwan. Data 
show that Indian gt 4 is apparently not able to infect humans and it has been 
suggested that this is probably due to the substitution of 26 amino acids, 16 in ORF- 
1, 8 in ORF-2 and 2 in ORF-3 [150]. Autochthonous hepatitis E gt 3 was first 
observed in the USA from comparing human sequences with pig sequences [52]. 
HEV seroprevalence in pig farms is high worldwide and it can be as high as 100%
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in some pig herds [130]. Furthermore, in some studies it is demonstrated that 
slaughterhouse workers, farmers, veterinarians and people that work in close contact 
with pigs may be exposed to a greater risk of HEV infection. The evidence is based 
on reports where this category of workers presents a higher HEV IgG 
seroprevalence relative to non-pig workers [151]. More than 20% of pigs close to 
the slaughter age are excreting HEV in faeces [152]. Watercourses may be HEV 
contaminated due to run-off of pig faeces from outdoor pig units. In addition HEV 
has been detected in slurry lagoons on pig farms, from urban sewage works, and 
from pig slaughterhouses [153]. The risks of spreading untreated slurry on farmland 
still need to be characterized but it should be remembered that rhesus monkeys have 
been infected with HEV recovered from sewage and slurry [154].
1.10 Pathogenesis, clinical signs and symptoms
1.10.1 In humans
Studies on HEV have facilitated the understanding of elements of its replication, 
host immune response, and liver pathology in HEV infected patients and primates 
[39, 130]. It has been estimated that the infectivity titre of HEV for macaques is 
10000-fold higher when inoculated intravenously compared with when it is ingested 
[8]. Clinical signs of hepatitis E are dose-dependent in these animal models and 
production of disease may require challenge doses 1000 times or more greater than 
that required for infection [113].
After ingestion, the virus probably replicates in the intestinal tract (the primary site 
of replication has not been identified yet) and reaehes the liver, presumably via the 
portal vein [42]. It replicates in the cytoplasm of hepatocytes [155] and is released 
into the bile and bloodstream, by mechanisms that are still poorly understood, and
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excreted in the faeces [113]. The incubation period is 4-5 weeks based on an oral 
infection study in human volunteers [130, 156]. Viral excretion in faeces begins 
approximately 1 week prior to the onset of illness and typically persists for 2-4 
weeks, in some cases RT-PCR has yielded positive results until 52 days after onset 
[157]. The viremia can be detected in the first 2 weeks after the onset of illness 
[156, 158, 159]. Viral excretion and viremia has been detected by RT-PCR also 
prior to liver abnormalities, which normally appear with an elevation of 
aminotransferase levels, and reach a peak by the end of the first week from the 
clinical symptoms. Simultaneously the humoral immune responses appear. Anti- 
HEV IgM or IgG levels are detected by enzyme immunoassay [160, 161]. Anti- 
HEV IgM appears during clinical illness and then gradually disappears over a few 
months (4-5 months). Some days later than IgM, anti-HEV IgG appears and persists 
for few years [162, 163]. The persistence of HEV antibody in the sera is still 
unclear. One study observed that 14 years after acute HEV infection anti-HEV 
antibodies were still circulating in 47% of patients [164]. To diagnose acute HEV 
infection, anti-HEV IgM is a useful tool, whereas IgG anti-HEV does not 
necessarily indieate recent HEV infection [40].
Hepatitis E symptoms are typical of acute icteric viral hepatitis; the most common 
recognizable symptom is an initial prodromal phase (preicteric phase) lasting a few 
days, with a variable combination of flu-like symptoms, fever, mild chills, 
abdominal pain, anorexia, nausea, aversion to smoking, vomiting, clay-coloured 
stools, dark or tea coloured urine, diarrhoea, arthralgia, asthenia and a transient 
macular skin rash [40]. These symptoms are followed in a few days by lightening of 
the stool colour and jaundice appearance. Itching may also occur. With the onset of
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jaundice, fever and other prodromal symptoms tend to diminish rapidly and then 
disappear entirely. Laboratory test abnormalities include bilirubinuria, a variable 
degree of rise in serum bilirubin (predominantly conjugated), marked elevation in 
serum alanine aminotransferase (ALT), aspartate aminotransferase, 
gammaglutamyltransferase activities and a mild rise activity in serum alkaline 
phosphatase. The magnitude of transaminase rise does not always correlate well 
with the severity of liver injury. The illness is usually self-limiting and typically 
lasts 1-4 weeks [40]. Recent reports described evidence of chronie HEV infection 
in transplant patients [165, 166]. A small number of patients with aeute HEV 
infection have a prolonged elinical illness with marked eholestasis (cholestatic 
hepatitis), including persistent jaundice and prominent itching. In these cases, 
laboratories observed a rise in alkaline phosphatase and a persistent bilirubin rise 
even after transaminase levels returned to normal [40]. The prognosis is good as 
jaundice finally resolves spontaneously after 2-6 months. Within the past few years, 
HEV has been demonstrated to be responsible for chronic hepatitis, which can 
rapidly evolve to cirrhosis in immunocompromised patients [167-169]. However, 
little data regarding HEV-related extrahepatie manifestations has been published, 
although an association between neurologic manifestations (e.g., Guillain-Barré 
syndrome, neuralgic amyotrophy, acute transverse myelitis) and acute HEV 
infection has been suggested [170-174]. Previously, the association between 
neurologic signs and symptoms and HEV infection has been based on detection of 
anti-HEV immunoglobulin (Ig) M in serum. However, Rianthavorn et al [175] 
reported a case of HEV gt 3-induced neurological amyotrophic in which HEV RNA 
was detected in the serum of patients with neurologic signs and symptoms [176]. 
Recently, Kamar et al [176] detected HEV RNA in the cerebrospinal fluid (CSF) of
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a kidney-transplant recipient with chronic HEV infection and neurological signs and 
symptoms [177]. In addition, Kamar et al reported 7 chronic HEV gt 3 infections, 
with development of neurological complications, from January 2004 until April 
2009 [84] and the disappearance of the neurological symptoms were correlated with 
a decreasing HEV titre.
Other infected individuals have a milder clinical course and develop only non­
specific symptoms that resemble those of an acute viral febrile illness without 
jaundice (anicterie hepatitis) [161]. Histological features of hepatitis E may differ 
from other forms of aeute viral hepatitis. Nearly half of hepatitis E patients have a 
cholestatic hepatitis, which is characterized by eanalicular bile stasis and gland-like 
transformation of parenchymal cells. In these patients, degenerative changes in 
hepatocytes are less marked [40, 178]. The Kupffer cells appear prominent. Portal 
tracts are enlarged and contain an inflammatory infiltrate consisting of lymphocytes, 
a few polymorphonuclear leucocytes and eosinophils. Polymorphonuclear cell 
volume is particularly increased in the cholestatic type of lesion [40, 178]. In cases 
with severe liver injury, a large proportion of the hepatocytes are affected, leading 
to sub-massive or massive necrosis with collapse of liver parenchyma [40]. At the 
beginning, HEV infection is entirely inapparent and asymptomatic. A small 
percentage of patients have more severe symptoms with fulminant or subacute (or 
late-onset) hepatic failure. The exact frequencies of asymptomatie infection and of 
anicteric hepatitis are not known but a large proportion of individuals test positive 
for anti-HEV IgG [40]. In resource-limited regions hepatitis E is common in young 
adult and adults (15-40 years of age). Hepatitis E appears to cause more-severe 
disease in pregnant women, particularly during the second and third trimesters [40].
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HEV commonly causes intrauterine infeetion as well as substantial prenatal 
morbidity and mortality [127], suggesting that the placenta may be the viral 
replication site as Lassa fever [179, 180]. Death is usually due to encephalopathy, 
haemorrhagic diathesis or renal failure. In a preliminary report [181] cynomolgus 
monkeys infected intravenously with HEV developed acute tubular necrosis with 
focal haemorrhages suggesting that HEV may replicate in monkey kidneys. In 
pregnant monkeys, however, no increased mortality has been observed [182]. In 
endemic countries such as India, the mortality rate of women with acute gt 1 
hepatitis E in the third trimester of pregnancy is usually fairly high (26-64%) [183]. 
Why acute HEV infection in pregnant women causes severe liver dysfunetion is not 
known.
Experimentally, HEV transmission has occurred from infected to uninfected in­
contact pigs confirming that the virus is contagious [184].
Many reports described that [167, 176, 177] in immunosuppressed transplant 
patients chronie HEV infection progress rapidly in cirrhosis [165]. Established 
cirrhosis has been shown in two HIV-infected patients, in 2009, in UK and France 
[185]. HEV and HIV coinfection still need to be better studied. [176] What it is 
known to date is that that it seems that there was no difference in anti-HEV 
seroprevalence between patients with HIV infection and control group [185].
1.10.2 In pigs
The mechanisms of HEV pathogenesis and replication are poorly understood due to 
the lack of a practical animal model and an efficient in vitro cell culture system for 
HEV. HEV might replicate in tissues and organs other than the liver [186].
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Williams et al [72] confirmed clinical and pathological findings of HEV infection in 
pigs previously reported by Halbur et al [149]. It is unclear how the virus reaches 
the liver and extra-hepatic site(s), but it is presumably that HEV is transmitted by 
the faecal-oral route. Primary the hepatocytes are the only known sites of HEV 
replication [79]. It has been hypothesized that liver damage induced by HEV 
infection may be due to the immune response to the invading virus and may not be a 
direet eause of viral replication in hepatocytes [79, 187]. Several studies with 
naturally infected pigs described HEV RNA detectable in different organs and 
tissues, even after viremia was cleared [188]. For swine HEV-infected pigs, viral 
RNA was detected in small intestines, colons, lymphnodes, and livers [79, 188]. 
Other extrahepatie tissues such as kidney, tonsil, and salivary gland had detectable 
HEV RNA for only 1 or 2 weeks [79]. It appears that lymphonodes and the 
intestinal tract are the main extra-hepatic sites of replication. The significance of 
identifying extra-hepatic sites of HEV replication is unclear at this time.
Experimentally infected pigs do not present any clinical signs, histological analysis 
shows signs of mild, focal liver necrosis but no fever or other signs (as for example 
lack of appetite) are observed.
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1.11 Diagnostic procedures
Enzyme-linked immunosorbent assays (ELISA), conventional reverse transcriptase 
PCR (RT-PCR) and real time RT-PCR, cell culture, confoeal microseopy and 
electron microscopy have been used for detection or confirmation of HEV infection. 
These methods differ significantly in their sensitivity and specificity. The 
eommonly used methods for HEV detection are described below in more detail.
1.11.1 ELISA
HEV recombinant proteins and synthetie peptides, corresponding to 
immunodominant epitopes of the 0RF2 and ORF3 structural proteins of the virus, 
have been sourced as the capturing antigen [113]. Subunits of ORF2 have been 
expressed in different systems such as prokaryotic, insect, animal and plant cells in 
order to obtain pure antigen for ELISA [189]. Recombinant antigens derived from 
ORF2 generally have a superior sensitivity and specificity. In common with all 
serological tests, ELISA can only be applied once antibody has developed, in most 
cases at least 2 weeks after infection. However, serological tests are able to 
discriminate between IgM and IgG, thus enabling distinction of the acute phase 
from the convalescent phase of infection. HEV antibody prevalence has been 
reported in several studies in industrialized countries [125, 189]. Commercially 
available ELIS As have improved in recent years, but it is suspected some of the 
earlier prevalence data reflected subelinical infections and serological cross­
reactivity that may have contributed to this high seroprevalence in the non-endemic 
areas [38, 113].
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1.11.2 Conventional RT-PCR
Conventional RT-PCR assays are currently utilized in direct diagnosis of HEV. The 
samples collected may be faeces, serum (from animal or human), cultures of 
infected cells cultivated in 2D and 3D configurations, or post mortem tissue highly 
positive as bile and liver [42, 190]. HEV is an RNA virus and the RNA needs to be 
extracted before being subjected to the reverse-transcription reaction phase to 
cDNA. This is a limiting step, because cDNA is easily degradable, if in the samples 
the viral load is so low at initial state, may give rise at the end to false negativity. 
Various sets of sense and antisense synthetic oligonucleotide primers may be used 
for the detection of the HEV genome, differing based on conservative region targets 
in the genome against the central or terminal part of ORFl or C terminal of ORF2 
[42]. There are reports which indicate broad-spectrum degenerate primers, for 
identifying positives samples from all genotypes. For example A l/S l and 3156/7 
primers [191] are used to amplify the ORF2 region. Often the first product of PCR 
amplification it is of insufficient quantity to be visualized by electrophoresis. 
However, if the first product of PCR has been amplified by nested RT-PCR with the 
internal primers A2S2 [192] and 3158/9 [191], respectively, the PCR product 
became clearly visible on the eleetrophoresis gel through ethidium bromide 
staining.
1.11.3 Real time RT-PCR
Real-time RT-PCR is becoming the most popular method for direct detection of 
HEV in clinical samples. The technique enables both detection and confirmation of 
specificity genotyping. In addition, real time RT-PCR is a sensitive tool in 
epidemiological investigations since that this technique is fast and reliable. The full
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viral genome of HEV was cloned in 1991 [35]. Since then several pairs of primers 
have been designed to amplify various segments of the genome. The primers are 
mainly designed to the conserved regions (heliease, polymerase and the terminal 
fragment of ORF2) of the HEV genome [42]. The development of real time RT- 
PCR, whereby the accumulation of the PCR amplicon can be deteeted in real-time, 
has allowed for the quantification of HEV.
1.11.4 Negative strand detection
Since HEV is a positive strand RNA virus that putatively codes for a RNA- 
dependent RNA-polymerase, HEV should replicate through a negative-strand RNA 
intermediate [35]. Nanda et al [193] already showed HEV negative-strand RNA in 
the liver tissue of infected rhesus monkeys, providing support for the putative 
mechanism of HEV replication.
Varma et al [194] described viral HEV replication in transfected PLC/PRF/5 cells 
and observed negative strand replication until 24h after the cells were transfected 
with ORF2, with a maximum RNA negative strand peak after 8h post transfection 
[194].
1.11.5 Cell culture and new technology for in-vitro propagation of the virus
Several cell lines for in vitro replication of HEV have been tested in the 2D 
monolayer culture system [32, 195, 196]. These cell lines were hepatocytes from 
non-human primates, human embryonic lung diploid cells (2BS), human carcinoma 
alveolar basal epithelial cells (A549), hepatocarcinoma cells (PLC/PRF/5), 
hepatocellular human carcinoma (HepG2) and primary hepatocytes from non­
human primates. However, the majority of the cell lines did not support replication
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of HEV or the virus growth was limited, i.e. low titre virus. The lack of an efficient 
and reliable cell culture system and a practical animal model for HEV have 
hindered studies on mechanisms of HEV replication, transmission, pathogenesis and 
environmental survival.
In a recent study, Tanaka et al have tested 21 cell lines including PLC/PRF/5 cells 
using a faecal suspension with high HEV load as inoculum [197]. A high load of 
HEV was detected in the eulture supernatant of cultivated PLC/PRF/5 cells from 
day 12 post inoculation. At AHVLA laboratory, several attempts were made to 
reproduce Tanaka’s work using field swine HEV PCR positive faecal materials as 
inoculum, but without success. Okamoto in 2011 described for the first time, a cell 
culture system capable of secreting infectious HEV in high titres into culture media 
[198]. The success with the original JE03-1760F strain has been extended to other 
strains that can support the replication of HEV with an even higher efficiency, and 
can be passaged through many generations [198]. Okamoto was able to infect 
PLC/PRF/5 cells with both sera and faeces of patients and observe high HEV titre in 
the cell culture system [198]. Furthermore Okamoto has engineered infectious HEV 
cDNA clones, in addition he affirmed that this system, reinforced by reverse 
genetics, will solve many mysteries and answer numerous questions surrounding the 
epidemiology, viral absorption/entry, packaging and delivery of viral particles, 
toward illuminating the life cycle of HEV. No other authors after Okamoto have 
been able to reproduce those experiments [198].
Hence, an efficient in vitro propagation system for HEV is crucial for HEV research 
in general, and to the VITAL project in particular. There are several reports in the 
literature demonstrating the potential of a new 3D culture system Rotating Wall
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Vessel (RWV) (Figure 1.10) [199], for the growth of fastidious viruses. The RWV 
is a cylindrical bioreactor which is rotated on an axis parallel with the ground. 
Subsequently, a solid body mass rotation of the culture medium is obtained, creating 
a low-fluid-shear environment [200]. The RWV culture method has been shown to 
be applicable for fluid shear stress-related studies in suspension. The cells are 
maintained in suspension by the resolution of the centrifugal, gravitational and 
Coriolis forces, so cells placed in the RWV bioreactor experience minimal 
mechanical stresses and high mass transport (of nutrients, oxygen etc.) and are thus 
able to assemble into tissue-like aggregates. This 3D culture system has been used 
to grow fastidious Norovirus from faecal materials [201]. The system offers a 
potential for in vitro cultivation of HEV. The RWV technology is used to simulate 
the low shear environment inherent to microgravity [202].
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Figure 1.10 Rotating Wall Vessel motor (RWV) or Rotary cell culture system.
A: The RCCS (RCCS-4DQ, Synthecon) is available as a one, two, four or eight 
station rotator base. The system depicted consists of a four Station Rotator Base, 
along with a power Supply with Tachometer. Each station is capable of rotation at 
independent speeds, enabling four experimental conditions and/or experiments to be 
run simultaneously. The system is supplied with four Rotary wall vessels (RWV). 
(B): The cylindrical RWV is completely filled with culture medium, cells and micro 
carrier beads through the filling port on the face of the vessel. All bubbles are 
removed from the RWV through the sampling ports to reduce shear. The vessel is 
attached to the rotator base by docking point and rotated on its axis that is parallel to 
the ground creating a solid body rotation. Cell-beads aggregates in the RWV are 
maintained in a gentle fluid orbit and do not collide with the walls or any others 
parts of the vessel (i.e., suspension culture). As 3D tissues grow in size, the rotation 
speed is adjusted to compensate for the increased settling rates of the larger 
particles. The cells and/or tissue particles join to form larger tissue particles that 
continue the differentiation process. Oxygen supply and Carbon dioxide removal 
are achieved through a gas-permeable silicone rubber membrane that covers the 
back of the RWV bioreactors. Schematic representation on how the system, works 
(section c). Figure taken from Nickerson et al, 2001; [199].
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1.11.6 Microscopy
Microscopy is the teehnical field of using microscopes to view samples or objects. 
There are three well-known branches of microscopy, optical, electron and scanning 
microscopy. Optical and electron microscopy involve the diffraction, reflection, or 
refraction of electromagnetic radiation/ electron beam interacting with the subject of 
study, and the subsequent collection of this scattered radiation in order to build up 
an image. This process may be carried out by wide-field irradiation of the sample 
(e.g. standard light microscopy and transmission electron microscopy) or by 
scanning of a fine beam over the sample (e.g. confoeal laser scanning microscopy) 
and scanning electron microscopy.
1.11.6.1 Confoeal microscopy
There has been a tremendous increase in the popularity of eonfocal microscopy in 
recent years. The technique of laser scanning confoeal microscopy has become an 
invaluable tool for a wide range of investigations in the biological and medical 
sciences for imaging of optical section in living and fixed specimens ranging in 
thickness up to 100 micrometers [203]. The basic key to the confoeal approach is 
the use of spatial filtering techniques to eliminate out of focus light or glare in 
specimens whose thickness exceeds the immediate plane of focus. Confoeal 
Microscopy offers several advantages over conventional wide field optical 
microscopy, including the ability to control depth of field, elimination or reduction 
of background information away from the focal plane (that leads to image 
degradation), and the capability to collect serial optical section. The choice of 
fluorescent probes for confoeal microscopy must address the specific capabilities of
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the instrument to excite and detect fluorescence emission in the wavelength regions 
made available by the laser system and detectors.
1.11.6.2 Electron microscopy, transmission and scanning
The transmission electron microscopy (TEM) technique is specific, labour intensive 
and expensive, but was a critical precursor for understanding the natural history of 
HEV, being the tool used to detect the viral particle causing non-A non-B non C 
hepatitis in 1975 [204]. The virus particle of 27-34 nm appeared non-enveloped, 
was detected in stool samples collected during preicteric and early icterie phases 
and to determine antibody titres in the sera [186]. In general, the TEM technique 
does not serve as a diagnostic tool since it usually requires large amounts of antigen 
and high antibody titre and further, virions are shed in degraded form in faeces [42].
The scanning electron microscope (SEM) produces very high-resolution of a sample 
surface, revealing details about 1 to 5 nm in size. Due to the way these images are 
created, SEM micrographs have a large depth of field yielding a characteristics 
three-dimensional appearance useful for understanding the surface strueture sample 
composition.
1.12 Vaccination
Due to lack of a reliable cell culture system for HEV, vaccine development has been 
difficult. Two candidate vaccines have successfully completed phase 3 clinical trials 
in humans. Baculovirus-expressed ORF-2 protein from a Pakistani strain of HEV 
has been licensed by Smith Kline-Beecham [205]. In the Royal Nepalese Army, a 
vaccination trial to prevent HEV clinical disease was conducted and it showed 
95.5% efficacy (95% Cl). Also in China, another trial was conducted. The vaccine
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was prepared with a recombinant protein from the HEV ORF-2 viral capsid 
expressed in Escherichia coli (HEV 239) [83]. Vaccine efficacy after three doses 
was 100% (95% Cl 72.1-100.0). It was considered that these two vaccines could 
prevent HEV morbidity and mortality in pregnant women, patients with chronic 
liver disease in endemie areas, patients with organ transplants and other 
immunocompromised subjects who may contract HEV gt 3 in industrialized 
countries.
As far as we know these two vaccines cover gt 1 but nothing is known about 
prevention of gt 3 and it is quite unthinkable to set up a vaceination plan for the 
entire worldwide population against HEV gt 3, mostly because in non-endemic 
areas HEV is sporadic and incidence is generally still very low. The production of a 
HEV vaccine for pigs would be more feasible and cheaper, but it is acknowledged 
that in the absence of any disease in pigs, it might not be justified or practicable to 
vaccinate pigs. However, in considering the options for control of autochthonous 
acquired gt 3 and gt 4 HEV in humans, it is important to have some data on the 
estimated impact and optional timing of HEV vaccination of pigs. This would be 
useful feasibility data in case of changes in the incidence of human gt 3 infections in 
developed regions or other events that may require the vaccination of pigs.
1.12.1 HEV vaccination modelling in pigs
Only a few studies regarding the dynamics of HEV transmission have been done but 
no vaccination modelling in pigs has been performed to date. Bouwknegt et al 2008 
[86] described HEV transmission among pigs from chains of one-to-one 
transmission. The model describes HEV transmission in pigs and it can be used both 
with animal contact exposure experiments and in the field. Each age group or
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contact-exposure animal is subdivided into three distinct compartments that consist 
of pigs that are susceptible (S), infectious (I) or recovered (R). The system 
described by this SIR model is assumed to be in an endemic equilibrium. This 
endemic equilibrium can only exist when the virus is suffieiently transmissible. The 
transmissibility is expressed by the reproduction number (Rq) and it is the number 
of infections by an infectious individual during its entire infectious period (in an 
infinite susceptible population). The endemic equilibrium assumes that Rq > 1. This 
SIR model means that the infected animals reach immunity after infection. The 
latent period between infection and excretion of infectious virus, is observed to be 3 
days in intravenously inoculated pigs [86].
The model is analysed by Monte Carlo (MC) sampling. This means that three 
random numbers of infectious animals are drawn from the distribution depending on 
the observed number of positive. Each Monte Carlo (MC) sample consists of three 
numbers of animals that signify the numbers of infectious weaners, growers and 
fatteners.
Bouwknegt et al 2008 [86] observed that Rq for contact-exposure was estimated to 
be 8.8 (Cl 95%,) showing the potentia] of HEV to cause epidemics in populations of 
pigs.
Casas et al reported a longitudinal survey study on swine HEV infeetion dynamics 
conducted in different herds [206], but the dynamics of HEV transmission was 
analysed using SPSS 15.1 software (SPSS Inc., Chicago, IL, USA) and not a 
mathematical model such as the SIR model.
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Only a couple of studies have applied mathematical model such as the SIR model in 
field samples to better understand HEV dynamics of transmission [207]. This 
mathematical model can better help in a theoretical way by mimicking the in vivo 
system to understand of how HEV is circulating between pigs in the same farms and 
between different age groups. Furthermore this model can also try to mimic how a 
vaccination model can help to eradicate an endemic virus such as HEV and it can 
help to understand at which age, during an early or later stage, it is more effective to 
vaccinate the animals [86].
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1.13 Aims of the VITAL PhD project
This PhD project was part of the European project VITAL (Integrated Monitoring 
and Control of Foodbome Viruses in European Food Supply Chains). This project 
included 15 laboratories in Europe and this PhD was developed to spend the first 
year in the UK, one year in The Netherlands and the last year in the UK. The main 
aims of the VITAL project were to:
i: Acquire data on virus contamination of food and environmental sources.
ii: Assess food borne viral risks for determining high-risk situations and efficacy of 
interventions.
iii: Develop new measures to prevent virus contamination of food and the 
environment.
iv: Develop and assess measures of reduction and control in case of virus 
contamination.
The specific aims of this PhD project were to investigate HEV presence and 
residual infectivity in the pork food chain in order to facilitate any future control 
measures. During this PhD project samples across the UK pork food chain were 
tested for HEV contamination. Furthermore, a cell culture system was optimised to 
demonstrate the infectivity of the virus in the food samples tested and HEV 
inactivation strategies were investigated. This will aid understanding of the 
mechanisms of HEV replication, pathogenesis and environmental (including within 
food matrices) survival. The knowledge derived from this study is going to be used 
to develop codes of practice aimed at reducing or eliminating zoonotic transmission 
of HEV via the food-borne route.
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The 3 objectives of the PhD project were:
1) a) To evaluate a new 3D cell culture system to assess HEV infectivity. This was 
set up to verify that the HEV virus content detected by PCR in pig products and 
environmental samples is infectious.
b) To compare the efficiency of the 3D system to the conventional 2D cell culture 
system. In addition, cells grown in the 3D system were transferred to a 2D system 
and infected. This aimed to produce the best tool with which to examine large 
numbers of samples being investigated for potential transmission routes.
c) The risk of HEV infection via the consumption or manipulation of HEV- 
contaminated pig livers raises further public health concern since it is not clear 
which conditions will be effective in inactivating the virus present in the 
contaminated pig livers. Inactivation studies were performed to better understand 
which is the best method to inactivate HEV in various matrices and environments.
The inactivation studies performed were heat, UV light and sodium hypochlorite 
HEV inactivation. The heat inactivation was performed to better understand at 
which temperature the virus is inactivated to produce guidelines for consumers, 
particularly in relation to cooking conditions. The other two studies were set up to 
provide information that could be incorporated in guidelines for pork chain workers.
2) To assess methods for HEV detection within the VITAL project, particularly 
from sampling in the UK pork food chain. The first step of the VITAL project was 
to optimise the Standard Operating Procedures (SOPs). It was requested that the 
sample collection laboratories involved in the project tested the SOPs. This was to 
be accomplished by means of blind ring trials. Samples were spiked with Human
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Adenovirus (HAdV) and the results obtained were evaluated by the ring trial leader. 
The second step was testing samples collected at the slaughterhouse (40 pig liver 
sample and 40 pig faeces), processing point (40 pork muscles) and point of sale (63 
pork sausages). The aim was to gain an insight into the frequency of HEV in the UK 
pork foodchain.
3) HEV dynamics of transmission study: Since HEV is a zoonosis that is 
widespread in the pig population in Europe, there might be an interest to produce a 
pig vaccine to reduce the impact of HEV infection in the human population. Prior to 
any vaccine development, modelling work is necessary to assess the impact of 
vaccination in the reduction of HEV excretion by the pigs. I participated in the 
collection of HEV prevalence data in European countries, and in the construction of 
the dynamics of transmission model.
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CHAPTER 2 
VITAL Ring Trial
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Introduction
This PhD project was part of the European project VITAL (Integrated Monitoring 
and Control of Foodborne Viruses in European Food Supply Chains). This project 
included 15 laboratories in Europe and one of the main aims was to assess methods 
for the detection of Human Adenovirus (HAdV) and Norovirus in the soft fruit and 
salad and detection of HEV in the pork products and shellfish. This PhD project was 
focused on the pork foodchain and its initial phase was the validation of the 
extraction and detection methods for two sample matrices (soft fruit and pork 
products). These methods were developed as standard operating procedures (SOPs) 
and assessed by means of a blind ring trial between all data gathering laboratories in 
the VITAL consortium. Samples were spiked with HAdV, the target virus and with 
Murine Norovirus (MNoV) the extraction control. All samples were tested by all the 
laboratories involved in the ring trial and the results were sent to the ring trial leader 
for evaluation.
Ring trial: In each data-gathering laboratory the first task was evaluating common 
SOPs, developed for the project, to test the robustness of all methodologies from 
virus extraction to detection methods (real time PCR).
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Materials and methods
Liver tissue and raspberries were the matrices selected for the ring trial. HAdV and 
MNoV, supplied from the Istituto Superiore della Sanita’, Rome (ISS), were used as 
the target virus and extraction control virus (called sample process control SPC), 
respectively. Each target virus suspension (HAdV) was tested blind and coded; the 
concentrations were known only by the ring trial leader. Fifty pi of each target virus 
suspension and 10 pi of SPC virus suspension were used to spike each sample. The 
MNoV was used as control to monitor the success of the extraction process.
2.1  Virus concentration and nucleic acid extraction
2.1.1 Sampling and virus concentration in pork liver tissue
Two hundred and fifty mg of liver tissue, obtained from a local UK supermarket, 
was cut from three different inner portions of a liver. Fifty pi of the coded sample 
virus was spiked into the sample and incubated for 2 h. The liver was then 
homogenized manually using surgical blades and mortar. The homogenized liver 
tissue was transferred into 1 ml lysis buffer (containing 0.14 M D-mercaptoethanol). 
Ten pi of the positive process control virus was added to the sample. The tubes were 
centrifuged for 20 min at 10.000 x g. Eight hundred pi of the aqueous phase was 
transferred to a new 2 ml microtube and the suspension used immediately for RNA 
extraction (VITAL SOP 009, Appendix C.4).
2.1.2 Nucleic acid extraction from pork liver tissue
Trizol (Invitrogen) (0.75 ml) and 0.2 ml of chloroform were added to the 
supernatant obtained in section 2.1.1. The samples were incubated for 5 min at room 
temperature and the tubes centrifuged for 15 minutes at 12.000 x g. One ml from
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the aqueous phase was transferred to a clean 2 ml microtube. An equal volume of 
Phenol : Chloroform: Isoamyl alcohol (25:24:1) solution was added and the solution 
was centrifuged for 15 minutes at 10.000 x g. Eight hundred pi from the upper 
aqueous phase was transferred to a clean 2 ml tube. LiCl (0.1 ml, 5 M) solution was 
added into the solution and mixed by vortexing. The tubes were incubated at -20°C 
for at least 4 hours. The supernatant after centrifugation (10 minutes at 10.000 x g) 
was removed and the pellet was washed with 70% ethanol, dried and resuspended in 
50 pi of nuclease-free deionised-distilled-water. The extracted RNA was stored at -  
80”C. (VITAL SOP Oil, Appendix C.6).
2.1.3 Sampling and virus concentration from soft fruit
Twenty five g of raspberries, obtained from a local UK supermarket, was weighed 
and transferred to a sterile beaker and 50 pi of Adenovirus (yielding stock titres of 
approximately 4x10^ plaque-forming units (PEU) ml“ )^ was spiked into the sample 
and incubated for 2 hours. Ten pi of the SPC and 40 ml of Tris Glycine 1% Beef 
Extract (TGBE) Buffer Including 6500 U of pectinase (250 pi of Pectinex Ultra 
SPL solutions) were added to the sample. The sample was agitated at room 
temperature for 20 min by rocking at 60 rpm. The supernatant was decanted from 
the beaker through a strainer into one 50 ml tube. The sample was centrifuged at
10.000 X g for 30 min at 4°C. The supernatant was decanted into a single clean 
tube/bottle. The pH of the sample was adjusted to 7.2 with Hydrochloric acid (1 N). 
5X electrolyte-polyethylene glycol / Sodium chloride (0.25 ml of solution) was 
added to the sample and incubated with gentle rocking at 4°C for 60 min. The 
solution was centrifuged at 10.000 x g for 30 min at 4°C and the supernatant 
decanted and discarded. The pellet was resuspended in 500 pi of PBS. Five hundred
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pi chloroform:butanol solution (1:1) was added to the solution and centrifuged at
10.000 X g for 15 min at 4°C. The aqueous phase was transferred to a clean tube and 
stored at -20°C. (VITAL SOP 005, Appendix C.3).
2.1.4 Nucleic acid extraction from soft fruits
Nucleic acid extraction from the samples processed in step 2.1.3 was performed 
according to the NucliSENSE lysis protocol (BioMérieux). Briefly 500 pi of the 
concentrated solution obtained from the soft fruit {section 2.1.3) were transferred 
into a clean centrifuge tube. Four and a half ml of NUCLISENSE lysis buffer were 
added to the tube, and mixed by vortexing briefly. The samples were centrifuged for 
2 min at 1.500 x g to ensure that the entire sample was brought down into the tube. 
Fifty pi of well-mixed magnetic silica solution (BioMérieux) was added to the tube 
and mixed by vortexing briefly. The supernatant was discarded after centrifuge for 2 
min at 1.500 x g.  Wash buffer 1 (400pl) was added and the pellet resuspended by 
pipetting/vortexing. The suspension was transferred to a 1.5 ml screw-cap tube. 
Another 2 washes (400 |il each time with washing buffer 2 and 3) were made, after 
every wash the pellet attached to the silica beads was resuspened. The final step 
consisted in adding 50 pi of elution buffer and transferring the tubes to a 
thermoshaker for 5 min at 60°C at 1.400 rpm. The tubes were placed in a magnetic 
rack to allow the silica to settle and the eluate was transferred to a clean tube. The 
RNA was retained at 4°C for a maximum of 24 hrs or at -80°C for up to one week 
(VITAL SOP 012, Appendix C.T).
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2.2 Positive standards construction
Within the VITAL project synthetic multiple-target DNA oligonucleotides were 
constructed for use as quantification standards for nucleic acid amplification assays 
for Human Adenovirus, Porcine Adenovirus and Bovine Polyomavirus [208]. For the 
DNA standard a synthetic DNA molecule was designed to contain target sequences 
for real time PCR assays for BPyV [209], HAdV [210] and PAdV [211]. The 
oligonucleotides were synthesised (Eurofins MWG Operon, Ebersberg, Germany) 
and cloned into a pCR 2.1-TOPO plasmid (Invitrogen, Breda, The Netherlands) 
{Figure 2.1) [208].
The DNA concentration was determined by UV spectrophotometry in a Nanodrop 
ND-1000 spectrophotometer (ThermoScientific, Wilmington, NC, USA). The 
measurement was performed in duplicate and concentration in grammes was 
converted to molecule number using the following formula:
DNA molecules x pi *
— [(g/pl)/(plasmid length in base pairs x 660)] 
X 6.022 X 10“
The standards used for the quantification of the target viruses were designed by 
Martinez-Martinez et al [208] and subsequently sent to all VITAL laboratories 
involved in the VITAL ring trial.
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2.3 Real time PCR protocols
2.3.1 Quantification of adenovirus by real-time PCR
This protocol was based on the SOP “General protocol for the quantification of 
Adenovirus by Real Time PCR” {see SOP 14 VITAL, AppendixC.9). Briefly, this 
assay was a duplex real time PCR using the primers and conditions described by 
Hernroth et al (2002) [210], with the inclusion of an internal amplification control 
(LAC) [212] to verify if PCR inhibitions occurred. The reaction contained 
IxTaqMan Universal PCR Master Mix (Applied Biosystems). The primers were 
used at a final concentration of 0.9 pM, Table 2.2. These primers targeted the 
HAdV hexon gene. The reaction mix was prepared following the manufacturer 
instructions (ABI PRISM HID 7000 SDA from Applied Biosystems) and consisted 
of 0.225 pM adenovirus TaqMan probe (labelled with F AM), 50 nM lAC probe (0.1 
pM, labelled with VIC), 100 copies of adenovirus lAC (Yorkshire Bioscience Ltd, 
UK) and enzyme mix (12.5 pi). Ten p.1 of the diluted nucleic acid extract was added 
to make a final reaction volume of 25 pi.
The total volume for one reaction after addition of target was 25 pi (15 pi mix plus 
10 pi sample or standard). Ten pi of nuclease-free deionised-distilled-water was 
added to the NTC samples (no template control). Two PCR replicates were 
performed for each sample. In each PCR run, positive (Synthetic multiple-target 
DNA oligonucleotides described in section 2.3) and negative (water) amplification 
controls were included to exclude possible contaminations. Following activation of 
the UNG (uracil Nglycosylase) (2 min, 50°C) and activation of the AmpliTaq Gold 
for 10 min at 95°C, 45 cycles (15 sec at 95°C and 1 min at 60°C) were performed. 
The data were analysed using the MX3000 software.
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2.3.2 Detection and quantification of Murine Norovirus by real-time RT-PCR
This protocol was based on the methods described by da Silva et al, Svraka et al, 
Loisy et al and Kageyama et al [201, 213-215]. The oligonucleodites used are 
described in Table 2.3. The MNoV PCR was performed using RNA UltraSense™ 
One-Step Quantitative RT-PCR System (Invitrogen) and primers and probe were 
designed by Baert et al in the ORFl/2 junction region: Fw-0RF1/0RF2 (5’- CAC 
GCC ACC GAT CTG TTC TG-3’) (location 4972-4991), Rv-0RF1/0RF2 (5’- 
GCG CTG CGC CAT CAC TC-3’) (location 5064-5080), MGB-ORF1/ORF2 (5’- 
FAM-CGC TTT GGA ACA ATG-MBG-NFQ-3’) (location 5001-5015) [216].
Ten pi of RNA extracted from the samples was added into each reaction, including 
the negative control (NTC) and 0.6 pi of lAC [213]. The total volume for one 
reaction after addition of target was 20 pi (10 pi mix plus 10 pi sample or standard). 
Ten pi of nuclease-free deionised-distilled-water was added in the NTC samples. The 
Real Time RT-PCR was performed in a real-time PCR platform (MX 3000, 
Stratagene): reverse transcription 50°C for 15 min, 2 min at 95°C followed by 40 
cycles of 15 s at 95°C and 1 min at 60°C. The data were analysed using the MX3000 
software.
2.3.3 The internal amplification controls (lACs)
Internal amplification controls (lACs) were constructed for incorporation into real­
time nucleic acid amplification assays for Hepatitis E virus. Human Adenovirus 
Murine Norovirus and Porcine Adenovirus. The addition of lAC into the assays was 
to provide a robust PCR control that can be routinely applied in the analysis of foods 
for viruses.
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The lAC was a chimeric DNA molecule containing non-target sequences flanked by 
target sequences complementary to the virus-specific primers [212]. This molecule 
was then cloned into a plasmid {Figure 2.4) [212]. The plasmid or the RNA 
transcript was the chimeric lAC which was co-amplified with the virus primers and 
detected using a fluorescent probe complementaiy to the internal non-target 
sequence [212]. When using a real-time PCR-based assay, the virus target 
amplicons were detected with specific hydrolysis probes, labelled with one 
fluorophore (e.g. FAM), and the LAC amplicons were detected with the specific 
lAC probe, labelled with a different fluorophore (e.g. VIC). Each lAC was designed 
by Diez.Valcarce [212] for the VITAL project as a DNA or RNA molecule 
containing sequences from the prfA gene from Listeria monocytogenes (nucleotide 
positions 2281-2348, AN AY512499) flanked by the sequences complementary to 
the primers used in the specific assays [212]. The chimeric DNA molecules were 
generated by PCR using as template 5 ng of L. monocytogenes strain CECT 935 
DNA [212]. The PCR products were excised from a 2% Ix TBE agarose gel and 
purified using QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany), then 
cloned into the pCR 2.1-TOPO Vector (Invitrogen) in the case of lACs for the HEV 
assays or into the pGEM-T Easy Vector (Promega, Madison, WI, USA) in the case 
of lACs for the Human Adenovirus (HAdV), Porcine Adenovirus (PAdV) and 
Murine Norovirus (MNoV) assays. lACP probe construction was also conducted by 
Diez- Valcarce et al [212]. The probe was targeting portion of the target virus and 
portion of the plasmid [212].
The lAC construction was performed by Diez-Valcarce et al [212], it was 
subsequently sent to Yorkshire Bioscience for manufacturing and finally bought 
from the VITAL members involved in the ring trial and data gathering.
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00GCCCCTAGATCCTACCCTCAACGGAATTCTAGACAAAGATGGTGTGTATCCTGTTGAGTGTTGGTGTCCAGATCCAAGTAAC7r^C4r0C/lCm’ GCC
GGGC4GG4CGK-CTCGGAG7ACCTGAGCCCaGGCCTGGrGC4G7TCGCCCGrGAACt3<3CCaCTACTGCAAOTTCCACATCCAGOTOCCiX:AAAAGTTCTTTGCÇÇT
ÇAAGAGCCTGCTOCTGCGGCCOC
pFBV2 
4159 bp
Figure 2.1 Graphie representation of pFBV2 containing the sequence of the 
synthetic DNA. The length of the plasmid is 4,159 bp. The viral insert was flanked 
by Apal and Notl sites. The sequences of the qPCR assays are shown (BPyV—bold, 
HAdV-2—italics and PAdV— underlined. The sequences corresponding to the 
TOPO vector are in normal type. Figure taken from Martinez-Martinez et al [208].
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Primers Sequences
Forward primer: AdP 5 ’- CWT ACA TGC ACA TCK CSG G-3’
Reverse primer: AdR 5 ’- CRC GGG CRA AYT GCA CCA G -3’
Adenovirus TaqMan 
Probe
5 ’- FAM- CCG GGC TCA GGT ACT CCG AGG CGT CCT-BHQ-3’
TaqMan probe: lACP 5 -VIC- CCA TAC ACA TAG GTC AGG -M GBNFQ- 3 ’
Table 2.2 Adenovirus oligonucleotides. The table describes primer sequences used 
for the Adenovirus PCR detection method. Figure adapted from Diez- Valcarce et al 
[212].
Primers Oligonucleodites
Forward primer FW -0RF1/0RF2 (5 ’- CAC GCC ACC GAT CTG TTC TG3’)
Reverse primer RV-0RF1/0RF2 (5 ’- GCG CTG CGC CAT CAC TC-3’)
Probe (Taqman MGB 
probe)
MGB-ORF1/ORF2 (5’-FAM- CGC TTT GGA ACA ATG -M G B ­
N F Q -3 ’)
lACP lACP (5’-VIC- CCA TAC ACA TAG GTC AGG -M G B - NFQ- 3 ’
Table 2.3 Murine norovius oligonucleotides. The table describes primer 
sequences used for the MNoV detection method. Figure adapted from Diez- 
Valcarce et al [212].
Detection target
Vims DNA/RNA
lAC target
L. monocytogenes DNA
Primer L.monoF 
#  #  #  #
# * # #
Primer L.monoR
Primer lACF 
# •  •  •
1st PCR
2nd PCR
•  •  •  •
Primer lACR
lAC
Chimeric DNA
T7 RNA pol + DNase
DNA RNA
Duplex real-time PCR Duplex RT-real-time PCR
Figure 2.4 lAC constructions. PCR amplification of non-target DNA is performed 
using hybrid oligonucleotide primers. This produces a chimeric DNA molecule 
containing non-target sequences flanked by target sequences complementary to the 
virus-specific primers. This molecule is then cloned into a plasmid. If the lAC is for 
RNA virus detection, the plasmid should contain a T7 RNA polymerase promoter, 
and lAC RNA transcripts are subsequently produced by T7 RNA polymerase. The 
plasmid or the RNA transcript is the chimeric lAC which is co-amplified with the 
virus primers and detected using a fluorescent probe complementary to the internal 
non-target sequence. Figure taken from Diez- Valcarce et al [212].
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2.4 Data interpretation: Results and data interpretation were described by 
D’Agostino et al 2011 [217, 218]. Briefly, each participant sent to the trial leader 
their data [217, 218]. When an assay showed a quantification cycle (Ct) value lower 
or equal to 40 or 45 for Murine Norovirus or adenovirus, respectively, 
independently of the corresponding lAC Ct value, the result was interpreted as 
positive [217, 218]. When an assay showed a Ct value more than or equal to 40 or 
45 for Murine Norovirus or Adenovirus, respectively, and the LAC Ct value lower 
or equal to 40, the result was interpreted as negative [217, 218]. When an assay 
showed both the target and its corresponding lAC Ct values > 40 or 45 respectively, 
the reaction was considered to have failed. When a participant reported that at least 
one of the HAdV replicates was positive, they were considered to have identified 
the sample as being Adenovirus contaminated [217, 218]. When a participant 
reported that both HAdV replicates were negative, but at least one replicate MNoV 
assay was positive, they were considered to have identified the sample as being 
Adenovirus uncontaminated [217, 218]. When a participant reported that both 
replicate HAdV assays were negative and both replicate MNoV assays were 
negative, they were considered to have reported that the analysis of that sample had 
failed. Interpretation of the results followed the principles outlined by D’Agostino et 
(2011) [219].
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Results
2.5 Detection of spiked Human Adenovirus in raspberries samples
Nine batches of raspberry samples were spiked with an equivalent number of blind 
coded samples, some of them known to contain human adenovirus (HAdV). Murine 
Norovirus (MNoV) was used as internal extraction control. At the end of the ring 
trial, the ring trial leader sent a feedback to each participant. The nine blind coded 
samples were revealed to be divided into three groups: three positive with high viral 
titre (5x lO"^  PFU) three positive with low viral titre (5x 10  ^ PFU) and three 
negative for HAdV. On three samples tested in duplicate for each category (high, 
low level and blank) for HAdV all the samples tested by AHVLA showed the 
expected Ct values (high HAdV contamination Ct values of 26, low HAdV 
contamination 33, blank HAdV contamination no Ct values).
Table 2.5 shows the results from the analysis of raspberry samples artificially 
contaminated with 5x 10  ^PFU of HAdV. The Ct values detected by real time PCR 
for these samples had an average of 26 Ct. All samples were correctly reported as 
contaminated with the target virus (HAdV) by real time PCR. Table 2.6 shows the 
results, obtained by real time PCR, from the analysis of raspberry samples 
artificially contaminated with 5x10^ PFU HAdV, in this case the Ct detected by real 
time PCR were around 33 Ct. Table 2.7 shows the results from the analysis of the 
non-artificially contaminated raspberry samples where no Ct values were detected 
by real time PCR.
Sixteen out of 18 duplicates tested were positive for MNoV. Percentages of 
concordance of the results provided at AHVLA by the ring trial leader are shown in 
table 2.8.
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Laboratoiy Sample A Sample B Sample C
HAdV MNoV HAd\^ MNoV HAdV MNoV
Rep. 1 Rep. 2 Rep. 1 Rep. 2 Int. Rq>. 1 Rqp. 2 Rep. 1 Rq>. 2 Int. Rep. 1 Rep. 2 Rep. 1 Rep. 2 In t
Table 2.5 Results of analysis of raspberry sample artificially contaminated with 5x10  ^
PFU human adenovirus (HIGH). Twenty five g of raspberry was artificially 
contaminated with 50 p.1 of HAdV and with 10 jil of extraction control (MNoV). 
Samples A, B, C represent the samples run in duplicate of raspberries contaminated with 
HIGH level of HAdV (Human Adenovirus), and spiked with MNoV (Murine 
Norovirus). Rep. - replicate; + target signal present by real time RT-PCR, lAC signal 
present or absent by real time PCR; -  target signal absent by real time PCR, LAC 
signal present; C-sample contaminated; Int -Interpretation. Figure adapted from 
D’Agostino et al, 2011 [217,218].
Laboratory Sample A Sample B Sample C
HAdV MNoV HAdV MNoV HAdV MNoV
Rep. 1 Rep. 2 Rep. 1 Rep. 2 Int. Rep. 1 Rep. 2 Rep. 1 Rep. 2 Int. Rep. 1 Rep. 2 Rep. 1 Rep. 2 Int.
Table 2.6 Results of analysis of raspberry sample artifîcially contaminated with 5x10  ^
PFU human adenovirus (LOW). Twenty five g of raspberry was artificially 
contaminated with 50 jil of HAdV and with 10 |il of extraction control (MNoV). 
Samples A, B, C represent the samples run in duplicate of raspberries contaminated with 
LOW level of HAdV (human adenovirus), and spiked with MNoV (Murine 
Norovirus). Rep. - replicate; + target signal present by real time PCR, LAC signal 
present or absent by real time PCR; -  target signal absent by real time PCR, LAC 
signal present; C- contaminated; Int - Interpretation. Figure adapted from D’Agostino 
erfl/,2011[217,218].
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Laboratory’ Sample A Sample B Sample C
HAdV MNoV HAdV MNoV HAdV iViNoV
RqrJ Rqi. 2 R ep .! Rep. 2 Int. R ep .! Rep, 2 Rep. 1 Rqr. 2 bit. Rep. I Rep. 2 Rep. 1 Rep, 2 bit.
TIC nr nr.
Table 2.7 Results of analysis of the non-artifîcial contaminated raspberry sample.
Twenty five g of raspberry was artificially contaminated with 50 |il of HAdV and 
with 10 jll of extraction control (MNoV). Samples A, B, C represent the samples run in 
duplicate of raspberries contaminated with no HAdV human adenovirus, and spiked with 
MNoV murine norovirus. Rep. - mean replicate PCR; + target signal present by real 
time PCR, LAC signal present or absent by real time PCR; -  target signal absent, LAC 
signal present; UC - uncontaminated; Int - Interpretation. Figure adapted from 
D’Agostino et al, 2011 [217, 218].
HAdV MnoV
High level: 100% concordance 88.88% concordance
Low level: 100% concordance
Blank: 100% concordance
Table 2.8 Percentage of concordance for raspberry samples of the results 
provided at AHVLA by the ring trial leader. The first column describes that all 3 
samples tested were reported as contaminated/uncontaminated with the High/ Low 
/Blank of HAdV. The second column represents the total MNoV concordance.
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2.6 Detection of spiked Human Adenovirus in liver samples
Nine batches of liver samples were spiked with an equivalent number of blind 
coded samples, some of them known to contain HAdV. MNoV was used as internal 
extraction control. At the end of the ring trial, the ring trial leader sent a feedback to 
each participant. The nine blind coded samples were revealed to be divided into 
three groups: three positive with high viral titre (5x lO'^  PFU), three positive with 
low viral titre (5x 10  ^PFU) and three negative for HAdV.
From the Collaborative Trial Table 2.9 shows the results from the analysis of liver 
samples artificially contaminated with 5x 10  ^PFU of HAdV obtained by real time 
PCR with an average of 29 Ct values. All samples were correctly reported as 
contaminated but one was detected at a higher Ct than expected (40). Table 2.10 
shows the results from the analysis of liver samples artificially contaminated with 
5x10^ PFU HAdV, in these samples the average of Ct values detected was 34. All 
samples were correctly reported as contaminated as judged by the ring trial leader. 
Table 2.11 shows the results from the analysis of the non-artificially contaminated 
liver samples and all samples were reported as negative where no Ct values were 
detected by real time PCR in all samples.
Percentages of concordance of the results provided at AHVLA and those disclosed 
by the ring trial leader are shown in Table 2.12. Of three samples tested in duplicate 
for each category (high, low level and blank) for HAdV all but one sample gave the 
expected Ct values. One replicate of sample contaminated with High HAdV level 
gave a Ct over 40, and was considered by the ring trial leader as negative. Thirteen 
out of 18 duplicates tested were positive for MNoV.
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Laboratory Sample A Sample B Sample C
HAdV MNoV HAdV MNoV HAdV MNoV
Rep. 1 Rep. 2 Rep. 1 Rep. 2 In t Rep. I Rep. 2 Rep. 1 Rep. 2 Int. Rep. 1 Rep. 2 Rep. 1 Rep. 2 In t
Table 2.9 Results of analysis of liver artificially contaminated vrith 5x10^ PFU 
human adenovirus (HIGH). Two hundred and fifty mg of liver tissue was 
artificially contaminated with 50 jitl of HAdV and with 10 [il of MNoV (the 
extraction control).Samples A, B, C represent the samples run in duplicate of 
raspberries contaminated with HIGH level of HAdV (Human Adenovirus), and 
spiked with MNoV (Murine Norovirus). Rep. - replicate R; + target signal present by 
real time PCR, lAC signal present or absent; -  target signal absent by real time PCR, 
LAC signal present; C - sample contaminated; Int - interpretation.
Laboratory Sample A Sample B Sançle C
HAdV MNoV HAdV MNoV HAdV MNoV
Rep. 1 Rep. 2 Rep. 1 Rep. 2 InL Rep. 1 Rep. 2 Rep. 1 Rep. 2 Int. Rep. 1 Rep. 2 Rep. 1 Rep. 2 In t
Table 2.10 Results of analysis of liver artificially contaminated with 5x10^ PFU 
human adenovirus (LOW). Two hundred and fifty mg of liver tissue was 
artificially contaminated with 50 |il of HAdV and with 10 jitl of MNoV (the 
extraction control). Samples A, B, C represent the samples run in duplicate of 
raspberries contaminated with LOW level of HAdV (Human Adenovirus), and 
spiked with MNoV (Murine Norovirus). Rep. - replicate; + target signal present by 
real time PCR, lAC signal present or absent; -  target signal absent by real time PCR, 
LAC signal present; C - sample contaminated; Int - interpretation.
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laboatarj* Sample A Sample B Sample C
RAdV MNoV HAdV MNoV HAdV MNoV
RepJ Rep. 2 Rep. I Rep. 2 bit. Rqi. 1 Rep. 2 Rep. 1 Rep. 2 bit. Rep, 1 Rep. 2 Rep. I Rep. 2 b it
Tir - no nr.
Table 2.11 Results of analysis of the non-artificial contaminated liver sample. Two
hundred and fifty mg of liver tissue was artificially contaminated with 50 jil of 
HAdV and with 10 |Lil of MNoV (the extraction control).Samples A, B, C represent the 
samples mn in duplicate of raspberries contaminated with HIGH level of HAdV (Human 
Adenovirus), and spiked with MNoV (Murine Norovirus). Rep.- replicate; + target 
signal present by real time PCR, lAC signal present or absent; -  target signal absent 
by real time PCR, lAC signal present, UC uncontaminated; Int - interpretation.
HAdV MNoV
High level: 83.33% concordance 72.22% concordance
Low level: 100% concordance
Blank: 100% concordance
Table 2.12 Percentage of concordance for liver samples of the results provided 
at AHVLA by the ring trial leader. The first column describes that all 3 samples 
tested were reported as contaminated/uncontaminated with the High/ Low /Blank of 
HAdV. Second column represents the total MNoV concordance.
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2.7 Discussion
In general, the results obtained at AHVLA proved capability of detecting the target 
virus (Human Adenovirus).
The method under trial proved capable of detecting Human Adenoviruses in berry 
fruit at a level of at least 10  ^ PFU per 25 g in artificially contaminated samples. 
Concordance of 100% was obtained for detection of HAdV in raspberries, and 
83.3% of concordance was obtained for detection of HAdV in pork liver, this is due 
to one duplicate of the sample with high titre found to be negative. However, a 
lower percentage of concordance (88.8%) for the raspberries (16 of 18 duplicates 
tested were positive) and 72.2% for the pork liver (13 of 18 duplicates tested were 
positive) for the process control virus (Murine Norovirus) (Tables 2.8 and 2.12) 
indicated that the protocol was in need of some refinement. Template inhibition (too 
much template in the reaction), pipetting error and some problems related to the 
extraction methods of the pork liver SOP (such as presence of fat in the samples) 
could have contributed to these differences. The SOPs of the EU VITAL project 
were assessed with overall good results.
The ring trial assessed the efficacy of the SOPs developed during the first year of 
the project and assessed the capability of the different data gathering laboratories in 
their implementation, thereby providing a system for integrating the monitoring and 
control of viruses in food supply chains.
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CHAPTER 3
Hepatitis E virus in the UK pork food chain
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3.1 Introduction: VITAL Data gathering
After optimisation of the SOPs during the VITAL Ring Trial, this project assessed 
hepatitis E virus (HEV) contamination of the pork food chain from production to 
point of sale.
Current systems for the monitoring and control of foodborne contaminations are 
largely based on measuring contamination with bacterial and fungal pathogens, with 
significantly lower emphasis on viral pathogens. As a consequence, the risks of viral 
contamination of food at various points in production chains are largely unknown, 
rendering construction of control measures and codes of practice very difficult.
HEV has been implicated in zoonotic foodborne acute hepatitis from contaminated 
pig products [134] (see chapter 1). This study investigated the various stages of the 
pork production foodchain from farm to retail outlet, to identify HEV contamination 
levels. The knowledge derived from these studies will be used to develop codes of 
practice aimed at reducing or eliminating transmission of HEV via the foodborne 
route.
This chapter reports the findings obtained within the VITAL project in the pork 
food chain in the United Kingdom.
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Materials and Methods
3.2 UK sampling scheme
Samples were collected in a UK pig slaughterhouse (livers and individual faecal 
samples), in a UK meat processing point (muscle samples), and in a UK 
supermarket and a local butcher’s shop (sausages). In addition, surface swabs were 
collected at the premises, in areas where viral contamination was considered more 
likely. These included work surfaces (e.g. chopping boards, scales), utensils (e.g. 
knives, points) and workers’ hands {Table 3.1). All samples collected were tested 
for the presence of HEV (target virus). In addition they were tested for porcine- 
adenovirus (PAdV) and HAdV, indicators of pig and human faecal contamination, 
respectively. Nucleic acid extraction and real-time PCR were performed according 
to standardised VITAL protocols. All samples were spiked with a control virus. 
Murine Norovirus (MNoV) during nucleic acid extraction, to demonstrate the 
extraction of amplifiable nucleic acid.
3.2.1 Sample collection:
3.2.1.1 Slaughterhouse: 40 carcasses were selected after slaughter. Ten carcasses 
were randomly selected from each of 4 batches of pigs slaughtered on that day 
(corresponding to 4 different farms). From each carcass the visceral pack was 
removed during the slaughter process and 2 to 3 grams of liver and 8 to 10 grams of 
faeces were collected. Ten surface swab samples were also collected at this point 
{Table 3.1).
3.2.1.2 Processing/cutting point: 40 carcasses were selected. Ten carcasses were 
randomly selected from each of 4 batches of pigs slaughtered (corresponding to 4
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different farms, all slaughtered in the abattoir visited within the study). From each 
carcass five grams of muscle were collected. Ten surface swab samples were also 
collected at this point {Table 3.1).
3.2.1.3 Point of sale: 63 sausages were collected in 11 batches from 2 different 
types of retail outlet (2 UK supermarkets and 1 butcher). Sausages were collected 
on different days to ensure that they were from different batches of pigs. Eight 
surface swab samples were collected at this point of the pork food chain {Table 3.1).
3.3 Sample preparation and nucleic acid extraction:
3.3.1 Faeces: Two hundred and fifty mg of soft faecal contents was suspended in 
2.25 ml of gentamycin-containing PBS solution and centrifuged at 3.000g x 15 min. 
Nucleic acid was extracted from 140 \i\ of the supernatant using the QIAamp® viral 
RNA mini kit (QIAGEN), according to the manufacturer’s instructions. (VITAL 
SOP 001, Appendix C.l, VITAL SOP 010, Appendix C.5).
3.3.2 Liver, meat, sausages: The samples were prepared according to the protocol 
described by Bouwknegt et al, 2007 [151]. Briefly, two hundred and fifty mg of 
pork meat or liver tissue taken from 3 different meat locations were disrupted in 
lysis buffer and microcarrier beads (BlOspec products, cat. no. 110791 lOzx) using a 
mechanical disruptor (3.000 rpm x 50 sec). Nucleic acid was extracted from the 
supernatant using the RNeasy Midi kit (QIAGEN), according to the manufacturer’s 
instructions. (VITAL SOP 009, Appendix C.4, VITAL SOP Oil, Appendix C.6).
3.3.3 Swabs: A sterile gauze square was swabbed five times in the operative’s hand 
and transferred to a plastic bag containing 20 ml of gentamycin- PBS solution (see 
recipe in Appendix C.2 and C.8). The gauze swab was squeezed to release the
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contents of the swab, the contents were vortexed and the eluate was centrifuged at 
3.000g X 5 min and stored at -20°C.
Nucleic acid was extracted using the NucliSENSminiMAGO kit (bioMérieux), 
according to the manufacturer’s instructions. (VITAL SOP 002 and VITAL SOP 
013 Appendix C.2 and C.8).
3.3.4 Extraction control: Each sample was spiked with 10 pi of a culture of MNoV 
(titre: 4.7x10^ PEU) before the lysis step of the extraction. Detection of MNoV 
RNA by PCR was used to demonstrate extraction of amplifiable nucleic acid.
3.4 Real time PCR: all real time PCR and real time RT-PCR were duplex PCRs 
containing probe of the target virus and probe for the specific lAC.
3.4.1 HEV: PCR to detect HEV in the collected samples was performed using the 
RNA Ultrasense™ One-Step Quantitative RT-PCR System (Invitrogen) and the 
primers and probe.
Jothikumar’s primers [220] and probes were used and they were designed on a 
multiple sequence alignment of HEV genome sequences in the ORF3 region 
available in GenBank [220].
- JHEV-F (5’- GGT GGT TTC TGG GGT GAC -3’) (10 pM);
-JVHEV-R (5’- AGG GGT TGG TTG GAT GAA -3’) (10 pM);
- JHEV-P (Taqman probe) (5’-FAM- TGA TTC TCA GCC CTT CGC -BG Q l-3’) 
(10 pM), [220].
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Ten pi of RNA were added to a mix containing buffer RNA Ultrasense reaction mix 
(5X), lAC probe (IpM), ROX reference dye (50x), RNA Ultrasense enzyme mix 
and 0.6 pi of lAC to a total volume of 20 pi.
The real time RT-PCR reaction was carried out at 50°C for 15 min, 95°C for 2 min, 
and 45 cycles at 95°C for 10 sec, 55°C for 20 sec and 72°C for 15 sec {VITAL SOP 
020, Appendix C .l2).
3.4.2 PAdV: PAdV PCR was performed using TaqMan Universal PCR Master Mix 
(Applied Biosystems). Hundesa et al (2009) [211] primers and probe were used: 
PAdV-F (5’-AAC GGC CGC TAC TGC AAG-3’), PAdV-R (5’ AGC AGC AGG 
CTC TTG AGG-3’), PAdV-P (5’- FAM-CAC ATC GAG GTG CCG C-BHQl-3’) 
at a final concentration of 0.225 pM. Location of oligonucleotides refers to PAdV -3 
hexon (GenBank accession number AJ237815).
Ten pi of RNA were added to a mix containing buffer reaction mix (2X) ,IAC-P and 
0.5 pi of lAC (0.1 pM) to a total volume of 25 pi. The PCR reaction was performed 
for 2 min at 50° C, 10 min at 95° C, and 45 cycles of 15 s at 95° C, 20 s at 55° C and 
20 s at 60° C [221]. (VITAL SOP 015, Appendix C.IO).
3.4.3 MNoV: Real time RT-PCR was performed as described in section 2.3.2. 
Briefly the MNoV PCR was performed using RNA UltraSense^^ One-Step 
Quantitative RT-PCR System (Invitrogen) and primers and probe were designed by 
Baert et al in the ORFl/2 junction region: Fw-ORFl/ORF2 (5’- CAC GCC ACC 
GAT CTG TTC TG-3’) (location 4972-4991), Rv-0RF1/0RF2 (5’- GCG CTG 
CGC CAT CAC TC-3’) (location 5064-5080), MGB-ORF1/ORF2 ( 5 -FAM-CGC 
TTT GGA ACA ATG-MBG-NFQ-3’) (location 5001-5015) [216].
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Ten pi of RNA were added to a mix containing buffer RNA Ultrasense reaction mix 
(5X), lAC probe (IpM), ROX reference dye (50X), RNA Ultrasense enzyme mix 
and 0.6 pi of lAC with a total volume mix of 20 pi. The RT-PCR reaction was 
carried out at 50°C for 15 min, 95°C for 2 min, and 40 cycles at 95°C for 15 s and 
60°C for 1 min (VITAL SOP 21, Appendix C .l3).
3.4.4 HAdV: Real time RT-PCR was performed as described in section 2.3.1 [210]. 
Briefly the HAdV PCR was performed using TaqMan Universal PCR Master Mix 
(Applied Biosystems). Hernroth et al (2002) [210] primers and probe were used. 
Primers have been selected from the conserved region of the first part of the 
Adenovirus hexon gene. AdF (5’- CWT ACA TGC ACA TCK CSG G-3’). AdR 
(5’- CRC GGG CRA AYT GCA CCA G-3’), AdPl (5’- FAM- CCG GGC TCA 
GGT ACT CCG AGG CGT CCT-BHQ-3’) [210] at a final concentration of 0.225 
pM. Ten pi of RNA was added to a mix containing buffer reaction mix (2X), lAC-P 
(0.1 uM) and 0.6 pi of lAC to a total volume of 25 pi. The RT-PCR reaction was 
performed at 2 min at 50°C, 10 min at 95°C, and 45 cycles of 15 s at 95°C and 1 min 
at 60°C [210]. (VITAL SOP 015, Appendix C.9). Only swabs samples were tested 
for HAdV.
3.4.5 Internal assay controls: All real time RT-PCRs and real time PCRs were 
performed with an internal assay control (lAC). lAC construction was explained in 
section 2.3.3. Briefly the lACs (lAC RNA or DNA depending on which virus was 
going to be tested) were added in each reaction to test for inhibitors of PCR 
amplification and to control for contamination of any of the real time RT- PCR 
reagents [212].
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The lAC was detected by a probe that targeted a different sequence to that of the 
target virus probe, and was distinguished from the target probe by using a different 
fluorescent label. A MGB TaqMan probe was used for each lACP assay, at a final 
concentration of 0.1 pM {VITAL SOP 22 and 23, Appendix C.14 and C.75).
The constmction of lACs was performed by Diez-Valcarce et al [212] with PCR 
amplification of non-target DNA using hybrid oligonucleotide primers containing 
sequences from the prfA gene from Listeria monocytogenes (nucleotide positions 
2281-2348, AN AY512499). This produces a chimeric DNA molecule containing 
non-target sequences flanked by target sequences complementary to the virus- 
specific primers [212]. The probes, labelled with one fluorophore (e.g. FAM), and 
the lAC amplicons are detected with the specific lAC probe, labelled with a 
different fluorophore (e.g. VIC) detected by real time RT-PCR with specific 
hydrolysis [212].
The number of lAC copies was calculated by dividing the amount of lAC in each 
stock solution by the weight of one lAC molecule [212].
3.4.6 Positive standards construction: Synthetic multiple-target RNA
oligonucleotides were constructed for use as quantification standards for nucleic acid 
amplification assays for Human Norovirus genogroup I and II, Hepatitis E virus. 
Murine Norovirus [208]. Briefly, a synthetic DNA molecule was designed to contain 
target sequences for reverse transcription real-time PCR (RT-PCR) assays for HEV 
[220], hNoV GI [214] and hNoV GII [222]. The oligonucleotide was synthesised 
(Burofins MWG Operon, Ebersberg, Germany) and cloned into a pCR 2.1- TOPO 
plasmid (Invitrogen, Breda, The Netherlands) [208], {Figure 3.2). The RNA 
concentration was determined by UV spectrophotometry in a Nanodrop ND-1000
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spectrophotometer (ThermoScientific, Wilmington, NC, USA). The measurement 
was performed in duplicate and concentration in grammes was converted to molecule 
number using the following formula:
RNA molecules x
— [(g/|.il)/(transcript length in nucleotides x 340)]
X 6.022 X 1(P
The standards used for the quantification of the targets viruses were designed by 
Martinez-Martinez et al [208] and subsequently sent to all VITAL data gathering 
laboratories.
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Slai^italioiBe Pl’ocesidng^ cutting po in t Point of sole
Bar under qp etator insp ecting livers B ench on v ^ c h  meat is sold Chopping board
Floor under carcasses in dean area Box in which cuts collected Cold-room
Doorhandle
Hand 1 Doorhandle Hands
Hand 2
Hand 3
Hand 4
Hand 1
Hand 2
Hook
Kni fe us ed immediately after scrapin g Kni fe
Knife used on livers immediately after Point
Evisceration Saw
FI oor under v^iich livers are hung Scale
Boxes in which livers are collected 
prior to freezing and sale
Knives
Sausage maker 
Sink 
Sheer 
Toilet
Table 3.1 Source of surface swab samples. The first column describes all the 
swabs samples collected at the slaughterhouse. The second column describes all the 
swabs samples collected at the processing point. The third and last column 
represents all the swabs collected at the point of sale.
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OCGOCCOdTCOACGCCATCTTCATTCACAAAACTGOGAGCCAGATT<3CGATCOCCCTO:CACOTGCTCAGATCTOAGAATCTCATCCATCTOAACATfc-C7X4GM
CGCCA7CA7CATTrACaKM7CQQQCAQQÂQA77QCQATCTCTaTCCA7AATCCGAG<n-CATOQMGCGCA7CCAGCQKQQOGTlGCllG<iMGWXMKG(i(i(iKX
TGCGAAGGGCTGACAATCAACCCGGTCACCCCAGAAACCACCOCOGCCOCAATAAGGOCOAATTCTOCAOATATCCATCACACTOOCGOCCGCTCGAOa
GCOTGGGGCCC
pCR2.1TOPO-rSTD 
4295 bp
Figure 3.2 Graphie representation of pCR2.1TOPO-rSTD containing the 
sequence of the synthetic rFBVl RNA. The length of the plasmid pCR2.1TOPO- 
rSTD is 4295 bp. The viral insert was flanked by Notl and Apal sites. The sequences 
of the RT-qPCR assays are shown (hNoV GII— within box, hNoV GI—italics, 
HEV—bold and MNV-1— underlined. The sequences corresponding to the TOPO 
vector are in normal type. Figure taken from Martinez-Martinez et al [208].
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Results
UK pork products (livers, muscles and sausages) and faeces collected in the various 
stages of the pork food chain (slaughterhouse, processing point and point of sale) 
were tested for HEV to identify the possible HEV contamination levels.
The samples that tested positive for the different PCRs are listed in Table3.3. The 
table describes the 3 points of the food chain where the pork samples were 
collected.
3.5 HEV detection
HEV RNA was detected at all three sites of the pork food supply chain as evidenced 
by real time RT-PCR. Table 3.3 shows the number of samples where HEV RNA 
was detected. In the production point (slaughterhouse) we detected 5 HEV positive 
faeces in a total of 40 samples collected (13%). One of the 40 livers (2.5 %) and 1 
of 10 (10%) surface swabs, a hand swab of a worker along the chain, were HEV 
positive.
In the processing plant none of the 40 pig muscle samples were HEV positive, 
whilst 1 of 10 (10%) surface swabs from a metal point used to hook the carcasses 
were HEV positive.
At the point of sale 6/63 (9.5 %) sausages and 2/8 (25%) surface samples (knife and 
slicer swabs) were HEV positive. Five of the 6 positive sausages were in 1 of the 11 
batches collected. All control results showed no evidence of cross contamination.
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3.5.1 PAdV detection
The indicator of pig faecal contamination, PAdV, was detected at 2 of 3 sites. 
Thirty-nine out of 40 (98%) faeces samples were PAdV positive in the production 
point as were 6 of the 40 livers (15%) and 4 of 10 (25%) surface swabs (knife swab 
immediately after evisceration, 2 hand swabs and floor swab from under which pigs 
are hung). At the processing point PAdV was not detected in any of the pig muscle 
samples (n=40) or swab samples (n=10) tested. At point of sale PAdV was not 
detected in any of the sausages (n=63) tested but 1 of 8 swab samples (12.5 %) from 
the door handle of the cold room was PAdV positive (Table 3. 3).
The highest number of PAdV positive swabs was observed in the production point 
(4/ 10) whilst no PAdV was detected in any swab at the processing point (Table
3.5.2 HAdV detection
Swabs collected in the three points of the pork food chain were tested for HAdV, 
but presence of virus was not detected in any of the swabs collected, as shown by 
real time PCR. (Table 3.3).
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Point in chain Sample type PAdVDNA + /n(% ) HEVRNA + /n(% )
HAdV+/n
Production point 
(slaughterhouse)
Faeces 3 9 /4 0  (98) 5 /4 0  (12.5) -
Liver 6 /4 0  (15) 1 /40 (2 .5 ) -
Surface swab 4 /1 0  (40) 1 /1 0  (10) 0 /1 0
Processing point Muscle 0 /4 0 0 /4 0 -
Surface swab 0 /1 0 1 /1 0  (10) 0 /1 0
Point o f sale Sausage 0 /6 3 6 / 63 (9.5) -
Surface swab 1 /8 (1 3 ) 2 /8 (2 5 ) 0 / 8
Table 3.3 Number of samples PAdV, HEV and HAdV positive. The first column 
represents the point of the chain: production point (sloughterhouse), processing 
point and point of sale. The second column describes the sample type: faeces, liver, 
surface swabs of the slaughterhouse. In addition it describes muscle and surface 
swabs of the processing point and sausages and surface swabs of the point of sale. 
The third columns describes the number and percentage of sample tested PAdV + 
(positive)/-(negative) as assessed by real time RT-PCR. The fourth column 
represents the number and percentage of samples tested HEV + (positive)/- 
(negative). The last column describes the number and percentage of samples tested 
HAdV +(positive)/-(negative).
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3.6 Discussion
The presence of HEV and/or faecal contamination was investigated at three points 
in the pork food supply chain in the UK, in the slaughterhouse, in the processing 
plant and at the point of retail sale. Samples of pig liver and faeces were collected at 
slaughter, samples of pig muscle (meat) during processing, and pork sausages at the 
point of sale. In addition, swab samples were collected from various surfaces 
considered likely sources of HEV and/or faecal contamination. All samples were 
tested by real time RT-PCR for HEV and real time PCR for PAdV, and for HAdV 
(swab samples only).
HEV has a high seroprevalence in the UK pig herds [121]. In this study HEV was 
detected in the faeces of 12.5% of pigs at slaughter-weight. In a previous study 
conducted in the UK [223] a similar percentage (13%) [121] of faeces collected at 
slaughter weight was positive for HEV. The presence of HEV in pig liver at 
slaughter has not been investigated in the UK prior to this study, but at 12.5% 
indicates that a high percentage of HEV faeces-positive slaughter pigs may have 
HEV present in the liver.
The failure to detect HEV in pig meat in the cutting (processing) plant compared to 
the detection in 9.5% of pork sausages at the point of sale is interesting. Liver is not 
permitted as a constituent of pork sausages in the EU (Commission Directive 
2001/101/EC), but it is possible that the samples of muscle tissue scanned for HEV 
at the processing point were not as representative as those for sausage meat, where 
mixing and mincing of meat occurs prior to sausage production. The sausages were 
collected on different days to ensure they originated from different batches of pigs.
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The choice of sausages as the type of point of sale pork product investigated for 
HEV was made because this product is consumed widely across the UK, unlike pig 
liver for instance, and a 9.5% HEV detection rate in pork sausages at point of sale 
could be a cause for concern.
In terms of viral transmission potential, the surface swabs provided evidence that 
both PAdV and HEV contamination does occur in the slaughterhouse and 
interestingly at the point of sale. In the processing point HEV was detected in just 1 
surface swab. The 98% positive rate recorded for pig faeces with the PAdV indicator 
provides validation of this approach for detection of faecal contamination of porcine 
origin. The detection of PAdV on a door handle swab is interesting. This may have 
been the result of transfer from a contaminated pig carcass, but the in-test controls 
and method of sampling exclude this contamination as a source of the HEV in the 
sausage meat.
No evidence of human faecal contamination was detected in any sample at any 
point in the chain, indicating that personal hygiene standards were high, and that the 
HEV detected was unlikely to have come from human contamination of the 
samples.
In industrialized regions, although the incidence of clinical hepatitis E in humans is 
low, the seroprevalence is relatively high, indicating a high proportion of subclinical 
disease and/or underdiagnosis. Whilst it is likely that a small proportion of this 
exposure to HEV results from travel to or migration from, endemic regions [117, 
142], this still leaves a substantial level of exposure to HEV that appears to have an 
indigenous source.
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Pork food products have been shown to contain HEV in several industrialized 
regions, including the UK and recently a cluster of cases in Southern France 
associated with the consumption of raw figatelli, a pig liver sausage mainly eaten 
raw [134]. However, these pork foodborne reports have to date involved pig liver, 
and although in other studies pig muscle tissue was shown to carry HEV [224], this 
current study shows that in the UK, a proportion of a point of sale pork product with 
a high volume, nationwide consumption (>193,000 tonnes of pork sausages 
consumed in GB in the year to February 2012, BPEX, UK), may be contaminated 
with HEV.
In efforts to determine the transmission routes of autochthonous hepatitis E, this 
data does indicate that the potential for exposure to HEV via consumption of 
undercooked pork sausages does exist in the UK.
It has to be remembered that the numbers of samples tested for viral contamination 
were relatively small in this study, so these results should be taken as indicators 
only, and for greater confidence in the results, a greater number of samples would 
have to be tested.
A corollary question to ask from these observations is in relation to the viability of 
the HEV detected in the pork sausages. Feagins et al [85, 138] have modelled the 
survival of HEV under various times and temperatures of cooking [85] observing 
that HEV is not completely inactivated when heated at 56 ° C for 1 hour. So from 
this evidence, adequate cooking of pork sausage should at least remove the threat of 
infection. Whilst the findings reported here do not provide any indications regarding 
the viability of the detected HEV, viability of HEV in the positive samples from this
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study was determined using a 3D cell culture system which we have shown is more 
sensitive than monolayer culture for in-vitro propagation of HEV {Chapter 4).
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CHAPTER 4
Replication of Hepatitis E virus in three- 
dimensional cell cultures system
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4.1 Introduction
In addition to the data gathering on the presence of HEV in the food chain, this 
project also aimed to develop a 3D cell culture system able to support the 
replication of HEV and investigate if HEV detected by real time RT-PCR in pork 
products corresponds to the presence of viable virus.
To date attempts to confirm the routes of transmission in epidemiological 
investigations of cases of autochthonous hepatitis E in developed regions have 
failed [113] but it is suggested that there may be several routes of zoonotic 
transmission, contributing to exposure to HEV and disease in humans [125] 
{Chapter 1).
A major impediment to the investigation of potential HEV routes of transmission 
from pigs to humans is the limited knowledge relating to the survival of the virus in 
pig tissues and faeces and in the environment. To a large extent this is due to the 
difficulty in propagating HEV in-vitro. A  method using hepatocellular carcinoma 
HepG2/C3A has been reported by Emerson et al [225]. However, the infection of 
HepG2/C3A with HEV was not able to be repeated at AHVLA (data provided by 
Malcolm Banks). Tanaka et al [197] reported that PLC/PRF5 cells were able to 
support replication of HEV. Moreover, Tanaka et al [197] reported that the virus 
progeny was infectious, as demonstrated by passage in the PLC/PRF/5 cells [197]. 
Infection of PLC/PRF/5 using as inoculum swine faeces, instead of human faeces, 
was attempted at AHVLA without success. There are several reports in the literature 
demonstrating the potential of a 3D culture system utilising a Rotating Wall Vessel 
(RWV), for the growth of fastidious viruses [201, 226-228]. This RWV low-shear, 
suspension culture system was introduced as a novel method to cultivate cell lines
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able to support bacterial replication in varying shear conditions [200]. The RWV is 
a cylindrical bioreactor that is rotated on an axis parallel with the ground. 
Subsequently, a solid body mass rotation of the culture medium is obtained, creating 
a low-fluid-shear environment {Figure 1.10, chapter 1) [200, 229, 230]. The cells 
are maintained in suspension by the resolution of the centrifugal, gravitational and 
Coriolis effects, so cells placed in the RWV bioreactor experience minimal 
mechanical stresses and high mass transport (of nutrients, oxygen etc). It has been 
shown that several 3D lines changed molecular mechanisms in the transduction of 
mechanical culture conditions into cellular effects [231]. Possible changes of the 3D 
cells could be in cell cycle and cell death pathways or upstream regulation of 
secondary messengers [231]. The cells are attached to porous, collagen-coated 
microcarrier beads and this allow the cells to assemble into tissue-like aggregates 
with a functionality similar to tissues in the human body [231]. The system offers a 
potential for in vitro cultivation of HEV, therefore, we investigated the use of 3D 
cultures as a means of improving the efficiency of HEV propagation.
Since that literature reported that the 3D cell culture system is an efficient and 
reliable cell culture system able to support the propagation of viruses, during my 
PhD project I aimed to:
1) Evaluate a new 3D culture system to assess HEV infectivity. Homogenate of 
HEV positive pig liver obtained from an animal experiment was used as inoculum 
to evaluate the 3D cell culture system. This was needed to verify if the HEV 
detected by PCR in pig and environmental samples was infectious.
2) Compare the efficiency of the 3D system to the conventional 2D cell culture 
system (PLC/PRF/5 cells grew in monolayer). In addition, cells grown in the 3D
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system were transferred to a 2D system and infected. Since that the 3D cell culture is 
difficult for a number of reasons (i.e limited number of samples for each experiment) 
the testing of 3D transferred to 2D was an attempt to exploit these cell 
receptor/differentiation advantages in a format i.e. microplate, that would allow for 
larger numbers of samples to be tested.
4.2 Use of the 3D Culture system to investigate the viability of HEV detected by 
RT-PCR in UK pork sausage and French liver sausage (figatelli)
The detection of HEV RNA by real time RT-PCR in six of 63 pork sausages 
collected at UK retail outlets {Section 3.5.1) needed further investigation to clarify 
the risks of foodborne transmission of HEV. The concern was: is the virus viable or 
is it present but inactivated?
This section describes the work undertaken to use the 3D culture system as a means 
of determining the infectivity of the HEV real time RT-PCR positive UK sausages. 
Pork liver sausages, known as figatelli, which are often eaten raw after cold 
smoking, have been linked to cases of clinical hepatitis E in France. A collaboration 
was made with the French ANSES Institute in Paris. A contact was made with Dr 
Nicole Pavio of ANSES, with the suggestion that by using the 3D system, the 
viability of HEV detected in the figatelli could be confirmed. The figatelli saiisages 
were then sent to AHVLA for further investigations.
The main aim of this section was testing via the 3D cell culture system if the UK 
sausages collected during the VITAL data gathering {chapter 3) and French figatelli 
contains viable virus, for this reason the UK and French sausages were used as 
inoculum to infect 3D cell cultures and evaluate the infectivity of those samples.
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Materials and Methods
4.3 Propagation of HEV in cell cultures: The Alexander hepatocarcinoma cell line 
(PLC/PRF/5) from the American Type Culture Collection (ATCC 8024) was used 
in the experiments. The cells were initially grown as 2D monolayers inside 
conventional cell culture flasks (BD Bioscience, USA) in the complete growth 
medium GTSF-2 [228] {Table 4.1) in preparation for seeding into the Rotating Wall 
Vessel (RWV, Synthecon, Inc, Houston TX, USA), at 3TC  in a 5% CO2 
environment. Cells were trypsinised at 95% confluence and resuspended in fresh 
medium at a density of 2x10^ cells/ml, the cell density required before being 
transferred in the vessel. PLC/PRF/5 cells were introduced into a RWV cell culture 
vessel with 10 mg/ml of porous Cytodex-3 microcarrier beads (collagen type-I- 
coated porous microspheres, average size 175 \xm in diameter -  Cat number C0646, 
Sigma). Cells were cultured in the RWV in GTSF-2 at 37°C and 5% C02, with a 
rotation speed appropriate to maintain the cell aggregates in suspension during the 
entire culture duration (approximately 17-25 rotations/min initially with subsequent 
increase to 27-35 rotations/min after the infection) [232]. The cells were grown for 
at least 28 days before being infected to allow differentiation as described by 
Navran [232]. For the 2D system experiments the cells were seeded in 48-well 
plates, each well containing 2x10"^  cells.
4.3.1 Comparison of efficiency of the 3D and 2D cell culture for HEV 
replication: The first experiment aimed to compare the efficiency of the 3D and 2D 
cell culture systems when infected with the same HEV PCR positive inoculum. 
Details of the protocol used are listed below.
107
4.3.2 Inoculum preparation: The positive HEV pig liver sample obtained from an 
animal experiment was provided by Central Veterinary Institute, Wageningen 
University and Research Centre [86]. A sample of the liver (0.3g) was homogenized 
manually using a pestle and mortar in 2.7 ml of GTSF-2 media. The homogenate 
was centrifuged at 8.000 x g for 3 minutes and the supernatant was filtered through 
a sterile spin-X centrifuge tube filter (0.22pm; Costar) at 10.000 x g at 4°C for 15- 
25 min. Two and half ml of inoculum was used to inoculate the cells.
4.3.3 Infection of the cells:
3D: the medium was removed from the vessels and 2.5 ml of viral inoculum was 
added to the cells in the vessel. One vessel was inoculated with the virus and one 
was used as a negative control (2.5 ml GTSF-2 non-infected media). Cells were 
incubated for two hours at 35.5°C and inserted into the Rotating Wall Vessel. After 
two hours the vessel was filled with 47.5 ml of fresh medium. Subsamples of 
medium (140 pi) were collected in duplicate and added to 560 pi of lysis buffer 
(Viral RNA, Qiagen), and stored at -20°C (0 days post infection, dpi). Samples were 
collected as described above at the following dpi: 3, 6, 9, 12, 15, 18, 24, 27, 30, 32, 
36, 39, 42,46,49, 58, 62, 67, 70, 85, 107, 126, 134, 155 and 175.
2D: the medium was removed from the cells and 200 pi of virus inoculum was 
added to each well of a 48 well plate. One column of the plate was used as negative 
control (200 pi of GTSF-2 non-infected media). The plate was incubated at 35.5°C 
for two hours and each well was replenished with fresh medium (300 pi) without 
removing the inoculum. A subsample (140 pi) of medium was collected in duplicate 
and added to 560 pi of Lysis buffer and stored at -20°C (0 dpi). Fresh medium (280
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pi) was added to replace the medium that was removed. Samples were collected 
twice a week for 27 days.
4.3.4 Comparison of 3D, 2D and 3D transferred to 2D cell cultures for HEV 
replication: In a further experiment, the 3D cells from a 3D vessel were transferred 
to a plate to be infected simultaneously with the 3D cell culture and the 
conventional 2D cell culture.
3D cells transferred to 2D: Each well of the plate contained 50 pi of cells and media 
from one vessel (33 days of differentiation in the 3D system) plus 450 pi of GTSF-2 
media. The plate was left in the incubator for 6 hours at 37°C to allow cell adhesion.
The preparation of the 3D and 2D cell culture was performed as described in section 
4..?..?.
The inoculum was the supernatant (real time RT-PCR positive for HEV) of the cells 
of the first experiment at 58 dpi {section 4.3.1).
The virus was used neat and diluted from 10'^  to 10'  ^ in the 2D and 3D transferred 
to 2D systems. In the 3D system only four vessels were available and they were 
infected with the virus undiluted, diluted 10 times (10'^), diluted 100 times (10'^) 
and a non-infected control.
The infection of the three systems for HEV replication was performed following the 
protocol described in section 4.3.3. The experiment was carried out for 40 days and 
subsamples (140 pi) were collected at the following dpi: 0, 5, 8, 12, 15, 19, 22, 26, 
29, 33, 36 and 40, for both 2D cells and 3D cells transferred to 2D, while for the 3D 
cells the experiment lasted 96 days and samples were collected once a week.
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4.3.5 RNA extraction from supernatant of 3D cell cultures, 2D cell cultures and 
3D cell transferred to 2D system infected with HEV: Nucleic acid extraction was 
performed according the Qiagen viral RNA kit (Qiagen) protocol. A subsample 
(140 pi) of medium was collected in duplicate, added to 560 pi of Lysis buffer and 
stored at -20°C (0 dpi).
4.3.6 Real Time RT-PCR: The real time RT-PCR reaction was set up according to 
the protocol of Jothikumar et al 2006 [220] using the Superscript III Platinum one- 
step quantitative RT-PCR kit (Invitrogen). The RT-PCR reaction was set up and 
performed according to the manufacturer’s instructions. Jothikumar’s primers and 
probes were used and they were designed on a multiple sequence alignment of HEV 
genome sequences in the ORF3 region available in GenBank [220].
-JHEV-F (5’- GGT GGT TTC TGG GGT GAC -3’)
-JVHEV-R (5’- AGG GGT TGG TTG GAT GAA -3’)
- JHEV-P (Taqman probe) (5’-FAM- TGA TTC TCA GCC CTT CGC -BG Q l-3’).
The 20 pi reaction contained 10 pi of 2x RT-PCR kit Master Mix (Qiagen), 0.2pl of 
enzyme, 2pl of RNA, and primers and probe at concentrations of 250 and 100 nM, 
respectively. The real time RT-PCR reaction was carried out at 50°C for 15 min, 
95°C for 2 min, and 45 cycles at 95°C for 10 sec, 55°C for 20 sec and 72°C for 15 
sec.
Negative (water) and positive (synthetic RNA constructed by Martinez-Martinez et 
al [208]) controls were included in each run.
4.3.7 Positive standard and copy number quantification: The standard used for 
the quantification of the HEV nucleic was constructed by Martinez-Martinez et al
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[208]. The plasmid construction was described in section 3.4.6. Briefly the 
construction of a plasmid for transcription of synthetic RNA was performed. A 
synthetic DNA molecule was designed to contain target sequences for real-time RT 
PCR assays for HEV [220], hNoV GI [214] and hNoV GII [222] [208]. The 
oligonucleotide was synthesised (Eurofins MWG Operon, Ebersberg, Germany) and 
cloned into a pCR 2.1- TOPO plasmid (Invitrogen, Breda, The Netherlands).
The RNA concentration was determined by UV spectrophotometry in a Nanodrop 
ND-1000 spectrophotometer (ThermoScientific, Wilmington, NC, USA). The 
measurement was performed in duplicate and concentration in grammes was 
converted to molecule number using the following formula:
RNA molecules x |il ^
=  [(g/|il)/(transcript lengtii in nucleotides x 340)]
>< 6 .02:2 >( 1()23
The 20 gl reaction contained 10 gl of 2x RT-PCR kit Master Mix (Qiagen), 0.2ml of 
enzyme, 2gl of standard, and primers and probe at concentrations of 250 and 100 
nM, respectively. The real time RT-PCR reaction was carried out at 50°C for 15 min, 
95°C for 2 min, and 45 cycles at 95°C for 10 sec, 55°C for 20 sec and 12°C for 15 
sec.
This synthetic plasmid, as previously mentioned, was designed by Martinez- 
Martinez et al [208] as part of the VITAL project.
The copy number of the samples was extrapolated from a standard curve produced 
from logio titrations of cloned amplicon. Copy number (HEV RNA copies per ml 
sample) was calculated as follows:
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copy number per 2 gl template RNA
X 30 (per 60 gl extraction elute = 140 gl sample, HEV positive supernatant)
X 7.14 (1000 gl/140 gl)
4.3.8 Definition of Ct values: Cycle threshold (Ct) is a measure of the number of 
PCR cycles (in Real-time RT-PCRs) needed to observe a fluorescent signal. Our Ct 
+/- cut off value was fixed at 40 to avoid false positive and non-specific signal; this 
means that only sample with Ct < or equal to 40 were considered positive. The Ct 
values were determined fixing the threshold just above the non-specific background 
fluorescence.
4.4 Materials and Methods to investigate the viability of HEV in UK sausages 
and figatelli samples
4.4.1 Cell Preparation: cell culture preparation was performed as described in 
section 4.3.
4.4.2 Inoculum preparation of figatelli sample and UK sausages: After one year 
from the first HEV RNA detection only three of the six sausages (section 3.1) were 
still HEV RNA positive by real time RT-PCR, possibly due the degradation of the 
HEV RNA after prolonged storage. The HEV real time RT-PCR-positive figatelli 
samples were obtained from a French processing point (Dr Nicole Pavio, ANSES, 
France). Two and half g of each of the four figatelli samples (four different subtypes 
of genotype 3) and the three UK sausages were homogenized manually using a 
pestle and mortar in 5ml of GTSF-2 media. The homogenate was centrifuged at
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8.000 X g for 3 minutes and the supernatant was filtered through 1.2 gm, 0.45 \im 
and 0.2 gm filters to reduce the risk of bacterial contamination.
4.4.3 Cell inoculation: cell inoculation was set up as described in section 4.3.3.
4.4.4 Determination of infectivity of progeny virus: To evaluate the infectivity of 
progeny virus from the primary inoculations, HEV real time RT-PCR positive 
supernatant from dpi 16, of one sample named as figatelli 84, was used to infect 
fresh 3D PLC/PRF5 cultures. Two and half ml of HEV positive supernatant was 
used as inoculum to infect the 3D cell cultures. The cell inoculation was performed 
as described in sections 4.3.3.
4.4.5 RNA extraction and real time RT-PCR: HEV RNA extraction and real time 
RT-PCR was performed as described in section 4.3.5 and 4.3.6.
4.4.6 Electron microscopy: In order to provide further confirmation of the validity 
of the real time RT-PCR results, a sample was sent to Reimar Johne and Jhone 
Reetz at the Bundesinstitut fur Risikobewertung (BfR) in Germany and submitted to 
electron microscopy examination. Supernatant of the cell cultures collected at 33 
dpi was exposed to polioformcarbon-coated, 400-mesh copper grids (Plano GmbH, 
Wetzlar, Germany) for 10 min, fixed with 2,5% aqueous glutaraldehyde (Electron 
Microscopy Science Company , Germany) solution for 1 min and stained with 2% 
aqueous uranyl acetate solution (Electron Microscopy Science Company, 
Germany) for 1 min. The specimens were examined by transmission electron 
microscopy using a JEM-1010 (JEOL, Tokyo, Japan) at 80 kV accelerated voltage.
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Component
Concentration or 
volume ^
Source/order number of 
designation
MEM -0 1  supplemented with 2.25 g/liter of 
L-Gln 400 ml (40%) Sigma
L-15 600 ml (60%) GIBCO
NaHC03 1.35gperL Sigma/S-5761
HEPES 3.0g Research Organic s/6003H-2
Folic Acid 67 /ig/ml lOOul SIGMA/F-8758
0.5% Nicotinic Acid 0.66 ul Sigma/N-4126
Bactopeptone 0.6g Difco/0118-01
I-inositol 0.024g Sigma/I-5125
Fructose 0.13g Sigma/F-3510
Galactose 0.25g Sigma/ G-5388
D-Glucose 0.33g Sigma/G-5250
200mML-Gln [2Mm] 18.3ml Sigma/G-5763
Gentamycin 1ml Gibco/600-5750AD
Fungizone 1ml Sigma A 2942
Ins ulin - Trans ferrin- S o dium-S e lenite (ITS S) 5ml Sigma/1-1884
Fetal bovine serum (FBS)
6% during 
differentation 
2% after infection Autogenbioclear
Table 4.1 GTSF-2 complex medium with relative supplements \
 ^ Concentrations are provided for the preparation of approximate by 1 L volume of 
medium.
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Results
4.5 Comparison of HEV replication in 3D cell and 2D cell culture systems
This experiment was set up in order to assess the efficiency of HEV replication in 
the 3D cells culture system and to compare it to the conventional 2D cell culture 
system.
After the inoculation with homogenate of HEV positive liver obtained from an 
animal experiment, in the 3D culture system, HEV nucleic acid was detected in the 
supernatant of the infected cells at all collection points (Figure 4.2 A). In contrast, 
no HEV nucleic acid was detected at any collection points in the 2D culture system 
(Figure 4.2 E), for this reason the 2D experiment was terminated at 27 dpi. In the 
3D culture system, the virus copy number showed a significant increase between 24 
to 39 dpi, peaking at 1.5 xlO^ viral RNA copies/ml of supernatant, followed by a 
second increase between 100 dpi to 155 dpi, peaking at 2.0 xlO^ viral RNA 
copies/ml of supernatant (Figure 4.2 A). HEV nucleic acid was still detectable at 
175 dpi. In both culture systems, the non-infected control cells remained HEV 
negative throughout the experiment. The real time RT-PCR controls (synthetic 
plasmid and water) performed as expected, with the positive control being positive 
while no Ct values were detected for the water samples (real time RT-PCR negative 
control).
4.6 Evaluation of the infectivity of the viral progeny and comparison of HEV 
replication in 3D and 2D culture systems and 3D cells transferred into 2D
During the secondary infection, where the inoculum was the supernatant collected at 
58 dpi from a vessel of the previous experiment (section 4.5), viral RNA was 
detected by real time RT-PCR at all dpi in the 3D cell culture system (Figure 4.3 A),
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and at all dilutions of inoculum {Figure 4.3 A, shows the Ct values and Figure 4.4 A 
shows the copy number/ml). In the supernatant of the cells infected with undiluted 
inoculum the viral RNA copies/ml was low and constant throughout all the 
experiment. In this experiment no trend was observed, the expectation was that in 
the non diluted inoculum the copy number detected by real time RT-PCR would be 
the highest followed by the sample infected with inoculum diluted 1 in 10 (10'^) and 
the lowest copy number should have been detected in the sample infected with 
inoculum diluted 1 in 100 (10'^).
In the supernatant of 3D cells infected with inoculum diluted one in ten, the number 
of viral RNA copies/ml increased sharply between 61 and 82 dpi, peaking at 3.5 
xlO \ After 82 dpi the number of genome copies in this sample remained constant 
{Figure 4.3 and Figure 4.4 A). The number of copies in the supernatant of the 
inoculum diluted one in 100 (10'^) was higher compared to the other 2 inocula 
during almost all the follow up of the experiment. Several other peaks were 
observed throughout the incubation period suggesting HEV replication.
In the 3D cells transferred to 2D system the trend was similar for the undiluted and 
10'^  dilution of inoculum and Ct values indicative of a positive signal were detected 
at all dpi. In the supernatant of the 3D cells transferred to 2D infected with 
inoculum diluted 100 times, Ct values were detected at all dpi but 12 dpi. However, 
all the other dilutions (from 10"^  to 10'  ^ dilutions) were considered negative as Ct 
values were above 40 for almost all dpi (Figure 4.3 C).
In the 2D system, the Ct values (Ct values range 25-35) for undiluted and 10'  ^
dilution of inoculum remained almost unchanged, throughout the experiment whilst
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the values for the 10'  ^ were negative at 26 dpi. All the other dilutions were equal to 
or above 40 and for this reason considered as being negative (Figure 4.3 B).
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Figure 4.2 Cq)v niiinbeis of HEV genome ml detected by real time RT-PCR in 
the 3D culture system. 3D and ZD PLC/PRF/5 cell cultures were infected with 
homogenate of HEV positive liver and supernatant was tested by real time RT-PCR.
A ------  represents the copy number/ml of supernatant of the 3D PLC/PRF/5,
 represents the copy number/ml of the supernatant of 2D cells. Both samples
were infected with homogenate of HEV pork liver obtained from an experimentally 
infected animal.
B Copy numbers per ml detected in the supernatant of 3D cells and 2D cells.
The table shows 10  ^ viral copy numbers per ml detected by real time RT-PCR. It 
details the viral copy number displayed in Figure 4.2 A to better describe that the 
copy number/ml observed in the first 27 days were not zero.
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Figure 4.3 Comparison of Ct values detected in the supernatant of the 3 
different systems infected with different dilutions of inoculum. The 3 different 
cell cultures were infected with HEV positive supernatant diluted serial times 
obtained in the previous experiment. The supernatant collected at different days post 
infection (X axis) was tested by real time RT-PCR. The graphs represent the Ct 
values during the course of the experiment. A Ct values in the 3 cell cultures system 
black dashed line represent the cut off, B Ct values in the 3D cells transferred into 
2D, black dashed line represents the cut o ff; C Ct values in the 2D cells cultures, 
black dashed line represent the cut off.
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4.7 Results of the use of the 3D cell culture system to investigate the viability of 
HEV in UK sausages and French liver sausages (figatelli)
Homogenates of 3 UK sausages and 4 French figatelli were used as inoculum to 
infect PLC/PRF/5 cells in the 3D cells culture system.
HEV RNA was detected by real time RT-PCR only in the supernatant of the 3D 
cells infected with 1 of 3 French figatelli samples (figatelli 84). HEV RNA was 
detected at all dpi in the cells inoculated with the figatelli homogenate (Figure 4.5 
A). At 0 dpi the viral RNA copies were 6 . 4 x 1 /ml, the HEV viral RNA copy 
number fell to 3.35x10^ /ml on 5 dpi, and then began to increase on dpi 26 to a peak 
of 1.75x10^ /ml, at dpi 49. At the last sampling point on dpi 55, the copy number 
was 8.9x10"^/ml. No further collections were performed due to mould contamination 
in the vessels.
The cells infected with progeny virus from the original figatelli homogenate 
cultures had detectable HEV RNA on all dpi tested. The copy numbers remained 
fairly constant from just after inoculation (0 dpi) to the final reading at dpi 35, and 
varied from 4.14x10^ to 1.71x10^ copies per ml suggesting viral replication (a slight 
increase of HEV RNA copy numbers/ml was observed).
HEV RNA was detected in the supernatant of 3D cells infected with the UK 
sausages until five dpi only in two out of three sausages used as inoculum to infect 
the 3D cells (Figure 4.6).
4.7.1 HEV viral particles observed by electron microscopy: In the EM picture 
(Figure 4.7) four HEV viral particles were detected by EM. The sample tested by 
EM was supernatant of figatelli 84 collected at 33 dpi.
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Figure 4.6 Supernatant of cells infected with UK sausages and French sausages 
tested hy real time RT PCR. Ct values detected by real time RT-PCR in the 
supernatant of PLC/PRF/5 cells infected with UK and French sausages (samples UK 
sausages 44, 46, 47, and French sausages 87, 100, 116)
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Figure 4.7 HEV-like particles in HEV positive supernatant obtained from the 
3D cell culture system infected with homogenate of Hgatelli 84. Four HEV like 
particles were observed by electron microscopy in the supernatant of 3D cells 
infected with homogenate of HEV positive figatelli and collected at 33 dpi. The 
arrows show four different HEV-like viral particles.
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4.8 Discussion
4.8.1 HEV replication in the 3D cell culture system
The aims of this work were to investigate an in vitro 3D culture system to facilitate 
studies into the viability of HEV detected by real time RT-PCR in pig products, and 
to compare the system with the conventional 2D system.
In a study by Tanaka et al [III,  197] the potential of in vitro replication of HEV in 
2D cultures of 21 cell lines, including PLC/PRF/5 (human hepatocarcinoma cell 
line) [233] was investigated. The PLC/PRF/5 cell line was able to support in vitro 
replication of HEV, yielding a high titre of HEV from 14 dpi to the end of the 
observation period at 88 dpi [197]. However, the methodology described by Tanaka 
et al [111] proved difficult to reproduce in our laboratory, prompting the 
investigation of 3D culture system for more efficient virus propagation as described 
by Straub [231].
The real-time RT-PCR results obtained in the 3D cultures, inoculated with 
homogenised liver samples from an experimentally infected pig, showed detectable 
HEV RNA at all dpi. In contrast, in the 2D system infected in parallel with the same 
sample, HEV RNA was not detectable at any dpi.
In the primary inoculation there was evidence of virus replication by the 
maintenance of the HEV RNA copy number close to the 0 dpi titre up to 24 dpi, 
followed by a burst of replication peaking at 36 dpi with a decline back to the level 
observed at 0 dpi at 42 dpi. This decline may have been due to synchronized 
infection of uninfected cells and subsequent internalization of virus. Thereafter the 
copy number gradually increased to reach a peak at 136 dpi (2 x 10  ^ viral RNA
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copies number per ml) followed by a gradual decline back to below the level 
detected at 0 dpi by the end of the experiment at 175 dpi, when probably cell and 
virus damage caused the rate of viral RNA production to be exceeded by that of 
degradation.
By setting up a secondary inoculation {Figure 4.3 A), using progeny virus from the 
first replication round, the viability of the virus detected by real time RT-PCR was 
demonstrated. This data illustrates that in our hands, the 3D system was more 
efficient in terms of demonstration of infectivity compared to the 2D system, since 
the virus was able to replicate up to five months in the 3D cell culture system with 
higher copy number/ml detectable by real time RT-PCR. Other studies have also 
demonstrated that the 3D cell culture system is a useful tool in the cultivation of 
fastidious bacterial and viral pathogens [199, 231, 234].
In the secondary passage titration experiment, the efficiency of propagation 
appeared to be indirectly proportional to the concentration of the inoculum. Walker 
et al [235] described that, depending on the cell line and the concentration of the 
cells, a lower multiplicity of infection (MOI) can ultimately result in a higher peak 
titre during the incubation period, and this phenomenon was also demonstrated by 
others using suspension cultures [235]. The inoculum with the highest dilution 
showed a phasic pattern of viral RNA copies number/ml not dissimilar to that of the 
primary inoculation, whilst the intermediate dilution maintained the RNA copy 
numbers/ml until a late single peak between 61 and 82 dpi. The undiluted inoculum 
maintained the HEV copy at or around that of the TO level for the duration of the 
experiment. Higher MOI represented by high copy number in real time RT-PCR 
could be attributable to the same phenomenon explained by Walker et al [235].
126
The inverse relationship between inoculum concentration and efficiency of 
replication, as measured by HEV copy number in the cultures, may indicate the 
presence of a high proportion of non-viable HEV particles in the inoculum. These 
could have a direct interfering effect by physical competition for receptor sites 
[236], or an indirect effect by induction of the interferon response [236]. Dilution of 
the inoculum would have the effect of reducing this interference. Since the cell line, 
PLC/PRF5 appears not to produce IFN as measured by CAT ELISA (see Appendix 
A), then the former interpretation is more likely to be correct.
In the serial dilution experiment, a small titration range was introduced to give some 
impression of the relative sensitivity of 3D, 3D transferred to 2D, and 2D alone. The 
virus was detectable by real time RT-PCR in all three systems until the end of the 
experiment {Figure 4.3). In both the 2D and the 3D transferred to 2D systems the 
virus was detectable at several dilutions at most dpi {Figure 4.3). The Ct values 
among the dilutions were very similar and did not follow a regular trend (the 
expected reduction would be three Ct of difference between each ten fold dilution). 
The global examination of the data indicated a similar sensitivity of the 3D 
transferred to 2D compared to the conventional 2D system in detecting HEV RNA. 
A possible explanation for the inconsistency in detection of HEV RNA observed 
with the 3D transferred to 2D system could be that not all the cells adhered to the 
2D wells when transferred. Consequently, every time that the supernatant was 
collected an undefined amount of cells was also removed. This would cause a 
gradual reduction of the cells in the wells which consequently might have limited 
the availability of cells for virus replication.
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An end point of the serial dilutions was not achieved but it was observed that with 
the increase of dilution, the Ct values progressively became higher in all systems 
except the 3D system. Since there was no true trend in the Ct values detected, the 
results obtained in the serial dilutions experiment were insufficiently consistent to 
draw any measurable conclusion in relation to the relative sensitivity of the 3D cells 
transferred to 2D and 2D system.
Regarding the results obtained from the serial dilutions of the virus in the 3D 
system, no conclusion can be made since the virus was able to infect the cells in all 
the dilutions. No trend was observed between the different dilutions, in terms of 
higher virus concentration higher copy number. In fact, higher HEV RNA copy 
number was detected in the cells infected with the inoculum diluted 100 times (10' 
)^. This may be because the cells better tolerated a lower concentration of virus 
allowing more efficient replication.
In conclusion, we demonstrated that the PLC/PRF/5 cells grown in the 3D culture 
system offers an efficient tool for HEV propagation. The same cell type grown in 
monolayer did not show significant evidence of supporting HEV replication. The 
described system, including the diagnostic procedures, is useful tools to investigate 
the biology of HEV virus and the viability of HEV in pork samples.
Research to optimise the described cell culture systems for the assessment of the 
infectivity of the HEV in food samples should be planned. This may contribute 
towards understanding the mechanisms of HEV replication, pathogenesis and 
environmental (including within food matrices) survival.
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4.8.2 Discussion of the use of the 3D cell culture system to investigate the 
viability of HEV in the UK sausages and French liver sausages (figatelli)
Figatelli sample 84 was shown to contain viable HEV that was able to replicate in 
the 3D cell culture system. There was an increase in the RNA copy numbers 
between 29 and 44 dpi. The relatively low copy number in the inoculum used did 
not affect the onset of viral replication in the 3D cell culture system {Section 4.8.1). 
It is possible that the virus needs a specific threshold for optimal, sustained, 
productive replication of HEV, and a low copy number in the inoculum would 
influence the time taken for this threshold to be reached [197]. The observation that 
at least one of the figatelli samples contained viable HEV provides a very good 
corroboration of the reports from France implicating consumption of these products 
as a cause of hepatitis E [134].
Regarding the culture of progeny HEV, RNA was detected at all dpi, but no 
significant increase in copy number was observed at the time of last sampling (dpi 
34). This result may indicate that to observe higher viral titre the virus probably 
needs more time. Tanaka et al [197] observed that HEV appears to require a high 
titre (between 10^  and 10 )^ to be able to infect 2D PLC/PRF/5 and HEV RNA was 
first detectable in the progeny at 36 days by real time RT-PCR [197]. In this 
experiment the viral copies number/ml was relatively low in comparison with the 
Tanaka’s experiment and probably for this reason the figatelli progeny could not 
replicate rapidly in the 3D system, giving a constant low copy number throughout 
the experiment (34 dpi). Unfortunately, the experiment had to be terminated due to 
mould contamination in the vessel. Due to this contamination we could not 
determine if the HEV copy number would have increased in the same way as that of
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figatelli 84, where the copy number began to increase around 36 dpi. Unfortunately 
due to time limit and the economical restraints of the project the experiment could 
not be repeated.
To provide further confirmation of the HEV real time RT-PCR results figatelli 84, 
samples of culture supernatant from dpi 33 were examined by EM. Several entire 
viral particles were observed in the sample showing that cell-free virus was present 
in the supernatant after replication and release from cells.
Three other figatelli samples (87, 100 and 116) and the 3 UK HEV real time RT- 
PCR positive sausages were tested using the 3D cell culture system, but other than 0 
and 5 dpi for the UK sausages and 8 dpi for the 2 figatelli samples number 87 and 
116, HEV RNA was not detected at any other time point. It may be that viral titre in 
the inoculum was not high enough to obtain viral replication in the cells, as 
previously reported by Tanaka et al [197] or because the virus contained in the 
figatelli and UK sausage samples was not viable. A consideration that should be 
taken into account is that in the two figatelli samples HEV RNA was detected until 
8 dpi and for the UK sausages HEV RNA was detected until 5 dpi, these results 
could be due to the fact that no viable virus in the UK sausages (due to bad 
conservation of the samples) and that for the other two figatelli sample the viral titre 
was not enough to support an in vitro infection. This would require further testing 
using greater numbers of field samples such as sausages.
In conclusion, these results showed a significant finding outside the normal range of 
experimental error. It is possible that in different homogenates or supernatants there 
will be variable proportions of intact, viable virus, defective interfering particles, 
free viral genomic RNA and degraded but still PCR reactive RNA. The differing
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proportions will be manifested by a different relationship between apparent copy 
number and kinetics of replication in-vitro. In theory, if all the RNA detected in the 
real time RT-PCR is inactivated/degraded but still PCR reactive there should be a 
decreasing in detection HEV RNA by real time RT-PCR.
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CHAPTER 5
Inactivation studies
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Introduction: After having evaluated the new 3D cell culture system the next step 
was to carry out inactivation studies to better understand how and if HEV can be 
inactivated.
In addition, to harmonise the VITAL project, three post-graduate students were 
focused on inactivation studies of three different viruses: Norovirus, HEV, and 
Adenovirus. In my case, the survival of HEV in pork products under various 
inactivation conditions was investigated.
This chapter is subdivided into the following sections 1) heat inactivation 2) UV 
light and NaOCl inactivation.
5.1 Heat inactivation
The risk of HEV infection via the consumption of HEV-contaminated pig livers 
raises public health concerns, since it is not clear whether cooking conditions will 
be effective in inactivating the virus. Feagins et al (2008) [85, 87] performed a HEV 
heat inactivation study in an animal model. The objective of this study was to 
determine if traditional cooking methods are effective in inactivating infectious 
HEV present in contaminated commercial pig livers. Four of the five pigs 
inoculated with a pool of two HEV-positive liver homogenates incubated at 56°C 
for 1 h developed an active HEV infection. The pigs inoculated with a homogenate 
of two HEV-positive livers stir-fried at 19UC for 5 min and the group of pigs 
inoculated with a homogenate of two HEV-positive livers boiled in water for 5 min 
showed no evidence of infection since there was no seroconversion, viremia, or 
faecal virus shedding in any of the inoculated pigs.
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HEV can be found in the liver, blood, and intestinal tract, which are all consumed in 
one form or another and often together, such as in sausages. How safe are these 
products? The question is difficult to answer because until recently it was difficult 
to propagate HEV in cell cultures and testing HEV viability in vivo requires the use 
of experimental animals, usually primates or pigs.
The in vitro 3D cell culture system described in the previous chapter was used to 
propagate HEV for a heat inactivation experiment based on Feagins’s work but 
replacing the use of pigs with 3D cell culture system.
5.2 UV light and NaOCl HEV inactivation studies
After having optimised the in vitro 3D cell culture system at AHVLA, as part of the 
PhD project, I moved for one year to the Central veterinary Institute (CVI, The 
Netherlands) transferring the 3D technology to continue the HEV in vitro studies 
and subsequently perform virus inactivation experiments.
The following inactivation strategies were selected in this project: UV light 
inactivation; NaOCl inactivation.
1) UV inactivation was investigated to clarify whether it could be a useful tool to 
inactivate HEV on tools such as knives used to process the pork meat, on surfaces 
and equipment such as found in farms, slaughterhouses, processing plants and 
points of sale.
In this study the effect of UV light on HEV was evaluated. A homogenate of HEV 
positive liver was exposed for 20, 30 and 50 minutes to UV light and the inoculum 
was used to infect 3D cell cultures. This experiment was set up because exposure to 
solar ultraviolet (UV) radiations is a primary means of virus inactivation in the
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environment, and germicidal (UVC) light is used to inactivate viruses in hospitals 
and other critical public and military environments [90, 91]. Safety and security 
constraints have hindered exposing highly virulent viruses to UV and gathering the 
data needed to assess the risk of environments contaminated with viruses that can 
cause high consequence in humans [92]. UV sensitivity of some viruses has been 
extrapolated from data obtained with UVC (254 nm) radiation by using a model 
based on the type, size and strandedness of the nucleic acid genomes of the different 
virus families [93, 94]. These predictions were based on viruses suspended in liquid 
solutions, instead of a dry state. Therefore, there was little information to allow 
accurate modelling, confident extrapolation, and prediction of the UV sensitivity of 
viruses deposited on contaminated surfaces, conditions more likely to be relevant to 
public health.
2) HEV inactivation by sodium hypochlorite (NaOCl) was also performed. Sodium 
hypochlorite solution, commonly known as bleach, is frequently used as a 
disinfectant. This disinfectant is one of the most common used in farms, in high 
containment level laboratories, in water and or surfaces to kill bacteria and viruses. 
US Government regulations (21 CFR Part 178) and the CDC: Guideline for 
Disinfection and Sterilization in Healthcare Facilities (2008), allow food processing 
equipment and food contact surfaces to be sanitized with solutions containing 
bleach, provided that the solution is allowed to drain adequately before contact with 
food, and that the solutions do not exceed 200 parts per million (ppm) available 
chlorine. Furthermore Zand et al (2012) [237] observed that different concentrations 
of NaOCl from 0.5% to 5.25% were able to inactivate E. Faecali growth [237].
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Only a few studies have been deseribed with sodium bypocblorite inactivation of 
viruses. Sabbab et al in 2010 [238] described that 5 minutes with peracetic acid or 
with chlorine dioxide are sufficient to reduce the level of bacteria in environmental 
surfaces as indicated in the disinfectant criteria standard guideline submitted by U.S 
Protection agency (EPA) Guidance manual showing that this disinfectant is a good 
tool to inactivate pathogens. Furthermore, this statement was also confirmed by 
Tburston-Enriquez et al in 2003 demonstrating that viruses like FCV, adenovirus 
and poliovirus type 1 are inactivated by chlorine [239].
Since NaOCl appears to be commonly used in the field we decided to set up an 
inactivation study with NaOCl. HEV positive supernatant was treated with NaOCl 
to a final concentration of 5% and the effect of the NaOCl was neutralised after 5 
minutes with 10% of sodium tbiosulpbate (NazSiOg). This approach for neutralising 
the cytotoxic effects of NaOCl was adopted from Sabbab et al, Benarde et al and 
Tburston-Enriquez et al [238, 240, 241] who performed studies to verify if bacteria 
and viruses were killed by the disinfectant.
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Materials and Methods
5.3 Cells preparation; The cells were propagated in the 3D cell culture system as 
deseribed in section 4.3.
5.3.1 Heat inactivation experiment
5.3.1.1 Inoculum preparation: The positive HEV sample was provided by the 
Central Veterinary Institute, Wageningen University and Research Centre - CVI. 
The sample was a liver tissue from an experimentally HEV infected pig [86]. The 
liver tissue (Ig) was homogenized with a mechanical disruptor in 1 ml of GSTF-2 
media and subsequently 8 ml of GTSF-2 media was added. The bomogenate was 
centrifuged at 8.000 x g for 3 minutes and the supernatant was filtered through a 
sterile spin-X centrifuge tube filter (0.22pm; Costar) at 10.000 x g at 4°C for 15-25 
min. [87].
The human bepatocareinoma cell line was infected with inoculum untreated, heated 
at 56‘^ C for Ibour or heated at 100°C for 15 minutes. In addition one vessel was 
used as non infected control.
5.3.1.2 Infection of the 3D cells: The medium was removed from the vessels and 
2.5 ml of inoculum was added. The vessels were incubated for 2 hours at 35.5°C, 
and gently agitated every 20 minutes. After two hours, 47.5 ml of fresh medium was 
added to each vessel (the inoculum was not removed).
The whole experiment lasted 69 days. The collection of the sample was performed 
on day: 0, 7, 13, 22, 33, 40, 48, 55, 62 and 69. On each collection day the following 
aliquots were collected: 140 jil in duplicate for each vessel added to Lysis buffer
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(Qiagen Viral RNA kit, Qiagen), to be stored at -20°C before RNA extraction. Fresb 
medium (47.5 ml) was added to eaeb vessel to restore tbe full volume (50ml).
5.4. UV inactivation experiments
5.4.1 Preparation of the inoculum: Tbe preparation of inoculum was performed as 
described in section 5.3.1.1.
5.4.2 HEV UV inactivation procedure: A 30 W UV lamp, 91 cm long (TUV 
30WAT, 254nm, UVC, Philips) was warmed up for ca 20 min before starting tbe 
experiments and tbe UV lamp was previously used for 30 hours (an UV light lamp 
can be used for ca. 8000 hours). This represented tbe range of time recommended to 
ensure that tbe light was 100% efficient. Tbe lamp was positioned above tbe sample 
Petri dish to allow a distance from tbe UV source to tbe sample surface of 20 cm, 
with tbe agitation set at 100 rpm.
Seven and half ml of liver bomogenate, prepared as previously described {Section 
5.4.1) was exposed for 20, 30 and 50 minutes respectively under UV light. Tbe UV 
irradiation dose that tbe inoculum received was: Dose UV light for 20 min= 99.6m 
(W*s)/cm^; 30 min= 149.4m (W*s)/em^; or 50 min= 256.6m (W*s)/cm^. These data 
were obtained from Philips website (bttp://www.pbilips.co.uk/) and they were 
calculated as if tbe sample was Im from tbe centre of tbe lamp. Tbe Intensity was 
83uW/cm^. Tbe depth of tbe inoculum in tbe Petri dish was 4mm. Tbe temperature 
of tbe inoculum exposed under UV light was tested and it did not change during tbe 
UV light treatment (ca 18°C).
A second experiment was performed as above but decreasing tbe depth of tbe 
inoculum (from 4 mm to <1 mm) whilst exposed to tbe UV light for 30 minutes.
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The duration of the first experiment where the inoculum was exposed under UV 
light for different length of time was 60 days, whilst the second experiment where 
the inoculum was exposed under UV light for 30 min and the depth of the inoculum 
in the Petri dish was less than 4mm was terminated after 36 days due to 
mycoplasma contamination. Each experiment was run with a positive control 
(bomogenate of HEV positive liver and a non infected control).
5.4.3 Inoculation of cultures and sample collection: tbe infection was performed 
as already deseribed in section 4.3.3. Briefly tbe medium was removed from tbe 
vessels and 2.5 ml of infected supernatant (bomogenate of liver) (previously UV 
inactivated) was added to tbe cells. Tbe vessels were incubated for 2 hours at 
35.5°C, and inserted in tbe Rotating Wall Vessel (RWV). After two hours 47.5 ml 
of fresb medium was added to each vessel (tbe inoculum was not removed). On 
each collection day (tbe samples were collected once a week for two months) tbe 
following aliquots were collected: 140 pi in duplicate for eaeb vessel was added to 
Lysis buffer, to be stored at -20°C before extraction and an aliquot of media (20 ml 
ca. from tbe infected vessels) was collected and stored at -80°C. After each 
collection tbe vessels’ volumes were restored to 50 ml by addition of fresb GTSF-2 
medium {Table 4.1).
5.4.4 Electron microscopy: Tbe electron microscopy procedure was performed as 
described in section 4.4.6. Briefly, R. Jobne and J. Reetz at BfR in Germany 
performed tbe EM examination, to provide more evidence of HEV replication. 
Supernatants of tbe cell cultures that received tbe inoculum treated for 20 min under 
UV light and collected at 21 dpi were applied to polioformcarbon-eoated, 400-mesb 
copper grids (Plano GmbH, Wetzlar, Germany) for 10 min, fixed with 2,5%
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aqueous glutaraldehyde (Electron Microscopy Sciences Company, Germany) 
solution for 1 min and stained with 2% aqueous uranyl acetate solution (Electron 
Microscopy Sciences Company, Germany) for 1 min. The specimens were 
examined by transmission electron microscopy using a JEM-1010 (JEOL, Tokyo, 
Japan) at 80 kV accelerated voltage.
5.4.5 Sodium hypochlorite inactivation
5.4.5.1 Preparation: In this experiment HEV positive supernatant was used as a 
surrogate to better simulate environmental surface disinfection in premises where 
pork and pork products are bandied. Five ml of a HEV positive supernatant 
collected at 13 dpi exposed under UV light for 20 min in tbe previous UV 
inactivation experiment and shown to be viable, was chosen to be treated with 5% 
Sodium hypochlorite for 5 minutes. Tbe Sodium bypocblorite was neutralized with 
10% of sodium tbiosulpbate [238, 240, 241].
Four vessels were used for this experiment. One vessel was used as positive control 
(positive supernatant). Tbe second vessel was infected with 2.5 ml of HEV positive 
supernatant treated with 5% NaOCl for 5 min. Tbe third vessel was tbe HEV 
negative supernatant treated with 5% of NaOCl. Tbe last vessel was tbe non 
infected control.
5.4.5.2 Treatment: Before tbe inoculum was added to tbe cells, to remove possible 
bacteria contaminant, tbe inoculum (HEV positive supernatant treated or non­
treated with NaOCl) was filtered with 0.45 pim filter. Infection was performed as 
described in section 5.4.3. Briefly, 2.5ml of HEV positive supernatant (previously 
tested by real time RT-PCR) was collected from tbe total 5 ml previously exposed 
to 5% NaOCl for 5 minutes and used as inoculum to infect tbe 3D cell cultures.
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Sample collection was performed once a week as described in section 5.4.3 for 36 
days before termination due to mycoplasma contamination.
5.4.6 RNA extraction and Real Time RT-PCR: RNA extraction and PCR of tbe
supernatant collected from tbe vessels was performed as described in section 4.3.5 
and 4.3.6. Briefly nucleic acid extraction from 140|il of eaeb sample was performed 
using tbe Qiagen viral RNA kit (Qiagen) following tbe protocol deseribed by tbe 
manufacturer’s guidelines.
Real time RT-PCR testing was performed according to tbe protocol described by 
Jotbikumar et al (2006) [220] using tbe Superscript III Platinum one-step 
quantitative RT-PCR kit (Invitrogen). Tbe real time RT-PCR reaction was set up 
and performed according to tbe manufacturer’s instructions as described in section
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Results
5.5.1 Heat inactivation treatment
Three aliquots of bomogenate of HEV positive liver were non treated, heated for lb 
at 56°C or heated for 15 min at 100°C and subsequently used as inoculum to infect 
tbe 3D cell culture system to better understand tbe optimal temperature to inactivate 
tbe virus.
HEV RNA was detected at all dpi except for 22 dpi in tbe cells infected with tbe 
untreated inoculum {Figure 5.1). At 33 dpi tbe Ct values decreased and remained 
almost constant until tbe end of tbe experiment (69 dpi). HEV RNA was also 
detected in tbe 3D system infected with tbe inoculum heated at 56^C for one hour, at 
0, 7, dpi with Ct values ranging between 43 and 40 and from 48 dpi until 62 dpi (Ct 
values between 35 and 40) {Figure 5.1).
No viral RNA was detected at any dpi in tbe 3D cells infected with tbe inoculum 
that was heated at 100°C for 15 minutes {Figure 5.1). In this experiment we set tbe 
cut-off at 40 Ct to exclude non specific signal meaning that all samples detected 
above 40 Ct were considered negative.
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Figure 5.1 Tientment of HEV infected liver nt 100 "C lends to irrnctiv atiair of 
the vims. 3D PLC/PRF/5 were infected with bomogenate of HEV positive liver and 
the inoculum previous the infection was untreated, heated for Ih at 56°C and heated 
for 15 min at 100 °C. Supernatant of the 3D cells was tested by real time RT-PCR. 
— ♦ supernatant tested by real time RT-PCR of the cells infected with non heated 
bomogenate of HEV positive liver. — supernatant of cells infected with 
bomogenate of HEV positive liver heated for Ih at 56°C . — supernatant of 3D 
cells infected with bomogenate of HEV positive liver heated for 15 min at 100°C.
■ represents +/- cut off at 40 Ct. Samples above this line are considered 
positive for HEV.
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5.5.2 Homogenate of HEV positive liver exposed to UV light to test HEV 
inactivation
A homogenate of a HEV positive liver previously shown to contain viable virus was 
exposed to UV light for 20, 30 and 50 min and aliquots of 2.5 ml were used to infect 
3D cell cultures and HEV infectivity was evaluated by real time RT-PCR. The 
experiment was repeated, decreasing the depth of the inoculum in the Petri dish 
during the 30 min of UV light exposure.
The real time RT-PCR analysis showed that Ct values were detected at almost all 
dpi in the supernatant of 3D cells infected with inoculum exposed to UV at different 
times.
In the 3D cells infected with non-treated inoculum, HEV RNA was detected at all 
except two dpi, 7 and 35 dpi. Ct values increased significantly at 13 dpi, indicating 
lower viral titre (Ct values during the experiment ranged from 25 to 40). From 13 to 
28 dpi, there was a difference of 8 Ct values (Ct values were between 30 and 38). 
HEV RNA was detected in the 3D system infected with inoculum treated with UV 
light for 20, 30 and 50 minutes at 0 ,7 , 13, 21, 28 and 42 dpi {Figure 5.2). At 35 dpi 
no Ct values were detected in the supernatant of all samples by real time RT-PCR in 
all the different treatments, suggesting that possibly the virus was replicating inside 
the cells or due to a problem with the RNA extraction on that particular dpi.
Figure 5.3 describes the decay of HEV in terms of Ct values observed by real time 
RT-PCR immediately after the UV light treatment. The non UV light treated (NT) 
inoculum showed higher Ct values in comparison with the Ct values observed in 
vessels receiving inoculum exposed to the UV light treatment during the 20, 30 and 
50 min, indicating no inactivation. It should be noted that the UV dose calculation
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provided by the UV light producer was made considering the UV lamp Im distant 
from the sample while in this case the samples were 20 cm distant from the UV 
lamp. Although the UV dose calculations are approximate, figure 5.3 shows there 
was a partial increase in Ct in parallel with increase of the UV dose.
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Figure 5.2 Analysis of the variation of Ct values overtime iir the UV light 
irractivatioir experiment irr tire supernatarrt of tire 31) cell cultures. 3D cells were 
infected with homogenate of HEV positive liver not treated, treated for 20 min under 
UV light, treated for 30 mm under UV light and treated for 50 min under UV light 
Supernatant o f the 3D cells cultures was tested by real time RT-PCR.—  represents 
the supernatant of cells infected with the homogenate of liver not treated under UV 
light, represents the supernatant of cells mfected with homogenate of liver treated 
for 20 minutes under UV light. —  represents the supernatant of cells infected with 
homogenate of liver treated under UV light for 30 min. —  represents the supernatant 
of cells mfected with homogenate of liver treated for 50 mmutes under UV light
 IS the cut off at 40 Ct values.
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Figure 5.3 HEV decay measured in the inoculum by real time RT-PCR after 
the UV light treatment. The graph describes the variation of the Ct values 
observed in association with the UV light dose that the inoculum (homogenate of 
HEV positive liver not exposed and exposed under UV light for 20, 30 and 50) 
received previous the 3D cell cultures infection. The UV dose was calculated 
considering the light at 1 m of distance from the centre of the lamp. The UV dose 
showed in this graph is an approximation of the UV dose during the time of the 
experiment. Black columns represent the increasing of UV light dose during the 
time. W hite column represent the Ct values detected after the UV light treatment.
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5.5.2.1 Homogenate of HEV positive liver treated for 30 min to UV light
An homogenate of HEV positive liver was exposed to UV light for 30 min and 2.5 
ml of the inoculum was used to infect 3D cell cultures; the HEV infectivity was 
evaluated by real time RT-PCR. This UV light experiment was repeated, decreasing 
the depth of the inoculum in the Petri dish.
HEV RNA was detected by real time RT-PCR during the entire experiment in the 
supernatant of cells infected with an untreated homogenate of HEV positive liver 
{Figure 5.4). Ct values increased from 0 dpi to 14 dpi from 20 to 30 Ct, at 18 dpi 
there was a modest decrease in Ct and then an increase again to 26. From 29 dpi 
until 36 dpi Ct values remained stable around 30, suggesting a stable replication.
The supernatant of 3D cells infected with the homogenate of HEV positive liver 
where the inoculum prior to infection was exposed for 30 minutes to UV light, was 
HEV positive by real time RT-PCR at all dpi but 3 dpi (10, 18, 29). The Ct values 
were slightly higher (around 5 Ct higher) compared to the non treated inoculum 
suggesting that viral particles may have been partially inactivated by the UV light. 
From 0 until 10 dpi, Ct values increased gradually then decreased at 14 dpi, 
increased again at 18 dpi and decreased at 26 dpi. At 29 dpi no RNA was detected 
by real time RT-PCR but lower Ct values were detected at 33 dpi, followed by a 
modest decrease of Ct at 36 dpi, suggesting that the virus was replicating.
5.5.2.2 Electron microscopy result
Following negative staining with uranyl acetate HEV-like particles were detected in 
the supernatant of cells infected with homogenate of HEV positive liver that had
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been exposed under UV light for 20 min and collected at 21 dpi. However, HEV 
viral particles were very sparse and only as single particles {Figure 5.5).
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Figiire 5.4 Ann lysis of the Ct values observed in the supernatant of 3D cells 
infected with inoculiun treated with XJ\' light for 30 min 3D cells were infected 
with homogenate of HEV positive liver not exposed under UV light and exposed 
under UV light for 30 min. The supernatant collected at different days post infection 
(X axis) was tested by real time RT -PCR. The inocula were untreated homogenate of 
liver (— ) or homogenate of liver exposed for 30 minutes under UV light (— ).The 
 IS the cut off at 40 Ct.
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Figure 5.5 HEV-like particles. The figure shows two HEV-like particles (arrow) 
obtained by negative staining with uranyl acetate. The two particles were detected 
in the HEV positive supernatant of 3D cell culture collected at 21 days post 
infection and infected with the inoculum exposed for 20 min under UV light and 
tested by electron microscopy.
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5.5.3 Inactivation of HEV positive supernatant with 5% of NaOCl
Figure 5.6 describes the results obtained in the NaOCl inactivation study. The 
supernatant (the inoculum was supernatant of 3D cells infected with HEV positive 
supernatant, exposed for 20 minutes under UV and collected at 13 days post 
infection) of cells not treated with NaOCl was positive at all time points except for 
supernatant collected at 26 and 36 dpi. Ct values after a peak at 3 dpi with a Ct of 20 
ranged between 32 and 40 during the course of the experiment. At 3 dpi, Ct values 
decreased then increased slowly until 26 dpi and then HEV RNA was detected 
again at 29 and 33 dpi, suggesting viral replication. Supernatant of the 3D cells 
infected with inoculum treated with 5% NaOCl was positive by real time RT-PCR 
at 0, 3 and 7 dpi.
In all experiments, to exclude a non specific signal, a cut off of 40 Ct was selected.
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Figure 5.6 Analysis of the Ct va hies of HEV positive supernatant treated with 
NaOCl and untreated. PLC/PRF/5 cells were infected with HEV positive 
supernatant obtained form the UV light experiment. The cells received inoculum not 
treated with NaOCl and treated with 5% of NaOCl for 5 min. — represents the Ct 
values detected by real time RT-PCR of 3D cells infected with HEV positive 
supernatant exposed for 20 min under UV light and collected at 13 dpi but not
treated with NaOCl.  represent the Ct values detected by real time RT-PCR of
3D cells infected with HEV positive supematant exposed for 20 min under UV light
and collected at 13 dpi then treated for 5 minutes with 5% of NaOCl. is the cut
off at 40 Ct.
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5.6 Discussion
5.6.1 Homogenate of HEV positive liver heated at different temperatures
A homogenate of pig liver known to contain infectious HEV was subjected to 
heating, simulating some normal cooking conditions, and was applied to 3D cell 
cultures to determine the effect of the virus inactivation as measured by HEV RNA 
copy numbers in cell supernatants.
Differences in the Ct values were observed between the supernatant of the cells 
infected with non- heated liver and supernatant of cells infected with HEV positive 
liver heated at 56°C for one hour. As we can see in figure 5.1 the Ct values were 
lower (ranging between 40 and 29) in the sample infected with the homogenate of 
non-heated liver compared to the supernatant of cells that received as inoculum the 
homogenate of liver heated at 56°C for one hour. The Ct values in the supematant of 
cells infected with HEV positive liver heated at 56°C for one hour were higher, 
probably reflecting partial virus inactivation. Full HEV inactivation was observed in 
the inoculum heated at 100°C since no HEV RNA was detected by real time RT- 
PCR at any point of the experiment. The results are similar to those of Feagins et al 
[85, 87] where the pigs infected with HEV positive liver heated at 56°C were 
shedding virus in the faeces, showing that the treatment was not sufficient to 
inactivate HEV. Furthermore, the similarity of the results of in vivo and in vitro 
experiments of this study underline the potential of the 3D cell culture system in 
replacing the traditional in vivo infectivity studies.
HEV transmission in industrialized regions is not fully understood. It has been 
suggested and is now widely accepted that HEV transmission is zoonotic [138,
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242]. Tel et al [133] reported direct evidence of zoonotic HEV transmission via the 
consumption of grilled or undercooked commercial pig liver purchased from local 
grocery stores in Japan [133]. The majority of the patients in that study had a history 
of consuming undercooked pig livers prior to the onset of the disease, indicating 
that consumption of pig livers is a risk factor for hepatitis E [133]. Eleven percent of 
livers purchased from local grocery stores in the United States, 6% in The 
Netherlands [243] and 9.5% in the United Kingdom were found to be contaminated 
by HEV (Chapters, section 3.5.1).
HEV inactivation and environmental resistance is not a well-covered topic and little 
information is available. As an orally transmitted virus, HEV is most likely resistant 
to inactivation by the acidic conditions of the stomach. The ability of HEV to 
survive harsh or extreme environmental conditions can be attributed at least in part 
to its non-enveloped viral structure [85, 87].
In Europe most pork meat is cooked prior to consumption, but there are some 
exceptions where pork meat is eaten raw, as for example liver sausages in France. 
The United States Department of Agriculture (USDA) and the United States 
National Pork Board (NPB) recommend a cooking method for fresh pork that will 
result in a minimum internal cooking temperature of 71 °C (http:// 
www.fsis.usda.gov/is_it_done_yet/, accessed on March 15, 2007). A time 
stipulation is suggested based on the level of heat but many of the recipes do not 
specify a minimum cooking temperature. Stir-frying and boiling are the two most 
widely used and accepted methods for cooking pig livers for consumption. Feagins 
at al evaluated that stir-frying and boiling of HEV-contaminated pig livers can 
effectively inactivate the virus by using a swine bioassay to determine the virus
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infectivity [85, 87]. By using an in vitro system, Emerson et al [225] reported that 
HEV is approximately 50% inactivated when heated at 56°C for 1 h. In this study 
we demonstrated that incubation of homogenate of contaminated pig livers at 56°C 
for 1 h (temperature that produced an internal cooking temperature slightly below 
the recommended 71°C without burning the tissue) did not fully inactivate the virus, 
as HEV RNA was detected during the course of the experiment. Our results support 
the in vitro results of Emerson et al [225] and the in vivo results of Feagins et al 
[87] confirming that adequate cooking of HEV-contaminated commercial pig livers 
will inactivate HEV in the tissue, thereby decreasing the risk of food-borne HEV 
transmission. Importantly these results confirm that partial inactivation of HEV 
(heat at 56°C for 1 h) may allow the virus to initiate an active infection in vitro 
while the treatment of the liver at 100°C appears to be efficient to inactivate the 
virus completely.
5.6.2 Inactivation of HEV positive supernatant with UV light
UV light inactivation studies are mostly performed with bacteria such as 
Sphingopyxisalaskensisa marine bacteria. Salmonella and E. Coli [244, 245]. Only a 
few UV light inactivation studies have been performed with viruses such as 
Hepatitis A virus (HAV), Feline Calicivirus (FCV) and two Picornaviruses [246, 
247] but never with HEV. This study was performed to find out if UV light would 
inactivate HEV under the conditions described. From the results obtained in this 
study the UV light applied was insufficient to completely inactivate the virus and 
the same results were also obtained in other studies. In fact it has been observed a 
decrease of 2 log in samples (lettuce, strawberry and onion) artificially 
contaminated with HAV and Feline Calicivirus [246, 247]. Using relative Ct as a
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crude measure of viral copy number, the amount of viral RNA detected did not vary 
significantly between cells infected with UV light treated and non UV light treated 
inoculum. HEV RNA was detectable in the 3D system by real time RT-PCR in the 
cells that received the UV light treated inoculum. The data showed that the Ct 
values for the 3D cells were not significantly different for all the different UV light 
treatments. This could be due to the fact that the UV light treatment is not effective 
in inactivating HEV or that the inactivation was partial and remaining viable 
particles were able to infect the cells.
When the experiment was repeated, reducing the depth of the inoculum during 
exposure, viral RNA was detected throughout the experiment, suggesting that viable 
virus was present and inactivation had been incomplete although an increase of 
almost 7 Ct values was observed during all the experiment in the supernatant of the 
cells infected with inoclulm exposed for 30 min under UV light suggesting partial 
inactivation of HEV. The depth of the inoculum in the Petri dish was reduced 
because in the first experiment the depth of the inoculum in the Petri dish was 4 mm 
and the literature advises to have less then 3mm of depth during the UV inactivation 
[246, 247]. Also in this second experiment, where the inoculum was previously 
exposed for 30 min under UV light, we detected RNA by real time RT-PCR at 
almost all dpi, confirming that under the conditions employed, UV light did not 
inactivate all the viral particles allowing some HEV replication in the cells.
The temperature of the inoculum exposed under UV light was tested and remained 
constant during the inactivation treatment, avoiding any chance that the temperature 
was affecting the experiment.
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A possible explanation of this UV inactivation result can be that the RT-PCR and 
3D sampling system is insufficiently sensitive to detect small variations in viral 
particles once the cells are infected with the virus under different treatments, in 
other words the 3D cells are able to pick up infectious virus also when it is present 
in small quantities. As we already observed similar results were obtained in another 
experiment where serial dilutions of the inoculum were performed {Chapter 4). In 
the HEV serial dilution experiment, as obtained in the UV inactivation study, no 
dose-related trend was observed after the cells were infected with HEV treated with 
UV light or with serially diluted inoculum {Chapter 4).
Fino et al in 2008 [248] showed that HAV and other viruses are partially inactivated 
in lettuce and that bacteria as for example E. Coli is inactivated by 99% with the 
same treatment. Our results confirm partially those of Fino et al [248] where viruses 
were partially inactivated by UV light.
In this study, we have shown that HEV, albeit partially inactivated by UV light 
(higher Ct values at 0 dpi compared to the non-treated inoculum), is able during the 
course of the incubation to replicate reaching the same Ct values or higher than the 
inoculum without UV light treatment.
Electron microscopy was performed on HEV positive supernatant exposed to UV 
light for 20 min and collected at 21 dpi. Only a few viral particles were detected, 
probably because the viral replication was inhibited by mycoplasma contamination 
in the 3D cell culture system and since the cells were supporting double replication 
from the bacteria and from the virus [249]. Clearly, the demonstration of HEV 
particles by EM is not easy since this is only the third electron micrograph since 
1983 to show a hepatitis E virion [130, 250]. These results show that hepatitis E
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virus is replicating in the 3D cells, since intact viral HEV particles have been 
detected in the supernatant of the 3D cell culture system after several days from the 
infection. In addition it is highly unlikely that the particles detected were from the 
residual inoculum because at every collection point almost half of the media (23 ml) 
content in the vessel was refreshed once a week. In conclusion, UV light under the 
conditions employed appeared to be insufficient to fully inactivate HEV.
5.6.3 Inactivation of HEV positive supernatant with 5% of NaOCl
In this experiment a sample of HEV positive supernatant (HEV infectious progeny 
virus obtained from a previous experiment) was treated with NaOCl at the final 
concentration of 5% and the effect of the chemical was neutralised after 5 minutes 
with 10% of sodium thiosulphate (Na2S203).
HEV RNA was detected only until 7 days post infection and Ct values detected by 
real time RT-PCR were increasing each successive day post infection, indicating 
that the virus was possibly inactivated by the NaOCl and the high Ct values detected 
were residuum of inoculum.
The lack of detection of HEV RNA by real time RT-PCR in further collection 
points could be also due to the fact that live virus was still present but the cells were 
damaged by the chemical and could not support viral replication. To minimize the 
cell damage 10% of sodium thiosulphate was used [237] to neutralize the effect of 
the NaOCl. Despite this, visual confirmation of partial cell damage was observed 
also in the negative control vessel (cells in contact with non-infected media treated 
with 5% NaOCl and 10% Na2S203). The cytotoxic effect of the NaOCl and 
thiosulphate should have been tested in this particular cell-system scenario before 
the experiment in the cells or the virus removed from the inactivation mixture by
159
pelleting and washing in PBS, despite the literature describing the neutralisation of 
the chemical (NaOCl) with 10% of sodium thiosulphate [237].
Alternatively, the inactivation might have worked, the treated inoculum was not 
cytotoxic and the RNA detected at 7 dpi was just residual inoculum as is shown in 
section 5.5.3 {Figure 5.6). Although definitive conclusions cannot be made, the 
consideration that NaOCl was efficient enough to inactivate the virus should be 
taken in consideration.
Guthmann et al [132] in 2006 reported a large outbreak of hepatitis E in the region of 
Darfur of Sudan in 2004. In 6 months, 2621 cases of hepatitis were recorded where 
contaminated water seemed to be the cause of this outbreak. Although the water 
before being distributed was chlorinated with standard level (0.3/0.6 mg/L) of 
chlorine, the drinking of chlorinated water was assessed as a risk factor for 
contracting hepatitis E [132]. So it appeared that during that outbreak the water 
disinfection was not effective to inactivate HEV. This highlights a need and it would 
be useful to set up another disinfectant study to better prove which chlorine or other 
chlorine derivate dose/time is effectively able to eliminate the virus from surfaces 
and HEV contaminated water [132].
In conclusion, we determined that probably the NaOCl could be a good tool to 
disinfect surfaces been in contact with pork products since that after the first week 
no HEV RNA was detected in the HEV positive supematant derived from 20 min 
UV light experiment and collected at 13 dpi treated for 5 minutes with 5% of 
NaOCl [238, 240, 241]. Furthermore, we also showed that the HEV progeny vims 
was able to infect other 3D cells providing once again that progeny is infectious and 
is able to infect 3D cells {Figure 4.4, chapter 4) until 33 days post infection.
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HEV can be identified at different points of the pork food chain and zoonotic 
transmission through consumption of contaminated pork meat has been 
demonstrated. There is still the need to understand which chemical and physical 
conditions can be utilized to inactivate viable HEV particles that could be present 
along the chain and in the final products.
In these studies we exposed viable HEV to heat, UV light and NaOCl. The 
effectiveness of these selected inactivation strategies was evaluated in a 3D in vitro 
system, previously shown to be able to support HEV replication.
Between the 3 methods used, the only one that gave indications of a consistent 
successful inactivation was the heat treatment. These data confirm results obtained 
by other authors in previous in vitro and in vivo models. Thoroughly cooking pork 
meat is an effective means of inactivating HEV, and should therefore be 
recommended.
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CHAPTER 6
Prevalence and transmission of hepatitis E virus 
in domestic swine population in different 
European countries
1 6 2
The final goal of this PhD project was estimating HEV prevalence in 6 different 
European countries and applied a mathematical model (SIR, described below) 
developed by Backer et al [251] to determine the HEV dynamics of transmission.
Below is a brief explanation about the mathematical model that Backer et al [251] 
applied to study HEV dynamics of transmission follow by the description of HEV 
prevalence in 6 European countries.
6.1 Pig dynamics of transmission modeling study
Field studies, both cross-sectional [192, 252] and longitudinal [206, 253] have 
shown a peak prevalence of HEV RNA in grower pigs, and a non-zero prevalence 
in finishing pigs at slaughter age. A mathematical model determined the prevalence 
pattern by how fast a susceptible animal can be infected (expressed by the 
transmission rate parameter) and how long an infectious animal excretes virus 
(expressed by the average infectious period). The product of these two parameters is 
the reproduction number Rq that represents the number of infections one infectious 
animal can cause in a fully susceptible population. However, the proportion of 
infectious animals at slaughter age depends on all transmission parameters and these 
have been determined in an experimental setting only [86]. Backer et al [251] 
estimated all parameters that determine the transmission dynamics of HEV between 
pigs, from field data confirming that HEV in pigs is endemic.
Briefly, each age group is subdivided in three distinct compartments that consist of 
pigs that are susceptible (S), infectious (I) or recovered (R) [254]. The SIR model 
assumed an endemic equilibrium. The virus is assumed not to be introduced by 
infected weaners or other external sources but the disease can sustain itself in the
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regenerating pig population. This endemic equilibrium can only exist when the virus 
is sufficiently transmissible. The transmissibility is expressed by the reproduction 
number Rq that represents the number of secondary infections caused by one 
infectious animal during its entire infectious period in a fully susceptible and 
infinite population [254]. When this number is smaller than one, the outbreak 
cannot sustain itself and will die out. Therefore, the endemic equilibrium 
assumption also contains the assumption that Ro > 1. This SIR model choice means 
that the latent period was ignored and the infected animals reach immunity after 
infection.
The same model described above was used to study HEV circulation in 6 different 
EU countries (Following section).
6.1.1 Introduction
In 2008, Di Bartolo et al [192] investigated the prevalence of swine HEV in 274 
pigs from six different swine farms of Northern Italy. Viral RNA was tested in 
faeces and HEV RNA was detected in 42% of the samples. All farms tested positive 
for HEV, with a prevalence ranging between 12.8% and 72.5%. All age groups 
tested HEV-positive, although infection was more prevalent in weaners than in the 
fatteners (42.2% vs. 27.0%).
Fernandez-Barredo et al [252] in 2006, tested 146 faecal samples of pigs from 21 
farms. HEV RNA was detected in faecal samples from 34 pigs (23.29%). Pigs in the 
first month of feeding (60%) and weaners presented the higher HEV prevalence 
(41.7%).
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De Deus et al [253] conducted a prospective study, where 19 sows and 45 piglets 
were tested for antibodies to HEV. HEV IgG and IgM antibody was detected in 
76.9% and 15.4% of sows, respectively. HEV RNA was detected in serum at all 
ages analysed with the highest prevalence at 15 weeks of age. HEV was detected in 
faeces and lymph nodes for the first time at 9 weeks of age and peaked at 12 and 15 
weeks of age [253]. This peak coincided with the occurrence of mild to moderate 
focal hepatitis as well as with HEV detection in bile, liver, mesenteric lymph nodes 
and faeces, and with highest IgG and IgM at 15 weeks [253].
Few HEV transmission dynamics studies have been performed so far in pigs. The 
common aim of those studies was evaluating the Rq that represents the number of 
infections that one infectious animal can cause in a fully susceptible population. 
Backer et al [251] estimated transmission parameters to explain the prevalence 
pattern between pigs of different age groups. Briefly, the model describes how soon 
after exposure a susceptible animal can be infected (expressed by the transmission 
rate parameter) and how long an infectious animal excretes virus (expressed by the 
average infectious period). The product of these two parameters is the reproductive 
number Rq that represents the number of infections once that one infectious animal 
can cause in a fully susceptible population.
Satou et al [207], using serology, tried to clarify the mechanisms of transmission 
within farms in order to facilitate an understanding of the age-specific patterns of 
infection, especially just prior to slaughter, estimating that more than 95% of pigs 
are infected before the age of 150 days at which pigs are ready to be slaughtered.
The objective of this study was to evaluate HEV prevalence and HEV transmission 
rates in different pig age groups in different countries. For this work, results from
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pig samples obtained from farms in United Kingdom, Portugal, The Netherlands, 
Italy, Spain and Czech Republic were used. For comparison of HEV transmission 
rates and HEV infectious periods the model developed by Backer et al was used 
[251].
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Materials and methods
6.2 Samplings
The UK data sets (UK2007 and UK2008) consisted of 10 herds sampled by age 
class: weaners (6-9 weeks of age), growers (10-12 weeks of age), fatteners (13-26 
weeks of age) and sows. Pig faecal samples were collected from 10 different pig 
farms in 2007 and 10 pig farms in 2008. Five faecal samples were obtained from 
each age group.
In the Portugal data set, each herd was tested at entering (weaning age of 3 weeks), 
growing (7 weeks) and at departure (slaughtering age of 21 weeks). A total of 200 
pig faeces samples were collected from 5 commercial pig farms (40 samples per 
farm) between December 2010 and February 2011. From each farm a total of 10 
stool samples were obtained from each age group.
The data sets of Italy and The Netherlands comprised of test results of one fattening 
group (21 weeks) of one single farm for The Netherlands (60 samples tested) and 3 
farms for Italy (100 pigs faeces tested, age of the pigs 150 days), whereas the data 
set obtained from Spain comprised of one group of sows in one single farm, and 23 
boars in 5 different farms where faeces were tested for HEV RNA.
Ten pig farms were selected in Czech Republic, faecal samples from 200 pigs of 
different age groups, weaners, growers, fatteners, sows and boars were tested for 
HEV.
In all farms, samples of a minimum of 1 g of faeces were collected aseptically in a 
sterile plastic container and maintained at 4°C (max. 24 h) or frozen at -20°C until 
processing.
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6.3 RNA extraction and RT-PCR procedures
6.3.1 UK 2007 and 2008
RNA extraction and PCR was performed as described by McCreary et al 2008 
[223]. Briefly, 0.2 g of faeces was suspended in 1.8 ml phosphate-buffered saline, 
140 pi of the supernatant was used to extract RNA, using the QIAamp Viral RNA 
mini kit (Qiagen) according to the manufacturer’s instructions. The first round of 
the PCR used 2 pi of RNA. The reaction conditions were 96°C for five minutes, 
then 35 cycles of 96°C for five seconds, 55°C for five seconds and 75°C for 30 
seconds, followed by 72°C for one minute. A second round was carried out with a 
nested PCR, using a fast cycling PCR kit (Qiagen). The primers targeted the ORF-2 
region; 3158N (forward): 5’ GTT(A)ATGCTT(C)TGCATA(T)CATGGCT-3’ and 
3159N (reverse): 5 -AGCCGACGAAATCAATTCTCTC-3’ (Huang et al 2002). 
The products of the amplification process were separated by gel electrophoresis, and 
visualised with UV light [223].
6.3.2 The Netherlands, Portugal, Italy, Spain and Czech Republic
Two hundred and fifty mg of soft faecal contents was suspended in 2.25 ml of 
gentamycin-containing PBS solution and centrifuged at 3.000g for 15 min. Nucleic 
acid was extracted from 140 pi of the supernatant using the QIAamp® viral RNA 
mini kit (QIAGEN), according to manufacturer’s instructions.
The real time RT-PCR was performed using RNA Ultrasense"^^ One-Step 
Quantitative RT-PCR System (Invitrogen) and primers and probe: JHEV-F (5’- 
GGT GGT TTC TGG GGT GAC -3’); JVHEV-R (5’- AGG GGT TGG TTG GAT 
GAA -3’); JHEV-P (Taqman probe) ( 5 -FAM- TGA TTC TCA GCC CTT CGC -  
BHQl-3’). Ten pi of RNA were added to a mix containing buffer RNA Ultrasense
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(Invitrogen) reaction mix (5X), ROX reference dye (50X) and RNA Ultrasense 
enzyme mix.
The real time RT-PCR was carried out at 50°C for 15 min, 95°C for 2 min, and 45 
cycles at 95°C for 10 sec, 55°C for 20 sec and 12°C for 15 sec.
6.3.3 HEV transmission modelling
The model to describe HEV transmission in a pig herd with the same structure has 
been described by Backer et al [251]. Each age group was subdivided into three 
distinct compartments consisting of pigs which are susceptible (S), infectious (I) or 
recovered (R) [21]. For the analyses, it was assumed that each susceptible animal 
can be infected by an infectious animal in its own group or any other group with the 
same probability.
These dynamics are characterized by the average infectious period p and the 
transmission rate parameter P that signifies the number of infections one infectious 
animal can cause per time unit. The product of these two parameters is the 
reproductive number Rq = p*p that expresses the number of infections one 
infectious animal can cause during its entire infectious period in a fully susceptible 
population. When the reproduction number is larger than one unity, Rq > 1, an 
outbreak can grow exponentially. Otherwise, when Ro < 1 the outbreak will die out. 
Our model assumes HEV transmission to be in endemic equilibrium, i.e. the disease 
can sustain itself in the regenerating pig population. For this reason, we have 
omitted the herds with few positive or only negative results, as endemic equilibrium 
could not be justified.
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The UK data sets (UK2007 and UK2008) consisted of herds subdivided into three 
groups: weaners (6-9 weeks of age), growers (10-12 weeks of age) and fatteners 
(13-26 weeks of age). Animals entering the weaning group are assumed to be 
uninfected. In the Portugal data set, the herds were assumed to consist of one group 
that was tested at entering (weaning age of 3 weeks) and at departure (slaughtering 
age of 21 weeks). The test results of the growers (age of 7 weeks) are used as proxy 
for the infection pressure in the entire herd. The data sets of Italy and The 
Netherlands comprise of test results of just one fattening group. For this reason, we 
cannot estimate the transmission rate parameter and the average infectious period 
separately, but only their product, the reproduction number. For both data sets the 
total residence time is assumed to be 20 weeks from weaning to slaughtering age. 
The data set of Spain and the Czech Republic did not include a significant number 
of positive samples. For this reason, we cannot estimate the reproduction number.
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Results
HEV prevalence in different age groups in the UK (2007, 10 farms and 2008, 10 
farms), in Portugal (2011, 5 farms), Italy (2010, 3 farms). The Netherlands (2011, 1 
farm), Czech Republic (2010, 10 farms), Spain (one farm between 2010 and 2011) 
are depicted in Figure 6.1. Briefly, the prevalence of weaners, growers, fatteners 
and sows in UK 2007 was 26%, 44%, 10% and 6% respectively. The prevalence of 
prevalence of weaners, growers, fatteners and sows in UK 2008 was 8%, 22%, 8.8% 
and 2%. The prevalence of weaners, growers, fatteners and sows in Portugal was 
30%, 20%, 30% and 4% respectively. The prevalence of fatteners in Italy was 23%. 
The prevalence of fatteners in The Netherlands was 73%, meaning that 44 out of 60 
pigs were shedding virus in the faeces on the day of the sample collection. The data 
set is similar between the age groups and the prevalence is in line with other studies. 
The prevalence in The Netherlands was relatively higher in the fattening groups 
compared to the other European fattening groups. One hundred and forty-four faecal 
samples from sows collected in Spain and tested by real time RT-PCR were found 
to be HEV negative, while 4.3% of the boars (1 positive out of 23) was positive. In 
none of the weaners and fatteners tested in the Czech Republic, HEV RNA was 
detected. Only one grower out of 32 (3.1%), 5 sows out of 103 (5%) and 1 boar 
(3.5%) out of 28 tested HEV positive by real time RT-PCR.
Table 6.2 shows the transmission rate parameter p, average infectious period p and 
reproductive number Rq of UK 2007 and 2008 and Portugal and the reproductive 
number R q for Italy and The Netherlands. The data set from Spain and Czech 
Republic could not be used in this study since all or almost all animal tested were 
HEV negative and we could not apply the model to those data. Briefly the 
transmission rate parameter p, that means how often a pig gets infected with HEV is
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one pig every 9 days for UK 2007, one pig every 11 days for UK 2008 and one pig 
every 27 for Portugal. The average of the infectious period p that means how long 
an animal stays infected with HEV is 43 day for both UK 2007 and 2008, and 101 
days for Portugal. The reproductive number for all countries where the model has 
been applied was greater than one, indicating that HEV is endemic.
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Figure 6.1 HEV swine prevalence in six different EU countries. HEV RNA
prevalence plotted for six countries and 5 pig age groups. The X axis represents the 
age groups weaners (UK 2007, UK2008 and Portugal), growers (UK 2007, UK 
2008, Portugal and CZ), fatteners (UK 2007, UK 2008, Portugal, The Netherlands 
and Italy), sows (UK 2007, UK 2008, Portugal and CZ) and boar (Spain and CZ). 
The Y represents the HEV prevalence in percentage observed in the different age 
groups and in the different EU countries. Error bars denote the standard error of the 
mean.
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Dataset transmission rate parameter p average infections reproductive number
(dayh period ) i (days)
UK 2007 0.11 (0.070-0.17) 43 (3 3 -5 9 ) 4.7 (3 .6 -6 .4 )
(10 herds)
UK 2008 0.071 (0.041 -0 .13) 43 (2 9 -7 3 ) 3.1 (2 .5 -4 .1 )
(8 herds)
Portugal 0.037 (0.0035-0.16) 101 (70 -403) 3.7 (1 .2 -  14)
(6 herds)
Italy - - 2.0 (1 .4 -3 .6 )
(3 herds)
Netherlands - - 8.4 (5 .3 -15 )
(1 herd)
Spain - - -
Czech Republic - - -
Table 6.2 Transmission rate parameter, average of infectious period and 
reproductive number. The first column describes the dataset (UK 2007, UK 2008, 
Portugal, Italy, The Netherlands, Spain and Czech Republic). The second column 
describes the estimated transmission rate parameter p. The third column shows the 
average infectious period \x and the fourth column describes the reproductive 
number Rq of each country. Median maximum likelihood estimates and 5% - 95% 
credible interval between brackets.
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6.4 Discussion
The HEV transmission dynamics in commercial pig farms in six different European 
countries (UK, Portugal, Italy, The Netherlands, Spain and Czech Republic) was 
studied.
The data collected show the HEV RNA prevalence in weaners ranging from 8% to 
30%. The average HEV prevalence in growers was between 3% and 44%. The 
fatteners prevalence ranged between 8% and 73%. Sow prevalence was similar in 
all countries ranging between 2% and 6%. Boar faeces were tested for HEV only in 
Spain and Czech Republic, and the prevalence was 4.3% and 3.5% respectively. 
The prevalence detected in these 6 European countries shows that HEV is actively 
circulating.
Overall, Figure 6.2 describes HEV RNA prevalence comparing Czech Republic, 
Italy, Portugal, Spain, The Netherlands and UK 2007, 2008. The data set is similar 
between the age groups and the prevalence is of the same order as with other studies 
[223, 252]. The prevalence in the Dutch fattening group was relatively higher 
compared to other European fattening groups [255] possibly due to an outbreak 
during the sampling collection.
Our data are similar to previously published Italian [255] and Spanish [252] data, 
confirming that HEV circulation during time is constant in terms of HEV 
prevalence detected in faeces and HEV is circulating in all farms in all age groups, 
from weaners to fatteners and that pigs close to the slaughter age can still be 
infected with HEV.
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The collected data sets were analyzed using a recently developed model to estimate 
the transmission dynamics of HEV in the different countries.
Satou et al in 2007 [207] using serology, studied HEV transmission in 6 different 
Japanese provinces and found the reproductive number in the order of 4.02 -  5.17, 
which agrees with our estimated reproductive numbers ranging from 2.0 to 8.4. The 
study by Satou et al [207] was the first report on HEV transmission estimated from 
field data. Bouwknegt et al in 2008 performed the first HEV transmission dynamics 
study in an animal experiment [86]. In this study, the Rq was found to be 8.8 and 32 
in two separate experiments, much higher than 1.0, indicating that swine could be 
assumed to be a true reservoir of HEV. The Rq values calculated by us are lower 
than the Rq values calculated by Bouwknegt et al [86]. This is because the 
infectious periods are comparable, but the transmission rate parameters for the 
experimental and field situation are different.
The average infectious period p in UK 2007 data was for instance estimated to be 
43 (33 -  59) days, whereas Bouwknegt et al [86] estimated average infectious 
periods of 49 (17-141) days and 13 (11 -  17) days.
The transmission rate parameter in our study was 0.11 (0.070 -  0.17) day'^ for UK 
2007, meaning that one infectious animal infects another animal every 9 days. The 
transmission rate parameters were 0.071 (0.041-0.13) day'^ for UK 2008 and 0.037 
(0.0035-0.16) day'^ for Portugal 2011. In the animal experiments, Bouwknegt et al 
[86] estimated a higher rate of transmission , i.e. 0.66 (95% Cl: 0.32-1.35) day '\ 
The difference can be explained by the fact that transmission experiment encounter 
animals that are in the early and possibly more infectious stages of virus shedding
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since they have been infected intravenously while in other hand the animals in the 
commercial farms are infected due to faecally-orally transmission.
The transmission rate parameters for the other EU countries could not be estimated 
because either only one age group was tested or the majority of the animals were 
negative and the model was not applicable.
This study gave a genuine contribution to better understand HEV prevalence in six 
different European countries by a mathematical model.
In conclusion, HEV is widely circulating in many pig farms in Europe and can be 
present in fattening pigs, where usually this age group is the one arriving to the 
table. In industrialized regions, although the incidence of clinical hepatitis E in 
humans is low, the seroprevalence is relatively high [86], indicating a high 
proportion of subclinical disease and/or underdiagnosis [124]. It is likely that a 
small proportion of this exposure to HEV results from travel to endemic regions, or 
migration from endemic regions [117], this still leaves a substantial level of 
exposure to HEV that appears to have an indigenous source and might be related to 
the presence of endemic HEV infections in the pig population.
HEV positive fatteners were found in all European countries where the fattening 
group samples were collected. This may pose an important risk for public health 
especially in those countries where pork products are eaten undercooked or raw.
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CHAPTER 7 
Overall discussion
178
This PhD project was funded by the EU FP7 project VITAL (Integrated monitoring 
and control of foodborne virus in European food supply chains).
The EU FP7 project VITAL aimed to develop a system for monitoring viral 
contamination of foodstuff intended for human consumption, by examination of 
selected food chains from production through processing to point of sale.
The main areas investigated during this PhD were:
• Standardization of methods for detection of viruses in different foodstuff 
(for example: soft fruit, fresh vegetables and pork products) via the VITAL ring 
trial.
• Investigation of HEV prevalence in the pork food supply chain in the UK
(slaughterhouse, processing plant and points of sale).
• Development of a cell culture system for HEV.
• Investigation of resistance of HEV to different inactivation strategies.
• Investigation of HEV prevalence and transmission dynamics in pig farms in
Europe.
As part of the VITAL project, standard methods were developed to facilitate 
harmonization of testing between the partner laboratories. In the first instance, this 
harmonization took the form of a Ring Trial where a panel of samples of soft fruit 
and pork products were tested blind by each data gathering laboratory. The aim of 
the ring trial was to assess the efficacy of the SOPs developed during the first year 
of the project, and to assess the capability of the different data gathering laboratories 
in their implementation. Developing and validating SOPs for detection of viruses in
179
foodstuff was needed considering the complexity of these matrices and the number 
of participating laboratories. Furthermore, viruses present in food matrices do not 
replicate in situ, and can therefore be present in small numbers, close to the limit of 
detection of the technique used but still potentially infectious. The nucleic acid 
extraction process is for this reason normally preceded by a concentration step and 
by a lysis step in the case of intracellular viruses. Particular attention had to be paid 
in reducing the concentration of inhibitors in the viral suspensions and extracts, 
such as not to compromise the PCR reactions. Real Time RT-PCR was selected as 
the best detection method for it's sensitivity in detecting viruses and the potential 
use for quantification.
Data on the presence of HEV in abattoirs and points of sale have been published 
previously [121] but a systematic investigation of the pork food chain was needed to 
assess where a risk of HEV contamination can occur. The results obtained in this 
project confirm the presence of HEV at slaughter, and underline the presence of 
HEV in fresh pork products at point of sale. Detection by real time RT-PCR showed 
the presence of HEV nucleic acid but gives no information of the virus viability, 
and therefore the infection transmission risk of PCR-positive food and 
environmental samples. The virus detected at point of sale was not able to cause 
active infection in cell cultures, most likely because it was inactivated during the 
meat preparation process or because the RNA detected by real time RT-PCR was 
not enough to infect the cells. The failure of the infection of the 3D cells culture 
could be also due to a prolonged -20°C storage or multiple freeze/thaw of the UK 
sausages. The sample size was very small however, and it would be valuable to 
follow up these results with a more focussed study involving a greater number of
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samples, with the power to generate significant results in order to inform evidence- 
based risk assessments and codes of practice for the food industry.
Detection by real time RT-PCR shows the presence of nucleic acid and gives no 
information of the virus viability, and therefore the risk, of PCR-positive food and 
environmental samples. The lack of a reliable HEV cell culture system for viral in 
vitro culture inhibits studies into the replication and environmental survival 
properties of HEV and into vaccine research. As HEV has proved difficult to 
propagate in conventional cell monolayer systems, we investigated the 3D cell 
culture [200, 231] for more efficient virus propagation. The results obtained with 
HEV-inoculated 3D cultures have showed detectable HEV RNA in real time RT- 
PCR at all dpi in the first 3D cell culture infection, although a big variation in copy 
number was detected during the data analysis. The wide copy number variation could 
be due to virus internalisation in the cells while it is replicating. In contrast, in the 2D 
cell culture system HEV RNA was not detectable at any dpi. These data illustrate 
that the 3D system is more efficient when compared to the conventional 2D system. 
Other studies have also demonstrated that the 3D cell-culture system is a useful tool 
in the propagation of fastidious viral pathogens such as Norovirus [256]. Although it 
proved very useful during the course of this project, the 3D cell culture system could 
still benefit from further optimisation and standardisation such as be able to run the 
experiments in duplicate to have a better and more efficient overview of the results 
obtained. For example, further studies could examine the reasons why there is a big 
variation in Ct values during the experiment.
The observation of HEV replication in PLC/PRF/5 cells in this system indicates that 
the 3D system may potentially be used as a tool to investigate elements of the
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pathobiology of HEV, which may, in turn, facilitate vaccine research, monitoring of 
HEV contamination and survival through processing to point of sale, and survival in 
other environmental samples and viricidal agents. Once developed, the 3D cell 
culture HEV infection system was used to investigate the infectivity of selected 
foodstuff that tested positive by RT-PCR (three UK sausages and four smoked 
French sausages-figatelli). Only one of the French sausages used as inoculum to 
infect the 3D cells culture system showed HEV replication in the 3D cell culture 
system, suggesting the presence of viable virus in the original sample and providing 
further corroboration of the evidence implicating consumption of these sausages with 
outbreaks of clinical hepatitis E in France. Furthermore, to better confirm that the 
HEV positive supernatant of cells infected with homogenate of HEV positive 
figatelli contained viable virus, the supernatant was tested by EM and a rare image of 
several HEV-like particles was obtained from the supernatant of the infected culture.
The presence of HEV along the pork food chain is a cause for concern, and 
inactivation strategies have been explored to reduce the contact of the consumer 
with viable virus. We investigated inactivation strategies that could either be applied 
during the production and processing phase of the pork meat, or during the 
preparation of foodstuff in the kitchen. Ultraviolet light inactivation (that can be 
applied in processing plants for disinfection) did not appear to be sufficiently 
effective in inactivating HEV under the conditions applied. The use of NaOCl 
caused a complete inactivation effect, but this could have been due to the toxic 
effect of this chemical on cell culture systems. The lesson learned from this is to be 
cautious when directly adopting published work without some initial pilot trial. Heat 
inactivation at 100°C caused viral inactivation, whilst viable virus was still
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detectable after exposure of pig tissue at 56°C for an hour. These data stress the 
importance of thoroughly cooking pork meat and other pig products prior to 
consumption.
Data on HEV prevalence in pigs of different age classes were collected across 
Europe, to study transmission dynamics and develop a model that could help the 
understanding HEV transmission dynamics in the pig population. HEV was 
confirmed to be endemic in pig farms across Europe. A mathematical model (SIR) 
was applied by Backer et al for studying HEV transmission dynamics in the field 
[251]. The results of this model suggested that the circulation of HEV is endemic in 
pig farms in all age groups (weaners, growers, fatteners).
It is now generally accepted that HEV gt 3 is zoonotic and strict safety measures 
should be taken to prevent the increasing of number of people detected with HEV. 
Until now, the only preventative advice can be found on the website of the America 
Ministry of Agriculture and DEFRA. The two websites suggest that pork foodstuff 
should be safe to eat within an internal temperature of 71°C [87]. Both Defra and 
the UK Food Standards Agency have been informed of the data relating to the 
presence of HEV in the UK pork chain and HEV inactivation and guidelines will be 
written and available for the public. For example providing cooking information and 
conditions in all pork foodstuff products could be a way to control HEV infection in 
humans.
In conclusion, the work carried out in this project helped in progressing the 
knowledge on HEV epidemiology and pathogenesis, with particular attention to the 
public health implications related to the consumption of pork meat [197].
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During the course of this PhD a broad range of biological disciplines were 
employed, including, classical and molecular virology, epidemiology, HEV 
transmission dynamics, advanced cell culture techniques, experimental design and 
data interpretation. With this PhD a better figure regarding HEV has been generate 
and it will hopefully help to improve future studies on this virus.
Future plans
Without doubt more studies are still necessary to better understand hepatitis E Virus 
in all its characteristics. I would mainly like to focus on 3 aspects:
1) Hepatitis E virus monitoring in the pork production chain in a larger scale: A
bigger UK study investigating the presence of HEV in pork food stuff is necessary to 
provide more confidence in the data on the prevalence of HEV in pork products in 
the UK. Furthermore, HEV investigation in pork food stuff should be planned also in 
resource limited regions to evaluate and confront which genotype is circulating in the 
humans and in the pig population.
Furthermore, thinking of what are the major unknown areas, principally on the 
veterinary side, but with links through to HEV in humans it is pretty well accepted 
now that the only credible source for the autochthonous, clinical hepatitis E 
infections in developed regions is the pig. Despite our evidence of foodborne virus, a 
significant number of the clinical cases of hepatitis E in the UK and other developed 
regions appear not to have this risk factor, according to retrospective questionnaires, 
indicating that other (i.e. other than direct foodborne) transmission routes from the 
pig to people may be contributing to the clinical (and possibly subclinical) cases. In 
this context the presence and survival (i.e. viability) of HEV in all sorts of
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environmental samples could shed light on some of the possible alternative 
transmission routes. These could include soil and water samples close to pig farms or 
sewage outfalls, slurry lagoons, vegetables and fruits at various points, including the 
water used to irrigate them (in fact one task of the VITAL project was the detection 
of HEV on fruit and vegetables) and shellfish samples. Analysis of these samples by 
the real-time RT-PCR and the 3D culture system could provide quantitative and 
qualitative information on the potential risk pathways, enabling an appropriate 
response to reduce or eliminate the HEV contamination. In addition, (as I already 
mentioned in chapter 5 but it would be good to re-emphasise at this point) this work 
could be supported by an extended examination by means of the 3D culture system, 
of HEV inactivating agents to improve our ability to eliminate HEV contamination at 
appropriate or practicable points in the transmission cycle. It should be remembered 
though that achievement of these objectives would be enhanced by further 
refinement of the 3D cell culture system to improve sample throughput numbers and 
robustness.
2) In  vitro studies
a) The 3D cell culture system, with a little more refinement, should be employed to 
undertake cell infection and replication characteristics, to understand how this virus 
enters the cells and which mechanism is used to replicate in and exit the cells.
b) Since that the 3D cell culture system is an expensive technique and it allows the 
testing of maximum 8 samples for each experiment and it is time consuming (i.e. 28 
days are required to allow the cells to differentiate in the 3D configuration before 
infection). It is still necessary to study different cell lines (i.e. stem cells) that allow
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HEV replication with the same efficiency but reducing the costing, the time and 
more important to have as many sample is possible in each experiment.
3) Diagnostic tools: Real-time RT-PCR, conventional RT-PCR, and ELISA, are the 
only practicable and reliable techniques able to detect HEV and HEV antibodies 
respectively. In developing countries, there is a need for reliable techniques able to 
detect HEV (RNA) faster and without the need of trained personnel and specialized 
laboratories.
a) Evaluate the use of isothermal nucleic acid amplification techniques, especially 
LAMP (loop mediated isothermal amplification). The main characteristics of this 
techniques include high sensitivity and specificity, rapid testing, constant 
temperature operation, easy to perform and interpret and the possibility of combining 
it with portable detection devices. This technique is used with great success for the 
detection of other RNA viruses and it could represent a great advantage for point of 
care screening of HEV in both specialized and non-specialized diagnostic labs, 
hospitals and pork production points.
b) The PCRs currently available are genotype specific or in the case of Jothikumar’s 
real time PCR based on recognising the 4 genotypes but without distinction, so 
sample sequencing is necessary to distinguish which genotype the possible positive 
sample belongs. The need of a multiplex RT-PCR able to detect and discriminate all 
four major genotypes it would be beneficial.
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Appendix A 
A.l Attempted construction of an Interferon knock-out cell line
An Interferon knock out cell line was planned to verify if the IFN-KN cells better 
allowed more efficient HEV replication. Before the IFN-KN constructions the IFN 
production was evaluated by CAT-BLISA to determine if HEV activates the 
interferon cascade in the cells otherwise the IFN-KN was not going to be 
performed.
A. 1.1 Introduction
This work is reported in the thesis although the experiment did not produce useful 
results, the techniques applied should be described.
1) Attempted Production of interferon knockout PLC/PRF/5 cell line to facilitate in- 
vitro replication of HEV.
A.1.1.1 Introduction CAT-ELISA test:
Signal Transducing Activator of Transcription-1 (STATl), regulates the innate 
cellular antiviral response through the transcriptional activation of interferon. 
Activation of the IFN gene and its respective receptor triggers intracellular signaling 
pathway resulting in the activation or expression of distinct but related signaling 
pathways, known as the Janus kinase and signal transducer and activator of 
transcription pathway (JAK-STAT).
These JAK and STAT proteins are known to perform distinct functions in cytokine 
signaling, mediating IFN-dependent biological responses, and inducing an antiviral 
state.
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The simian virus 5 (SV-5) V protein is a specific inhibitor of STATl. The 
construction and use of cells constitutively expressing the SV-5 V protein in a 
lentivirus vector has been established to enable the propagation of viruses that are 
difficult to grow in-vitro [257].
The aim was to construct a STATl knockout (IFN KO) of the hepatocarcinoma cell 
line PLC/PRF5 to increase permissivity/sensitivity to HEV infection and to evaluate 
the cell line in 3 culture systems (2D, 3D and 3D transferred in to 2D). The 
approach was to transfect PLC/PRF5 cells with the SV-5 lentivirus vector to alter 
gene expression in the target cell line PLC/PRF/5 such that they no longer produce 
IFN, therefore allowing a more efficient replication of HEV.
Type I IFN bioactivity of expressed interferon alpha subtypes was determined using 
an Mx/CAT (chloramphenicol acetyltransferase) reporter gene assay developed for 
the quantification of IFN I [258]. This assay was performed to check if HEV 
stimulates IFN activation.
It is known that a large variety of cells can produce IFN-y. In the liver NK cells and 
NKT cells are known to be potent sources of IFN-y [259].
In HBV infection, IFN-y produced in the liver has been shown to recruit 
neutrophils, macrophages, NK cells, and NKT cells. NK, NKT, and CD4+ cells that 
express a glycoprotein that induces cell death. IFN-y also has non cytopathic 
antiviral activity, which is important for HBV and HCV clearance [259]. In patients 
with hepatitis A virus, HBV, and HCV infections the CD8+ cytotoxic cells play the 
major role in the pathogenesis of viral clearance [273]. However, no increase in 
HEV-specific cytokine-producing CD8+ cells was found in patients with hepatitis E 
[259] and the CD3+ cells produced less IFN-y- and TNF-«- in response to activation
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with PMA. Srivastava et al [259] noticed an increased of IFN-y production in 
patients with acute hepatitis E and this may be important in the pathogenesis of liver 
injury in patients with acute hepatitis E virus [259]. Furthermore, the study 
suggested [259] that during the acute phase of hepatitis E infection there is no 
detectable HEV 0RF2-specific immune activation of CD4+ and CD8+ cells in the 
peripheral blood of those patients. However, the increasing of IFN-y production 
with no specific CD8+ cell responses suggests that probably no-specific innate 
mechanisms are involved in the activation of NK or NKT cells and this could play a 
significant role in hepatitis E pathogenesis [259].
A.2 Material and Methods of CAT-ELISA (enzyme immunoassay for the 
quantitative determination of chloramphenicol acetyltransferase (CAT) from E. coli 
in transfected eukaryotic cells) test:
A.2.1 Type I IFN bioassay of recombinant HEV-IFN-a
The assay is based on MDBK cells transfected with a plasmid, containing a human 
MxA promoter driving the expression of the reporter CAT gene.
MDBK-t2 cells maintained under blasticidin selection were seeded into 96-well 
microtitre plates at a density of 2.5x10^ cells/well. Expressed recombinant IFNa 
proteins alongside a serial dilution of recombinant porcine IFN-al (R&D Systems, 
Abingdon, UK) which served as a standard to calculate the activity of the expressed 
protein were added to the cells. Cultures were incubated for 24 hours at 37°C 5% 
C02. Lysates were prepared from the MDBK-t2 cultures and the amount of CAT 
expression induced by recombinant IFNa was quantified by ELISA using an 
enhanced substrate (Roche, Welwyn garden City, UK) [258]. Luminescence was
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read at 405nm using a FLUOstart OPTIMA microplate reader (BMG Labtech, 
Aylesbury, UK).
A 3 Results of the CAT ELISA test:
A.3.1 Biological activity of expressed recombinant protein
To confirm that the expressed recombinant proteins are biologically active, the cell 
supernatants were analyzed using the Type I IFN bioassay. Addition of cell culture 
supernatants to the MDBKt2 reporter cell line alongside quantified commercial 
IFNa standards resulted in no expression of CAT enzyme, indicating no induction 
of the interferon responsive MX promoter. Figure 1 shows the IFN type I 
concentration, measured from each sample (Figure 1).
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Figure 1: IFNa CAT ELISA, IFNU/ml comparison between MocK positive 
control cells, not HEV infected supernatant and HEV positive supernatant. (IFNU = 
type I interferon unit per ml).
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A.4 Discussion of CAT ELISA
This assay demonstrated that HEV positive supernatant was apparently not 
activating INF signalling. For this reason, INF-KO cells were not produced.
Yu et al described the pathogenesis of Hepatitis E Virus and Hepatitis C Virus in 
Chimpanzees. Result of Yu et al [260] study was that the expression of adaptive 
immune-associated genes and immune-specific cell markers, was dramatically 
lower in HEV-infected chimpanzees than in HCV-infected chimpanzees [260].
Kamar et al [261] described three-month pegylated interferon-alpha-2 a therapy for 
chronic hepatitis E virus infection in a haemodialysis patient. Result obtained in the 
study was that after 3-month of Peg-IFN-a-2a treatment. Serum HEV RNA patient 
became negative by third week of Peg-IFN-a-2a therapy [261].
Furthermore, literature describes infection with bovine viral diarrhea virus (BVDV), 
the virus exists in two biotypes, cytopathic and non-cytopathic [262]. BVDV 
cytopathic and non-cytopathic biotypes have specific immune response and only the 
non-cytopathic BVDV virus can establish persistent infection [262]. Non-cytopathic 
BVDV fails to induce interferon type I in cultured bovine macrophages. Non- 
cytopathic BVDV may dispose of a mechanism suppressing a key element of the 
antiviral defence of the innate immune system [262]. Since interferon is also 
important in the activation of the adaptive immune response, suppression of this 
signal may be essential for the establishment of persistent infection and 
immunotolérance [262].
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A possible conclusion from these four studies is that probably INF type I probably 
does not play a significant role in hepatitis E pathogenesis as also Srivastava et al 
[259] suggested.
After this possible explanation, for this study was essential a cell line able to permit 
the virus to replicate efficiently and the production of an INF-KO cell line was not 
beneficial for the study. The KO cell line would have probably been able to support 
HEV replication as the wild type, so there was no point in putting effort in 
producing a KO cell line in PLC/PRF-5.
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